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CHAPTER 1
General introduction
PEDIATRIC HEART DISEASE
The term “pediatric heart disease” covers a range of heart conditions in children. 
Pediatric heart disease can be congenital (i.e., present from birth) or acquired (i.e., 
developed after birth).
Congenital heart defects
Congenital heart defects (CHDs) encompass multiple structural abnormalities of 
the heart and/or intrathoracic great vessels which, by definition, arise before birth 
[1]. Affecting approximately 8 out of 1,000 live births, congenital heart disease is 
the most common birth defect [2-6]. CHDs range from simple (e.g., patent ductus 
arteriosus, atrial and ventricular septal defects) to more complex (e.g., hypoplastic 
left heart syndrome, transposition of the great arteries). Consequently, CHDs are 
asymptomatic or cause a variety of clinical symptoms, such as shortness of breath, 
cyanosis, edema, impaired growth, and decreased exercise capacity. Despite the 
tremendous improvement in preventive care and diagnostic and therapeutic 
interventions (e.g., heart surgery, catheter interventions, or drug therapy) and 
subsequent improvement in survival rates [7], CHDs still are a leading cause of 
infant mortality in the Western world [8-10]. Estimates now indicate that 95% of 
children with a simple CHD, 90% of children with a moderately severe CHD, and 
80% of children with a complex CHD survive into adulthood [11, 12].
Cardiomyopathy
Cardiomyopathies are acquired myocardial disorders (i.e., affecting the heart 
muscle) characterized by structural and functional abnormalities of the heart. 
Cardiomyopathies are approximately 700 times less prevalent than CHDs [13]. 
Dilated cardiomyopathy (DCM) is the most common subtype, accounting for 
approximately 60% of cardiomyopathies [13, 14]. The two other main subtypes are 
restrictive and hypertrophic cardiomyopathy. In DCM, systolic function is impaired 
and the left ventricle is dilated [15]. Estimates of annual incidence rates of DCM 
range from 0.57 [16] to 0.73 [14] per 100,000 children. In the majority of children, 
the cause of DCM is unknown (i.e., “idiopathic”). The cause of DCM can also be 
genetic or multifactorial [17, 18]. There is a wide spectrum of symptoms, ranging 
from asymptomatic to arrhythmias and/or depressed exercise capacity, progressing 
to heart failure or sudden death [19]. The prognosis of DCM is poor: the two-year 
transplant-free survival rate equals approximately 60% [16]. DCM is the leading 
indication for cardiac transplantation worldwide [20-22].
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1PSYCHOSOCIAL PROBLEMS IN PEDIATRIC HEART DISEASE
Considering the somatic symptoms, the single or multiple invasive interventions, 
and medical treatment of CHDs and DCM, a substantial impact on psychosocial 
well-being of affected children and their parents and siblings can be expected. 
Psychosocial well-being is a broad concept which encompasses aspects of health 
on the following domains:
· emotions;
· behavior;
· social functioning;
· cognitive functioning;
· and family functioning.
Psychosocial problems in children with CHDs
Due to tremendous medical advances, as previously mentioned, survival rates 
of children with CHDs have greatly increased over the past decades [7]. Even in 
complex CHDs, adults nowadays outnumber children [6]. CHDs have become a 
chronic condition affecting individuals of all ages rather than a predominantly 
pediatric disease, which has caused a shift from acute treatment to long-term care, 
including the assessment of psychosocial well-being. Therefore, numerous studies 
have examined the psychosocial well-being of children with CHDs. Accumulating 
evidence has shown that children with CHDs are at increased risk of a range of 
psychosocial problems, encompassing multiple domains of their lives [23, 24].
Posttraumatic stress. Children with CHDs undergo medical procedures such as 
cardiac catheterization, heart surgery, thoracic drains, other invasive procedures, 
and magnetic resonance imaging scans. Understandably, this causes significant 
acute stress in most children [25]. In the majority of children, stress decreases 
spontaneously after a medical procedure or hospitalization [26, 27]. Still, 
approximately 12% of children with CHDs show elevated posttraumatic stress 
symptoms 4 to 8 weeks after cardiac surgery [28, 29], such as flashbacks, avoidance 
of reminders of the traumatic event, sleeping problems, and hypervigilance [30, 
31]. If such symptoms are persistent and result in significant distress, a child 
can eventually be diagnosed with a posttraumatic stress disorder (PTSD) [30]. 
Approximately 12% [29] to 29% [32] of children and adolescents with CHDs 
develop a PTSD after cardiac surgery [28]. PTSD is associated with emotional and 
behavioral problems [28], decreased therapy compliance [31, 33], impaired quality 
of life [34, 35], and increased use of health care services [36].
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Emotional and behavioral functioning. Emotional and behavioral problems have 
already been reported in infants with CHDs, who more often show symptoms of 
irritability and lethargy and are more often difficult to soothe [37, 38]. As reported 
by parents and teachers, preschool and school-age children with CHDs are at 
risk of internalizing (i.e., anxiety, depression) and externalizing (i.e., aggression, 
hyperactivity) problems [39-41]. If left untreated, these problems may persist 
into adolescence and adulthood and may convert to psychiatric disorders. As 
to adolescents with CHDs, parents [23, 24, 42] and adolescents themselves [43] 
mainly report internalizing problems such as depression, loneliness, and anxiety 
[44-46].
Social functioning. Though contradictory results have been found [47], in general, 
physical activity levels of children with CHDs seem to be reduced compared to their 
healthy peers [48-50]. This may have a negative impact, as reduced levels of physical 
activity and exercise capacity have been found to be associated with a lower quality 
of life in children with CHDs [48]. Moreover, reduced exercise capacity decreases 
children’s capacity to play and engage in social physical activities, which limits their 
opportunities to develop their social skills [51]. Indeed, in general, children and 
adolescents with CHDs participate less in social activities [52, 53]. Children and 
adolescents [53] with CHD tend to be perceived as more withdrawn, less accepted 
by peers, and too dependent on others [54]. Also, multiple studies have reported 
impaired social functioning and deficits in social cognition [54-60].
Cognitive functioning. Several systematic reviews [24, 55, 56, 61-63] and meta-
analyses [23, 64] have shown that children with CHDs, particularly children with 
hypoplastic left heart syndrome [55, 65, 66], are at increased risk of a range of 
neuropsychological deficits. These deficits may be attributed to pre-operative and 
perioperative factors, such as reduced blood flow and oxygenation of the brain in 
utero and after birth [24, 56, 67] and vital organ support during surgery [24]. More 
extensive reviews of possible causes of neuropsychological deficits in CHD are 
provided by Marino et al. [24], Cassidy et al. [56], and Nattel et al. [67]. Though the 
level of neuropsychological deficits may vary by disease complexity, children with 
CHDs show problems on various domains of executive functioning (i.e., higher-order 
thinking skills) [55, 59, 68-72], attention [73-76], memory [70, 77-80], visuospatial 
skills [70, 79-81], and language [76, 82]. These neuropsychological deficits can 
lead to school problems and have a negative impact on academic achievement 
[83, 84]. Indeed, reduced levels of school performance and academic outcomes 
have been reported for all types of CHD [42, 54, 55, 85-87]. Moreover, rates of 
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1grade repetition [41, 68, 73, 75, 88, 89], use of remedial teaching and academic 
tutoring [70, 73, 75, 90], and attendance of special education [52, 70, 75, 90] are 
higher in children with CHDs than in their healthy peers. Neuropsychological 
and psychosocial difficulties associated with childhood CHD often persist into 
adolescence and adulthood [53, 57, 61, 91-93], and negatively affect educational 
and occupational status, employability, lifelong earnings, insurability, and quality 
of life [94-100].
Family functioning. CHD not only affects the psychosocial well-being of the child 
itself, but also impacts other family members. Parents, mothers in particular, are at 
risk of several psychosocial problems [101, 102]. Increased levels of mental health 
problems have been found, such as depression and anxiety symptoms [102]. Parents 
also experience elevated levels of parenting stress [39] and adjustment problems 
and have a lower quality of life than parents of healthy children [103, 104]. Such 
difficulties are more profound shortly after diagnosis [102, 103, 105] and in the 
months following cardiac surgery [102, 106], but remain present on the long-term 
[103, 107-109]. Moreover, approximately 30% of parents experience symptoms of 
posttraumatic stress or even meet the diagnostic criteria of a posttraumatic stress 
disorder [106, 110]. Families are also confronted with practical problems such as 
financial burdens [102, 111] and CHD negatively impacts parents’ employment due 
to caregiving and hospital appointments [111].
Siblings of chronically ill children are often overlooked [112, 113]. Little research 
has been done specifically into the psychosocial well-being of siblings of children 
with CHDs. However, the available studies have demonstrated that siblings may 
be negatively affected as well [39, 114, 115]. Moreover, according to meta-analyses 
[116, 117], the psychosocial well-being of siblings of chronically ill children is 
negatively affected, although to a lesser extent than the psychosocial well-being of 
the chronically ill child itself. Siblings are especially at risk of internalizing problems 
[117].
Psychosocial problems in children with DCM
It is well-established that adults with heart failure show increased levels of anxiety 
and depression [118, 119]. Moreover, in these adults, anxiety and depression 
predict adverse clinical outcomes such as hospitalization and mortality [118, 120-
125]. Regarding psychosocial well-being in children with DCM, however, very little 
research has been done. The available pediatric studies have mainly focused on 
health-related quality of life, which has been reported to be lower for children 
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with DCM than for their healthy peers [126-129]. Furthermore, two studies 
have shown that physical health-related quality of life predicts mortality and 
cardiac transplantation in children with DCM [127, 129]. Regarding other aspects 
of psychosocial well-being, two studies with limited sample sizes (n ≤ 19) have 
reported conflicting results as to emotional and behavioral problems in children 
with DCM [130, 131]. Considering the scarcity of research in this domain, in the 
current thesis we aimed to examine the level of emotional and behavioral problems 
in children with DCM compared to the general population.
PSYCHOSOCIAL INTERVENTIONS IN PEDIATRIC HEART DISEASE
Considering the psychosocial problems that children with CHDs and their families 
experience, evidence-based psychosocial interventions are needed. It is widely 
acknowledged that a psychosocial intervention for children with CHDs should 
be provided by a multidisciplinary team on a family-centered level [106, 132-
137]. Parental psychosocial functioning is known to be an important mediator in 
children’s well-being [102, 134, 135]. Maternal mental health and worry have even 
appeared to be more important predictors of children’s psychosocial well-being 
than illness severity [134, 138, 139]. Unfortunately, as discussed previously, parents 
of children with CHDs are at risk of psychosocial problems themselves [39, 101-
110]. Therefore, parents should be actively involved in psychosocial interventions.
Furthermore, developmental milestones present more difficulties for children 
with CHDs and their families than for their healthy peers [56, 140]. An important 
milestone is the developmental transition of starting school, considering the 
emotional and cognitive vulnerability and the difficulties concerning exercise 
capacity and social development. Providing intervention to young children has 
several benefits [51]. Difficulties may be easier to solve, because they are likely less 
ingrained and neuroplasticity in young children is high [141]. Also, by intervening 
early, the negative impact on further development can be minimized [141-143]. 
Therefore, the psychosocial intervention should be attuned to young children who 
are in the developmental transition of starting school.
CHIP-interventions to improve psychosocial well-being of young children with 
CHDs and their families
At the start of our project, worldwide, the only scientifically examined psychosocial 
intervention for young children with CHDs who are starting school was the 
Congenital Heart Disease Intervention Program – School (CHIP-School) [134]. 
12
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1CHIP-School targeted parents of young children with CHDs who were entering 
school. The intervention consisted of a one-day multidisciplinary group workshop 
and a follow-up appointment with a clinical psychologist. The theoretical rationale 
of CHIP-School was based on Thompson’s transactional stress and coping model 
[144] which states that the effect of illness factors on a child’s psychosocial 
well-being is mediated by familial, especially maternal, coping and appraisal. By 
strengthening parental mental health and parenting skills through CHIP-School, 
it was aimed to indirectly increase the emotional resilience of children with CHDs. 
CHIP-School significantly improved maternal mental health, perceived strain on 
the family, and school absence of the child. However, no significant improvements 
were found as to child psychosocial well-being.
In this thesis, we aimed to improve the effectiveness of CHIP-School by extending 
and innovating the program. As CHIP-School only consisted of a parent module, we 
expected that the obtained results could be improved by including a child module, 
thereby also aiming to directly improve children’s resilience and psychosocial well-
being. For this reason, we extended the CHIP-School program by adding a specific 
child module for children with CHDs and their siblings, thereby creating “CHIP-
Family”.
We integrated elements of the cognitive behavioral Fun FRIENDS protocol [145] 
into the child module. Fun FRIENDS was originally developed for 4-year-old to 
7-year-old children with anxiety disorders. The Fun FRIENDS program aims to 
increase emotional resilience, social-emotional skills, and coping skills, and to 
decrease emotional and behavioral problems; especially anxiety and depressive 
symptoms. The effectiveness of Fun FRIENDS has been shown in two large 
preventive, classroom-based studies [146, 147]. In clinical samples, the program 
has been insufficiently examined, although three small studies show promising 
results [148-150]. In this thesis, we also conducted a clinical open trial to examine 
whether anxiety problems in young children with anxiety disorders improved after 
completing the Fun FRIENDS program.
EMDR treatment for medically-related posttraumatic stress symptoms
Apart from a psychosocial intervention to improve the overall psychosocial well-
being of children with CHDs, an effective intervention specifically targeting 
posttraumatic stress symptoms and PTSD in children with pediatric heart disease is 
needed. Eye movement desensitization and reprocessing (EMDR) offers promising 
results [151]. The EMDR treatment method is based on bilateral stimulation whilst 
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processing memories of traumatic experiences [151]. Advantages of EMDR are 
that it does not require detailed descriptions of the traumatic event, extended 
exposure, or homework [152]. Moreover, it appears to be an efficient treatment 
method requiring relatively little time and costs [153, 154]. In adults, EMDR is 
well-established as an effective treatment for posttraumatic stress symptoms 
and PTSD [155-157]. In child populations with trauma’s caused by abuse, violence, 
or natural disasters, EMDR has shown promising results [158, 159]. In children 
with CHDs, however, EMDR has not been examined yet [28], which is alarming 
considering the high previously reported prevalence rates of posttraumatic stress 
symptoms and PTSD [28, 29, 32]. For this reason, in this thesis, we aimed to examine 
the effectiveness of EMDR in treating medically-related posttraumatic stress 
symptoms.
AIMS AND OUTLINE OF THIS THESIS
In Chapter 2, we describe the results of a small open trial in which we provided 
the cognitive behavioral Fun FRIENDS program to a clinical sample of young 
children with anxiety disorders. Our aim was to examine whether these children 
showed less anxiety after participating in Fun FRIENDS. As stated, we integrated 
components of the Fun FRIENDS protocol into the child module of the psychosocial 
CHIP-Family program for young children with CHDs and their families. In Chapter 
3, we elaborate on the content of CHIP-Family and describe the rationale and 
design of our randomized controlled trial into the effectiveness of the CHIP-
Family program. Subsequently, in Chapter 4, we present the results regarding the 
effectiveness of CHIP-Family. We aimed to investigate the effect of CHIP-Family 
on the psychosocial well-being of young children with CHDs and their families.
In Chapter 5, we study emotional and behavioral problems in children with DCM. 
More specifically, we studied the frequency of emotional and behavioral problems 
in children with DCM compared to normative data. Furthermore, we investigated 
whether anxiety and depressive problems in children with DCM predicted cardiac 
transplantation or mortality.
In Chapter 6, we describe the results of a randomized controlled trial into the 
effectiveness of EMDR in children with medically-related subthreshold (i.e. 
subclinical) PTSD. We examined whether EMDR was effective in treating 
posttraumatic stress symptoms, depression, anxiety, and sleep problems in children 
14
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1who had been hospitalized because of a CHD and in children had been admitted to 
an emergency department because of acute illness or injury.
Finally, in Chapter 7, we discuss our findings, clinical implications, remaining 
questions, and propose directions for future research.
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Cognitive behavioral therapy for anxiety 
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ABSTRACT
Anxiety disorders in young children are highly prevalent and increase the risk of 
social, school, and familial problems, and also of psychiatric disorders in adolescence 
and adulthood. Nevertheless, effective interventions for this age group are 
lacking. One of the few available interventions is the Fun FRIENDS program. We 
examined whether young children with anxiety disorders showed less anxiety after 
participating in Fun FRIENDS. Twenty-eight clinically anxious children (4-8 years 
old) participated in the cognitive behavioral Fun FRIENDS program. The program 
consists of 12 weekly 1.5-hour sessions and was provided in groups of 3 to 5 
children. At pre-intervention and direct post-intervention, parents completed the 
Anxiety Disorders Interview Schedule for Children and Child Behavior Checklist. 
Clinically and statistically significant decreases were found in number of anxiety 
disorders, symptom interference, emotional and behavioral problems, internalizing 
problems, and anxiety problems. The decrease in anxious/depressed problems and 
externalizing problems was not significant. Furthermore, higher pre-intervention 
anxiety levels predicted more treatment progress, whereas sex and age did not. The 
Dutch version of Fun FRIENDS is promising in treating anxiety disorders in young 
children. Randomized controlled trials are needed to draw definite conclusions on 
the effectiveness of Fun FRIENDS in a clinical setting.
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2INTRODUCTION
Scientific interest in anxiety disorders in young children has increased in the past 
decade. Anxiety symptoms and diagnostic categories in young children resemble 
those in older children [1]. In young children, prevalence rates of anxiety disorders 
ranging from 9.4% [2] up to 22.2% [3] have been found. Unfortunately, anxiety 
disorders are often unrecognized in young children, because anxious children 
are considered to be shy, cooperative, and compliant [4]. If left unnoticed and 
untreated, this can have harmful consequences as early-onset anxiety disorders can 
become chronic [5, 6]. Research also shows that a diagnosis of an anxiety disorder 
in early childhood predicts anxiety and depression in adolescence and significantly 
increases the risk of having psychiatric disorders in adolescence and adulthood [5, 
7-12]. Moreover, childhood anxiety disorders are associated with social [13], school 
[13, 14], and familial [15] problems. Anxiety disorders have a significant impact 
on societal costs due to poorer academic outcomes, financial dependence, and 
unemployment in adulthood [16, 17].
Considering these alarming outcomes, early intervention is urgently needed. 
Providing intervention at a young age has important advantages. First, anxious 
thoughts and behaviors may be easier to modify in younger children, as anxiety 
symptoms are likely to be less ingrained and neuroplasticity in young children 
is high [18]. Second, intervening early in the lifespan can minimize the impact of 
anxiety symptoms on the development and future of the child [18-21].
Despite the serious need for an evidence-based intervention for anxious young 
children, only a few studies have been conducted into interventions for this age 
group [21-23; for a complete overview, see 24]. An intervention that has been 
developed for 4- to 7-year-old children with anxiety disorders is the cognitive 
behavioral Fun FRIENDS program [25, 26]. The Fun FRIENDS program is an 
adaptation for young children of the evidence-based FRIENDS for Life program 
[27], which was based on the Coping Cat program [28]. The Fun FRIENDS program 
aims to increase children’s emotional resilience, social-emotional skills, coping skills 
and to reduce emotional and behavioral problems. The program consists of 12 
group sessions and is provided in a play-based manner, based on an experiential 
learning approach.
Until now, only two studies have examined the effectiveness of Fun FRIENDS 
delivered as a preventive program [22, 29]. In addition, three studies have studied 
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the outcomes of Fun FRIENDS delivered as a treatment program for young children 
with clinical internalizing symptoms or anxiety disorders [30-32].
Both prevention studies were randomized controlled trials in which Fun FRIENDS 
was delivered in a universal, classroom-based manner by psychology students 
or classroom teachers. In the first prevention study (N = 263, mean age = 4.56, 
SD = 0.51) [29], both the Fun FRIENDS intervention group and the waitlist control 
group showed comparable improvements on parent reports of anxiety, behavioral 
inhibition, and social-emotional strength. Regarding teacher reports, however, the 
Fun FRIENDS intervention group showed greater improvements than the waitlist 
control group as to behavioral inhibition and social-emotional strength, especially 
for girls. For ethical reasons, 12-month follow-up assessments were only completed 
for the intervention group. From pre-intervention to 12-month follow-up, the Fun 
FRIENDS intervention group showed improvements in anxiety, social-emotional 
strength, and, for girls, behavioral inhibition. In the second prevention study 
(N = 488, age range 4-7 years, mean age = 5.42, SD = 0.67) [22], children who had 
participated in Fun FRIENDS showed greater improvements as to behavioral and 
emotional strength and behavioral inhibition than children from the active control 
group (cognitive behavioral “You Can Do It” program [33]) and waitlist control 
group.
As to Fun FRIENDS as a treatment program, the first study consisted of a pilot 
study (N  =  6, age range 4-7 years). This study suggested that Fun FRIENDS 
was effective in reducing anxiety of young children referred to a mental health 
service for anxiety symptoms [32]. The second treatment study was an open trial 
including young children (N = 31, age range 5-7, mean age = 5.68, SD = 0.54) who 
were diagnosed with one or more anxiety disorders [31]. From pre-intervention to 
immediate post-intervention, significant improvements as to anxiety symptoms, 
shyness, number of anxiety disorder diagnoses, and resilience were found. These 
results were maintained at 12-month follow-up. The third treatment study also 
was an open trial targeting young children (N = 178, age range 5-7, mean age = 5.27, 
SD = 0.93) with internalizing symptoms [30]. Their parents simultaneously received 
a resilience building program [34, 35]. For child outcomes, from pre-intervention 
to immediate post-intervention, significant reductions in internalizing symptoms 
and significant improvements in resilience were found.
Considering these promising outcomes, the Fun FRIENDS protocol was translated 
and adjusted for the Netherlands [36, 37]. The aim of the current study is to examine 
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2whether young children with anxiety disorders show fewer anxiety symptoms 
after participating in the Dutch version of the Fun FRIENDS program, and to 
identify predictors of treatment progress. We thereby aim to add to the limited 
available knowledge concerning evidence-based treatment for young children with 
anxiety disorders and to contribute to the cross-cultural knowledge regarding this 
innovative cognitive behavioral program. We hypothesized that anxiety symptoms 
and the number of anxiety diagnoses would decrease after participating in Fun 
FRIENDS.
METHODS
Participants
Children who were 4-8 years old and met the Diagnostic and Statistical Manual of 
Mental Disorders (4th ed.; DSM-IV) [38] diagnostic criteria for at least one anxiety 
disorder were eligible to participate in the Fun FRIENDS program. DSM-IV anxiety 
disorder criteria were assessed based on the parent version of the Anxiety Disorders 
Interview Schedule for Children (ADIS-C) [39]. All participants were referred to the 
Department of Child and Adolescent Psychiatry of the Erasmus Medical Center - 
Sophia Children’s Hospital in Rotterdam between December 2008 and November 
2013. Children with an IQ below 70 or a diagnosis of a posttraumatic stress disorder 
without a comorbid anxiety disorder were excluded from participation. In total, 
28 children participated in the Fun FRIENDS program. Participant characteristics 
can be found in Table 1. As parental education is associated with persistence and 
severity of mental disorders [40], we have presented maternal education levels. 
Participants’ primary anxiety disorder diagnoses are shown in Table 2 and all 
anxiety disorder diagnoses are shown in Table 3.
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Table 1 Participant characteristics.
N (%) or M (SD)
Characteristic (N=28)
Total sample 
(N=28)
ADIS-C completers 
(N=22)
CBCL completers 
(N=15)
Sex
Male 57.1% 13 (59.1%) 7 (46.7%)
Female 42.9% 9 (40.9%) 8 (53.3%)
Age
Years 6.6 (1.1) 6.5 (1.0) 6.7 (1.0)
Nationality
Dutch 20 (71.4%) 15 (68.2%) 13 (86.7%)
Unknown 8 (28.6%) 7 (31.8%) 2 (13.3%)
Total IQ 96.8 (15.7) 97.1 (17.6) 95.2 (9.6)
Maternal education level*
Low 5 (17.9%) 5 (22.7%) 3 (20.0%)
Average 7 (25.0%) 4 (18.2%) 5 (33.3%)
High 6 (21.4%) 6 (27.3%) 4 (26.7%)
Unknown 10 (35.7%) 7 (31.8%) 3 (20.0%)
*Conform Dutch classification system [41].
Table 2 Participants’ primary anxiety disorder diagnoses based on the ADIS-C at pre-
intervention and post-intervention.
Primary anxiety disorder diagnosis Pre-intervention, N (%) Post-intervention, N (%)
Social anxiety disorder 8 (28.57%) 4 (14.29%)
Specific phobia 6 (21.43%) 4 (14.29%)
Separation anxiety disorder 4 (14.29%) 3 (10.71%)
Generalized anxiety disorder 3 (10.71%) 1 (3.57%)
Selective mutism 1 (3.57%) 2 (7.14%)
Obsessive compulsive disorder 2 (7.15%) 1 (3.57%)
No anxiety disorder 0 (0.00%) 11 (39.3%)
Unknown 4 (14.29%) 2 (7.14%)
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intervention.
Anxiety disorder diagnosis Pre-intervention, N Post-intervention, N
Social anxiety disorder 15 10
Specific phobia 10 7
Separation anxiety disorder 6 4
Generalized anxiety disorder 8 2
Selective mutism 4 2
Obsessive compulsive disorder 4 1
No anxiety disorder 0 11
Unknown 4 2
Procedure
This retrospective open trial study was conducted using a one-group pretest-
posttest design. All parents were asked to complete assessments as part of the 
routine intake procedure (pre-intervention) and directly after the Fun FRIENDS 
intervention (post-intervention). As the Fun FRIENDS program was provided within 
the framework of regular treatment, assessments were completed as usual, and 
data were analyzed retrospectively, this study was not subject to the Dutch Medical 
Research Involving Human Subjects Act. The local research ethics committee was 
informed about the study and confirmed that full ethical approval of the study 
was not required. Participants were informed that collected data would be used 
anonymously in scientific research and that they could always opt out without any 
consequences for the treatment of their child.
Treatment
All children participated in the Dutch version of the Fun FRIENDS program [25, 42]. 
The program was delivered to seven consecutive treatment groups. Five groups 
consisted of 4 children, one group of 5 children, and one group of 3 children (n = 28). 
The children received 12 weekly 1.5-hour sessions. On average, the program was 
delivered over a time period of 3.5 months. All sessions were led by two licensed, 
experienced psychologists. One of them received training from the developer of 
the Fun FRIENDS program. At each session, a master’s student in psychology was 
present to make observations, take notes, and assist the psychologists. The content 
of each session is described in Table 4. During the last 15 minutes of each session, 
the master’s student observed the children during free play while in a separate 
room, the psychologists gave the group of parents further information about the 
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home assignments and the exercises performed during the session. The last child 
session was a booster session in which parents were present and actively involved. 
All families received a Fun FRIENDS workbook [43, 44], which contained home 
assignments and additional information about the program.
Measures
Anxiety Disorders Interview Schedule for Children (ADIS-C)
The ADIS-C [39, 45] is a semi-structured interview that was used to assess the 
presence and severity of DSM-IV anxiety disorders in children and adolescents. 
The ADIS-C was conducted with parents to assess the following DSM-IV diagnoses: 
selective mutism, generalized anxiety disorder, social phobia, specific phobia, 
separation anxiety disorder, panic disorder, agoraphobia, obsessive-compulsive 
disorder, and posttraumatic stress disorder. For each diagnosis confirmed based on 
the interview, the parent was asked to rate to what extent the symptoms interfered 
with the child’s daily life on a 9-point scale (i.e., 0-8, higher scores indicating a higher 
level of interference). Subsequently, the interviewer rated the level of interference 
on the same 9-point scale, yielding the Clinician Severity Rating (CSR). A CSR of 4 
or higher indicates that a DSM-IV diagnosis can be confirmed and assigned. Strong 
interrater reliability, retest reliability, and concurrent validity have been found for 
the ADIS-C C [39, 46]. Pre-intervention and post-intervention interviews were 
conducted by a different interviewer. All ADIS-C interviews were administered by 
trained psychologists or trained master’s students in psychology. To ensure that 
all interviewers conducted reliable and valid scoring, the master’s students were 
thoroughly trained by observing live and videotaped interviews. Moreover, they 
received regular supervision regarding their ADIS-C interviews by their supervising 
experienced clinical psychologist or psychiatrist and all ADIS-C interviews were 
reviewed and discussed in multidisciplinary meetings.
Child Behavior Checklist (CBCL)
The CBCL 1½-5 (100 items; for 5-year-olds) [47] and CBCL/6-18 (120 items; for 6- 
to 8-year-olds) [47] were completed by parents to assess emotional and behavioral 
problems in children before and after the intervention. Response categories 
range from 0 to 2, higher scores indicating more problems. The CBCL yields two 
broadband scales of externalizing and internalizing behaviors and an overall total 
score. Furthermore, both the CBCL 1½-5 and the CBCL/6-18 encompass the 
Anxious/Depressed syndrome scale and the DSM-oriented Anxiety Problems 
scale. Adequate psychometric properties have been found [48].
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First, differences in baseline characteristics between children with complete 
assessments and children with incomplete assessments were examined using 
independent samples t-tests for continuous data and Chi-squared tests or Fisher’s 
exact tests for categorical data.
Second, for the ADIS-C, a Wilcoxon signed-rank test was computed to assess 
the difference between the number of anxiety disorders at pre-intervention and 
post-intervention. The difference between average pre-intervention and post-
intervention interference scores rated by parents was examined through a paired 
samples t-test. Unfortunately, too many CSRs were missing at pre-intervention 
and post-intervention to complete statistically warranted reliable analyses on 
these data. CSRs were missing due to the retrospective design of the study. As 
all assessments were conducted as part of regular clinical care, data was not 
systematically entered into a scientific database. Moreover, changes in digital 
medical file systems caused logistical difficulties in retrieving a sufficient number 
of CSRs.
Third, CBCL scores were standardized using t-scores as two different versions were 
used (i.e., CBCL 1½-5 and CBCL/6-18). Differences between pre-intervention and 
post-intervention CBCL scores were examined using paired samples t-tests.
Finally, it was examined whether sex, age, or pre-intervention anxiety scores 
independently predicted treatment progress. Treatment progress was calculated 
by subtracting post-intervention anxiety problem scores on the CBCL from pre-
intervention anxiety problem scores (primary outcome). To examine whether 
children’s sex predicted treatment progress, an independent samples t-test was 
conducted. To examine whether children’s age at the start of participation in the 
Fun FRIENDS program predicted treatment progress, a simple linear regression 
analysis was performed. Another simple linear regression analysis was performed 
to examine whether pre-intervention scores on the anxiety problems subscale of 
the CBCL predicted treatment progress.
37
Open trial of Fun FRIENDS
Table 4 Outline of Fun FRIENDS sessions
Session Content of session
Session 1 · Introduction to the group.
· Development of a positive sense of identity.
· Social skills promotion, ‘being brave’ (e.g., using a brave voice, making 
eye contact, smiling).
· Acceptance of differences and similarities between people.
Session 2 F: Feelings
· Identification and recognition of various emotions.
· Understanding feelings in self and others.
· Empathy building, awareness of own emotional responses, and 
emotion regulation.
Session 3 F: Feelings (continued)
· Coping with emotions; helpful (thumbs up) and unhelpful (thumbs 
down) behaviors to regulate feelings.
· Children think of ways to help others when they experience certain 
emotions.
· The link between emotions and behavior is discussed.
Session 4 R: Remember to relax
· Identification of physiological arousal (‘body clues’) related to anxiety.
· Teaching of relaxation strategies to feel more calm and brave (e.g., 
diaphragmatic breathing, progressive muscle relaxation, visualization).
Session 5 I: I can try my best!
· Introduction of cognitive components of the program.
· Identification and awareness of inner thoughts (self-talk), unhelpful 
(red) and helpful (green) thoughts. To explain red and green thoughts, 
the analogy of a traffic light is used. When we have happy green 
thoughts, we want to go! When we have unhappy red thoughts, we 
want to stop!
Session 6 I: I can try my best! (continued)
· Challenging ‘red’ thoughts and changing unhelpful ‘red’ thoughts into 
helpful ‘green’ thoughts.
Session 7 E: Encourage
· The concept of coping step plans is explained. Children are taught 
how to try new things by breaking tasks down into small steps (graded 
exposure anxiety hierarchies). Step plans are also explained to parents.
· Focus on friendship skills (e.g., sharing, helping, smiling).
Session 8 N: Nurture
· The idea and importance of people who help us achieve our goals 
(support teams) in different environments is discussed.
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Session Content of session
Session 9 D: Don’t forget to be brave
· Support teams continued.
· Planning for difficult (future) situations.
Session 10 S: Stay smiling
· Party session: celebration of success in completing the program. 
Children dress up as their favorite brave person and receive their Fun 
FRIENDS certificate. Parents are also present.
Session 11 & 12 Booster sessions: review learnt strategies and prepare for future 
challenges.
RESULTS
Mean scores are presented in Table 5. One child missed 6 out of 12 sessions due 
to logistical reasons, but was included in the analyses according to the intention-
to-treat principle. For two children, both the ADIS-C and the CBCL were not fully 
completed. Therefore, these children were excluded from all analyses.
Table 5 Mean scores for outcome variables and statistical comparisons between pre-
intervention and post-intervention.
Mean (SD)
Measure Pre-intervention Post-intervention p-value Effect size
ADIS-C (N = 22)
Number of anxiety disorders a 2.09 (1.07) 1.00 (1.16) .002 0.65c
Interference score rated by 
parents b
1.22 (0.77) 0.63 (0.78) .003 0.76d
CBCL t-scores‡ (N = 15)
Total problem score b 60.20 (9.70) 56.60 (11.25) .032 0.34d
Internalizing problems b 62.27 (11.70) 58.87 (11.14) .036 0.30d
Externalizing problems b 54.07 (9.79) 52.47 (10.98) .321 0.15d
Anxiety problems b 66.13 (8.99) 62.07 (7.97) .048 0.48d
Anxious/depressed b 64.60 (9.85) 61.33 (8.20) .094 0.36d
‡ Mother-report. 
a. Wilcoxon signed-rank test. 
b. Paired samples t-test. 
c. r = z / √N 
d. Cohen’s d.
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ADIS-C
Parents of 22 children completed the ADIS-C at both pre-intervention and post-
intervention. Children with complete ADIS-C assessments did not differ from 
children with incomplete ADIS-C assessments in terms of age, sex, total IQ, and 
maternal education level (all p ≥ .08).
The mean number of anxiety disorders decreased significantly from pre-
intervention (M  =  2.09, SD  =  1.07) to post-intervention (M  =  1.00, SD  =  1.16), 
z = -3.04, p = .002. The effect size was r = 0.65, indicating a large to very large effect 
[49]. The average interference score rated by parents also significantly decreased 
from pre-intervention (M  =  1.22, SD  =  0.77) to post-intervention (M  =  0.63, 
SD = 0.78), t(22) = 3.34, p = .003. The effect size was d = 0.76, indicating a large 
effect [49].
CBCL
Unfortunately, the number of CBCLs completed by fathers was too small to analyze. 
Therefore, only CBCL data reported by mothers was analyzed. Mothers of 15 
children completed the CBCL at both pre- and post-intervention. Children with 
complete CBCL assessments did not differ from children with incomplete CBCL 
assessments in terms of age, sex, total IQ, and maternal education level (all p > .27).
A significant decrease in CBCL total problem scores was found, t(14)  =  2.38, 
p = .032, d = 0.34, which indicates that overall emotional and behavioral problems 
decreased from pre-intervention to post-intervention. A significant decrease was 
also found for internalizing problems, t(14) = 2.32, p = .036, d = 0.30, and anxiety 
problems, t(14) = 2.17, p = .048, d = 0.48. The effect sizes indicate small to medium 
effects [49]. The observed decrease in scores of the anxious/depressed subscale 
was not significant, p = .094, d = 0.36. The decrease in externalizing problems was 
also not significant, p = .321, d = 0.15.
Predictors of treatment progress
Treatment progress was defined as the difference between pre-intervention and 
post-intervention CBCL anxiety problems score (primary outcome). A positive 
score indicates treatment progress (i.e., a lower anxiety problems score at post-
intervention than at pre-intervention).
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Treatment progress of boys (mean Δ = 3.00, SD = 7.94) and girls (mean Δ = 5.00, 
SD = 7.05) did not significantly differ, p = .614, d = 0.27, indicating that sex does not 
predict treatment progress. Moreover, children’s age at start of participation in Fun 
FRIENDS did not significantly predict treatment progress, p = .73.
Anxiety problems at pre-intervention
The level of pre-intervention anxiety problems did significantly predict treatment 
progress, β  =  .537, F(1)  =  5.27, p  =  .04, R2  =  .29. This indicates that a higher 
pre-intervention anxiety problems score predicts more treatment progress 
(demonstrated by a larger positive difference between pre-intervention and post-
intervention anxiety problems).
DISCUSSION
The current study examined whether anxiety in young children with anxiety 
disorders decreases after participating in the cognitive behavioral Fun FRIENDS 
program. As expected, we found significant decreases in the number of anxiety 
disorder diagnoses and symptom interference with young children’s daily lives as 
reported by parents. Moreover, we found significant decreases in emotional and 
behavioral problems, internalizing problems, and anxiety problems. These results 
suggest that the Dutch version of the Fun FRIENDS program is promising in treating 
anxiety disorders in young children in a clinical setting, which is in line with previous 
findings [31, 32]. Children with higher levels of pre-intervention anxiety problems 
seemed to benefit most from the Fun FRIENDS program, which is also in line with 
previous findings [31]. Sex and age did not predict treatment progress.
The decrease in anxious/depressed symptoms, however, was not significant. This 
might be surprising, as the Fun FRIENDS program specifically targets issues such 
as anxiety and depression [26]. Moreover, previous studies have shown that the 
FRIENDS for Life program (for children aged 8-12 years), on which the Fun FRIENDS 
program was based, is effective in reducing both anxiety and depressive symptoms 
(e.g., 50-52]. The difference in results may be explained by the used outcome 
measures. To measure depressive symptoms, previous studies used the Children’s 
Depression Inventory (CDI) [53] and the Revised Child Anxiety and Depression 
Scale (RCADS) [54], whereas the current study used the CBCL. Moreover, the 
children who participated in the current study received treatment because they 
were diagnosed with anxiety disorders. Based on pre-intervention ADIS-C scores, 
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no children were diagnosed with a depressive disorder at baseline. It should also 
be noted that, considering the trend towards significance, the decrease in anxious/
depressive symptoms may have reached the level of significance if the sample size 
had been larger.
It is not surprising that externalizing problems did not significantly decrease after 
participating in the Fun FRIENDS program because Fun FRIENDS mainly targets 
internalizing problems [26]. In addition, overall, participants’ pre-intervention 
externalizing problem scores were relatively low and not the main target of 
treatment. Therefore, a significant decrease in externalizing problems might not 
have been likely.
This study has several strengths. First, it adds to the limited evidence-based 
knowledge body concerning treatment for young children with clinical levels 
of anxiety. Second, this is the first European study examining the Fun FRIENDS 
program. It is important to cross-validate findings across countries using the 
same validated assessment instruments and protocols. This enables us to draw 
more robust conclusions as to outcomes after participating in the Fun FRIENDS 
program. Third, the senior psychologist providing the Fun FRIENDS program was 
trained by the program developer; and, fourth, treatment was fully manualized 
and standardized.
However, although promising, the results of the current study should be interpreted 
with caution as the study did not include a control group, which limits the internal 
validity [55]. In this study, internal validity refers to whether the decline in symptoms 
can be attributed to participating in the Fun FRIENDS program. Without the use of 
a control group, it is not possible to draw definite conclusions as to the effectiveness 
of an intervention, because other influences on the outcome cannot be ruled out. 
For example, the decline in symptoms may also be influenced by maturation (i.e., 
naturally occurring changes over time) or regression to the mean (i.e., the tendency 
to score less extremely on a posttest assessment than on a pretest assessment). In 
the future, randomized controlled trials with larger groups of participants should 
be conducted in order to draw definite conclusions as to the effectiveness of the 
Fun FRIENDS program. It would also be useful to include a long term follow-up 
assessment to examine whether the obtained results remain over a longer period 
of time.
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research should focus on which elements of the Fun FRIENDS program are most 
useful. Future research could also consider the format in which the intervention 
is delivered. A randomized controlled trial has shown that the FRIENDS for Life 
program [27] (translated by [42]) is equally effective in diminishing anxiety through 
individual treatment as through group treatment [56]. Whether this also holds 
true for the Fun FRIENDS program should be examined in future research. The 
psychologists, parents, and children involved in the current study considered the 
group format to be beneficial. The group format seemed to enable children to learn 
from each other and to encourage each other in learning the cognitive behavioral 
techniques. However, when delivering an intervention in a group format, children 
may drop out due to different issues (e.g., change in parents’ working schedule), 
which may also have a negative influence on the rest of the group. For this reason, 
prior to participating in the program, we asked parents to fully commit to the 
treatment.
In conclusion, the Fun FRIENDS program is one of the very few cognitive behavioral 
treatment programs for young children with anxiety disorders. The current study 
shows promising results as to the outcomes after participating in the Fun FRIENDS 
program. To determine the effectiveness of the program in a clinical setting, 
randomized controlled trials with longer follow-up periods are needed.
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ABSTRACT
Background. Children with congenital heart disease (CHD) are at increased risk 
for behavioral, emotional, and cognitive problems. They often have reduced 
exercise capacity and participate less in sports, which is associated with a lower 
quality of life. Starting school may present more challenges for children with CHD 
and their families than for families with healthy children. Moreover, parents of 
children with CHD are at risk for psychosocial problems. Therefore, a family-
centered psychosocial intervention for children with CHD when starting school is 
needed. Until now, the ‘Congenital Heart Disease Intervention Program (CHIP) – 
School’ is the only evidence-based intervention in this field. However, CHIP-School 
targeted parents only and resulted in non-significant, though positive, effects as 
to child psychosocial wellbeing. Hence, we expanded CHIP by adding a specific 
child module and including siblings, creating the CHIP-Family intervention. The 
CHIP-Family study aims to (1) test the effects of CHIP-Family on parental mental 
health and psychosocial wellbeing of CHD-children and to (2) identify baseline 
psychosocial and medical predictors for the effectiveness of CHIP-Family.
Methods. We will conduct a single-blinded randomized controlled trial comparing 
the effects of CHIP-Family with care as usual (no psychosocial intervention). 
Children with CHD (4-7 years old) who are starting or attending kindergarten 
or primary school (first or second year) at the time of first assessment and their 
families are eligible. CHIP-Family consists of a separate one-day workshop for 
parents and children. The child workshop consists of psychological exercises based 
on the evidence-based cognitive behavioral therapy Fun FRIENDS protocol and 
sports exercises. The parent workshop focuses on problem prevention therapy, 
psychoeducation, general parenting skills, skills specific to parenting a child with 
CHD, and medical issues. Approximately four weeks after the workshop, parents 
receive an individual follow-up session. The baseline (T1) and follow-up assessment 
(T2 = 6 months after T1) consist of online questionnaires filled out by the child, 
parents, and teacher (T2 only). Primary outcome measures are the CBCL for 
children and the SCL-90-R for parents. 
Discussion. This trial aims to test the effects of an early family-centered psychosocial 
intervention to meet the compelling need of young children with CHD and their 
families to prevent (further) problems. If CHIP-Family proves to be effective, it 
should be structurally implemented in standard care.
52
Chapter 3
3INTRODUCTION
Children with congenital heart disease (CHD) are at elevated risk for behavioral, 
emotional, and cognitive problems in childhood [1, 2], adolescence, and adulthood 
[3]. Previous cohort studies from our research group have indicated that CHD-
children are two times more likely to develop psychopathology than healthy 
children (16-27% versus 10% in the general population) - irrespective of the type 
of cardiac defect [4, 5]. Especially internalizing behavior problems, problems with 
social contacts, and reduced quality of life have been reported [6]. Moreover, 
neuropsychological problems and intellectual impairments are well known in 
these children [7, 8] and elevated percentages of CHD-children attending special 
education (24% versus 4% in norm) have been reported [3]. The most common 
morbidity affecting the quality of life in school-aged children with CHD is the 
combination of behavioral/emotional problems, developmental delay, and school 
difficulties [9]. Such problems can have long-term consequences: two long-term 
studies have shown that adults with CHD overall had a lower occupational and 
educational status compared with the general population [10, 11]. Furthermore, 
children with CHD often have reduced exercise capacity and participate less in 
exercise and sports, which has been associated with a lower quality of life [13]. It 
has been shown that participation in an exercise program improves quality of life 
of children with CHD [12].
In addition, parental factors play a crucial role in children’s psychosocial wellbeing 
[2, 14-16]. Maternal mental health and worry have appeared to be more important 
predictors of psychosocial wellbeing of children with CHD than illness severity [2, 
17, 18]. Unfortunately, parents of children with CHD are also at risk for psychosocial 
problems themselves (e.g. anxiety, depression; one year prevalence 7-22%) [19].
Considering the above and the fact that milestones such as starting kindergarten 
and primary school present more challenges for children with CHD and their 
parents than for families with healthy children [20], a family-based psychosocial 
intervention tailored to their needs when starting school is required [19, 21, 22]. 
This need has also been expressed by parents and patients [21, 23]. Through such 
an intervention, psychosocial problems of children with CHD and their parents may 
be recognized, reduced or prevented. In addition, school functioning, emotional 
resilience, and sports participation of these children can be improved [21, 24]. Until 
now, the only evidence-based intervention in this field is the Congenital Heart 
Disease Intervention Program (CHIP) – School [2]. The CHIP-School study aimed to 
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promote psychosocial wellbeing of preschoolers with CHD indirectly by providing 
an intervention for their parents. CHIP-School resulted in significant gains in 
maternal mental health, reduced perceived strain on the family, and less school 
absence of the child. As to child psychosocial wellbeing, only a non-significant, 
though positive, trend was found [2].
A limitation of CHIP-School was that a separate child module was not included. 
Therefore, in collaboration with the original authors of the previous CHIP 
intervention, we have translated, extended and modified CHIP, by adding a tailored 
child module for CHD-children and their siblings. The child module includes 
evidence-based cognitive behavioral exercises [26] and sports exercises. The newly 
developed CHIP-Family is a psychosocial intervention for 4- to 7-year-old children 
who have undergone at least one medical intervention for CHD and are starting or 
attending kindergarten or primary school (first or second year) and their families.
The aim of this study is (1) to test the effects of CHIP-Family on parental mental 
health and psychosocial wellbeing of CHD-children who are starting or attending 
kindergarten or primary school and to (2) identify baseline psychosocial and 
medical predictors for the effectiveness of CHIP-Family.
METHODS
This study is a single-center, single-blinded randomized controlled trial (RCT) 
comparing the effects of the CHIP-Family intervention with care as usual (CAU; 
regular medical treatment) on mental health of parents and psychosocial wellbeing 
of young children with CHD. This RCT is designed according to the CONSORT 
guidelines [27].
Inclusion and exclusion criteria
Over a one-year period (September 2016 – September 2017) children and their 
families living in the Netherlands will be recruited. Eligible are all children who 
(1) underwent at least one invasive procedure (catheter intervention or surgery) 
for CHD and (2) are starting or attending kindergarten or primary school (first 
or second year) at the time of first assessment (as the children are approximately 
4-7 years old). Exclusion criteria are: (1) child’s intellectual impairment (IQ < 70) 
as ascertained by previous standardized assessment or diagnosed by a clinician, 
(2) insufficient mastery of the Dutch language, and (3) prematurely born children 
54
Chapter 3
3(gestational age at birth < 37 weeks) with no other CHD than a patent ductus 
arteriosus.
Recruitment and procedure
Parents of 4- to 7-year-old children who receive treatment at the department of 
pediatric cardiology of the Erasmus Medical Center – Sophia Children’s Hospital 
and eligible members of the Dutch Patient Association for Congenital Heart 
Disease whose children receive treatment in a cardiac centre in the Netherlands 
will receive an information leaflet explaining the purpose and procedures of the 
study. Before inclusion, parents will receive a verbal explanation of the trial. After 
obtaining written parental informed consent, patients are randomly allocated to 
the CHIP-Family intervention or CAU group. To avoid a delay of more than 1 month 
between baseline assessment and the intervention, patients are randomized prior 
to the baseline assessment. Patients are allocated to the CHIP-Family intervention 
or CAU group by means of block randomization, performed by an independent 
researcher. Randomization will be stratified by CHD severity (limited to no 
residual heart defects or moderate to severe residual heart defects [after medical 
intervention]; see Table 1) and school year (kindergarten or primary school). To 
avoid bias, the researcher performing the assessments and analyses will be blinded. 
Considering the nature of the CHIP-Family intervention, it is not possible to blind 
the participants and the health care professionals providing the intervention.
Table 1 Stratification factor “CHD severity”.
Type 1 Limited to no residual heart 
defects
Type 2 Moderate to severe residual heart 
defects
Atrial Septal Defect (ASD)
Patent Ductus Arteriosus
Pulmonary valve stenosis
Total Anomalous Pulmonary Venous 
Connection
Ventricular Septal Defect (VSD)
ALCAPA (Anomalous Left Coronary 
Artery from the Pulmonary Artery)
Aortic Valve Stenosis
Atrioventricular Septal Defect (AVSD)
Coarctation of the Aorta
Complex Biventricular (e.g. Truncus 
Arteriosus, aortic arch defects)
Double Inlet Ventricle – Fontan circulation
Ebstein’s Anomaly
Subvalvular Aortic Stenosis
Tetralogy of Fallot (TOF)
TOF with MAPCA (Main Aorta to 
Pulmonary Connecting Artery)
Transposition of the Great Arteries
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Intervention
CHIP-Family consists of a parent module and a child module. Parents and children 
participate in a separate, but simultaneously given, 6-hour group workshop. An 
overview of the content of the workshops is given in Table 2. Over the course of 
a 11-month period (Nov. 2016 – Sept. 2017) 11 workshops will be given to 3 to 5 
families per workshop.
Table 2 Outline of the CHIP-Family workshops.
Parent workshop
Health care professional(s) Content
Psychologists · Problem prevention therapy [50]. A DO ACT acronym 
is applied: Define problem and turn into a specific goal; 
Option brainstorm; Assess pros and cons of various 
options; Choose a strategy; Take action and evaluate
· Psychoeducation
· General parenting skills
· Specific parenting skills for children with CHD
Pediatric cardiologist · Information on medical diagnoses, treatments, future 
issues (e.g., career, pregnancy), insurance, and healthy 
living (e.g., sports, diet)
Child workshop
Health care professionals Content
Psychologists · Relaxation
· Promoting autonomy
· Strengthening self-esteem
· Making friends
· Problem solving skills
· Positive thinking
Physiotherapists · Playful, age-attuned sports exercises: warming-up, 
fitness, gross motor skills, balance, aiming and catching
Parent module
The parent module is based on the evidence-based CHIP-School protocol [2].
Workshop. The parent workshop focuses on problem prevention therapy, 
psychoeducation, general parenting skills, skills specific to parenting a child with 
CHD (given by two senior psychologists with expertise in the field; 4 hours), and 
medical issues (given by a pediatric cardiologist; 1 hour). The lunch break (1 hour) 
offers families more opportunity to interact and share (similar) experiences. During 
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that will be covered during the workshop and a home assignment on problem 
prevention therapy. Parents also receive handouts and a teacher information 
leaflet.
Follow-up booster session. Approximately four weeks after the workshop, parents 
receive an individual follow-up booster session with a psychologist who was 
present during the parent workshop and a psychologist who was present during the 
child workshop. Questions or worries that may have come up after the workshop 
regarding their child with CHD or their family members are discussed. Also, aspects 
of the workshop which have been (most) helpful for parents and will be helpful in 
the future are reviewed. Moreover, the session focuses on the problem prevention 
home assignment and on how to promote future use of problem prevention therapy.
Child module
To normalize participation in the workshop and to stimulate practice at home, each 
child is allowed to bring a 4- to 10-year-old sibling or friend. The psychological 
exercises (given by two junior psychologists; 4 hours) are based on the evidence-
based cognitive behavioral therapy Fun FRIENDS protocol [26]. The exercises 
are provided in a playful manner and focus on regulating emotions, relaxation, 
promoting autonomy, strengthening self-esteem, making friends, problem solving 
skills, and positive thinking. The playful, age-attuned sports exercises (given by a 
physiotherapist and assistant physiotherapist; 1 hour) are based on a standardized 
training program. Previous research has shown that these exercises are effective 
in improving the quality of life in children with CHD [12].
Training and protocol adherence
CHIP-Family is performed in a standardized manner. Prior to the workshops, 
four senior and five junior psychologists receive a one-day CHIP-training by 
developmental psychologists Prof. McCusker and Dr. Doherty, developers of 
the original CHIP-protocol. To ensure consistency, the same senior and junior 
psychologist will be present at each workshop. In both the parent and child 
workshops, another psychologist will be present. Master’s students in Psychology 
will assess treatment integrity during the parent and child workshop through a 
standardized form. Follow-up sessions are audiotaped and treatment integrity is 
assessed through a standardized form afterwards.
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Outcome measures
An overview of all variables and questionnaires per assessment moment is given 
in Table 3. All questionnaires are (inter)nationally validated and Dutch normative 
data is available. Children and their families are enrolled into the study in groups 
of 6 to 10 families (3 to 5 families in the CHIP-group and 3 to 5 families in the 
CAU group). In both the CHIP-Family and the CAU condition, the first assessment 
will take place within 2 weeks before the CHIP-Family intervention (T1) and the 
follow-up post-assessment (T2) will take place 6 months after T1. Patients who 
are randomized into the CHIP-Family intervention group complete a social validity 
questionnaire assessing satisfaction with regards to the CHIP-program within 2 
weeks after the intervention and at T2. All questionnaires are completed at home 
through a secure website.
Primary outcomes
Child behavioral/emotional problems. The problem section of the Child Behavior 
Checklist (CBCL) [28] 1,½-5 (100 items; for 4- and 5-year-olds) and CBCL/6-18 (120 
items; for 6- and 7-year-olds) will be used to obtain standardized parent reports of 
emotional and behavioral problems in their child. Response categories range from 
0 to 2, with higher scores indicating more emotional and/or behavioral problems. 
Adequate reliability and validity have been reported[29].
Parental mental health. The Symptom Checklist-90-Revised (SCL-90-R) [30] is 
a self-report scale (90 items; response categories: 1-5, higher score indicates 
more symptoms) which assesses 9 primary symptom dimensions: Somatization, 
Obsessive-Compulsive, Interpersonal Sensitivity, Depression, Anxiety, Hostility, 
Phobic Anxiety, Paranoid Ideation, and Psychoticism. Adequate reliability and 
validity have been reported for the Dutch version [30].
Secondary outcomes
School days sick/absent. Through the Rotterdam Quality of Life interview [31] 
parents and teachers will be asked how many days the child was absent from school 
and what the reasons for absence were.
Disease-specific knowledge and illness perception. The Rotterdam Knowledge 
Questionnaire for Congenital Heart Disease [32] is used to assess parents’ 
knowledge about CHD and parents’ illness perception.
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(100 items)[33] or the TRF/6-18 (120 items) [34] will be completed by the teacher 
of the child. The TRF assesses problem behavior (at school). Response categories 
range from 0 to 2, with higher scores indicating more emotional and/or behavioral 
problems.
Executive functioning. The Dutch Behavior Rating Inventory of Executive Functioning 
(BRIEF)[35, 36] (63 items; 2-5 years) and BRIEF-Preschool version (BRIEF-P)[37] 
(63 items; 5-18 years) will be used to assess executive functioning skills in daily 
life. Response categories range from 0 to 2, with higher scores indicating more 
problems.
Enjoyment of leisure-time physical activity. The Groningen Enjoyment Questionnaire 
(GEQ; 10 items; response categories 1-3, higher score indicates more enjoyment) 
[38, 39] is adjusted for parents assesses enjoyment of physical activity. Children 
themselves answer two questions to assess how often they engage in physical 
activity and to assess enjoyment of physical activity.
Parental worry. The Penn State Worry Questionnaire (PSWQ; 16 items; response 
categories 1-5, higher score indicates higher level of worry)[40] assesses the 
excessiveness and uncontrollability of parental worry.
Parenting stress. The Nijmeegse Ouderlijke Stress Index verkort (NOSIK)[41, 
42] (25 items; response categories 1-6, higher score indicates higher level of 
stress) measures stress due to parenting. Parents will also complete the Distress 
Thermometer (DT-P) [43] (40-42 items), which consists of a problem list and a 
thermometer on which parents are asked to rate their overall distress.
Quality of life of children and siblings. The Child Health Questionnaire Parent Form-
50 (CHQ-PF50; 50 items)[44] is used to assess quality of life of the child with CHD 
and, if possible, of one sibling.
Parental quality of life. The Short-form (36) Health Survey (SF-36) [47] (36 items; 
score per domain 0-100, higher score indicates less disability) assesses eight health 
status domains: physical functioning, role limitations due to physical problems, 
bodily pain, general health, social functioning, role limitations due to emotional 
functioning, mental health, and vitality.
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Family functioning. The general functioning subscale of the Family Assessment 
Device (FAD) [45] (12 items; response categories 1-4, higher total score indicates 
poorer functioning) assesses problem areas of family functioning.
Social validity. Through a questionnaire, parents will be asked about their satisfaction 
regarding CHIP-Family. Furthermore, data on attendance and completion of CHIP-
Family will be recorded.
Predictors
Demographic variables. Demographic variables such as age, gender, and socio-
economic status will be assessed through the Rotterdam Quality of Life interview 
[31].
Medical variables. Information about cardiac diagnosis, surgery, and intrusive 
procedures will be retrieved from medical records.
Life events. The ‘life events’ subscale of the Cognitive Emotion Regulation 
Questionnaire child version (CERQ-k) [47] is adjusted as such that parents can 
answer the questions about their child.
Table 3 Assessment instruments and moments of assessment.
Assessment moment
Instrument Variable T1
Direct 
follow-up
T2
Primary outcomes
· Child Behavior Checklist (CBCL) 
[33]
Child behavioral/
emotional problems
M, F M, F
· Symptom Checklist-90-Revised 
(SCL-90-R) [30]
Parental mental health M, F M, F
Secondary outcomes
· Rotterdam Quality of Life  
interview [31]
School days sick/absent M, F M, F, T
· Rotterdam Knowledge 
Questionnaire [32]
Disease-specific 
knowledge and illness 
perception
M, F M, F
· Teacher Report Form (TRF) [33] School functioning T
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Assessment moment
Instrument Variable T1
Direct 
follow-up
T2
· Behavior Rating Inventory of 
Executive Functioning (BRIEF) [35, 
36] or BRIEF-Preschool Version 
(BRIEF-P) [37]
Executive functioning M, F M, F, T
· Adjusted Groningen Enjoyment 
Questionnaire [38]
Sports participation, 
enjoyment of physical 
activity
M, F M, F, T
· 2 sports-related questions Sports participation, 
enjoyment of physical 
activity
C C
· Pennstate Worry Scale (PSWQ) [51] Parental worry M, F M, F
· Nijmeegse Ouderlijke Stress Index 
verkort (NOSIK) [41]
Parental stress M, F M, F
· Stress thermometer (DT-P) [52] Parental stress M, F M, F
· Child Health Questionnaire (CHQ-
PF50) [53]
Quality of life of child 
and sibling
M, F M, F
· Short-form (36) Health Survey (SF-
36) [54]
Quality of life of parents M, F M, F
· Family Assessment Device, general 
functioning subscale (FAD) [55]
Family functioning M, F M, F
· Medical record Medical consumption R R
· Social validity questionnaire Satisfaction, 
attendance, and 
completion of CHIP-
Family
- M, F M, F
Predictor variables
· Rotterdam Quality of Life interview 
[31]
Demographic variables M, F -
· Medical record Cardiac diagnosis R R
· Life event subscale of the Cognitive 
Emotion Regulation Questionnaire, 
child version (CERQ-k) [47]
Life events M, F M, F
M=Mother; F=Father; C=Child; T=Teacher; R=Medical records. 
T1=baseline; Direct follow-up=within 2 weeks after CHIP-Family intervention (only for 
participants in intervention group); T2=follow-up, 6 months after T1.
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Sample size calculation
To conduct a repeated measures ANOVA with two assessment moments, Cohen’s 
d of 0.6, an alpha of .05 (two-tailed), and a power of .80, a sample size of 90 patients 
is needed, of which 45 patients in the intervention group.
Statistical analysis
To test the effectiveness of CHIP-Family on the primary outcome measures (for 
parents: mental health [SCL-90-R]; for children: behavioral/emotional problems 
[CBCL]) repeated measures ANOVAs will be conducted, for parental and child 
outcomes separately. Group (CHIP-Family versus CAU) will be the between-
subjects variable and assessment (T1 versus T2) will be the within-subjects variable. 
Likewise, repeated measures ANOVAs will be conducted for the secondary 
outcome measures.
Additional regression analyses will be conducted to investigate in what way 
demographic factors, medical factors, and life events moderate the effect of CHIP-
Family on the primary outcome measures.
DISCUSSION
Several cohort and longitudinal studies have shown that there is a compelling 
need for a family-based psychosocial intervention for children with CHD and 
their families [1-3, 18-21]. Since key milestones such as starting kindergarten and 
primary school present more challenges for children with CHD and their parents 
than for families with healthy children [20], an intervention tailored to their needs 
when starting school is needed. The previously examined CHIP-School intervention 
[2], the only evidence-based psychosocial intervention for this population to 
date, significantly improved maternal mental health, diminished perceived strain 
on the family, and resulted in less school absence of the child. However, CHIP-
School targeted parents only, aiming for an indirect effect on child psychosocial 
wellbeing. CHIP-School resulted in a non-significant, though positive, increase in 
child psychosocial wellbeing.
To improve these outcomes, we will modify and extend CHIP by adding a tailored 
child module for children with CHD and their siblings, thereby creating the CHIP-
Family intervention. The child module consists of evidence-based cognitive 
behavioral and sports exercises. We will conduct an RCT to examine the effect 
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psychosocial wellbeing of young children with CHD.
This study has several strengths. Firstly, if CHIP-Family proves to be effective, this 
would be the first evidence-based psychosocial intervention for young children 
with CHD and their families, thus meeting the previously described need for an 
intervention. Secondly, as recommended by the guidelines of the Association for 
European Pediatric Cardiology working group [22], CHIP-Family provides early 
intervention. CHIP-Family aims to reduce and prevent psychosocial problems. 
As mental health problems in childhood may persist into adulthood [22, 48], 
the prevention of psychosocial problems is important. Thirdly, CHIP-Family is a 
family-centered intervention. It is widely acknowledged that family functioning 
and parental factors play an important role in children’s development [2, 14, 15]. 
As parents of children with CHD are at risk for psychosocial problems [19], a family-
centered intervention may reduce their problems [49]. This, in turn, may enhance 
family functioning. Furthermore, siblings are involved in the workshop and receive 
attention from the hospital staff, which normalizes the position of the child with 
CHD.
In conclusion, this intervention aims to fulfill the need for an evidence-based family-
centered psychosocial intervention for children with CHD and their families. If 
CHIP-Family proves to be effective in improving parental mental health and 
psychosocial wellbeing of children with CHD, it should be structurally implemented 
in standard care.
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results of a randomized controlled trial
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ABSTRACT
Objective. Children with congenital heart disease and their families are at risk 
of psychosocial problems. Emotional and behavioral problems, impaired school 
functioning, and reduced exercise capacity often occur. To prevent and decrease 
these problems, we modified and extended the previously established Congenital 
Heart Disease Intervention Program (CHIP) - School, thereby creating CHIP-Family. 
CHIP-Family is the first psychosocial intervention with a module for children with 
congenital heart disease. Through a randomized controlled trial, we examined the 
effectiveness of CHIP-Family.
Methods. Ninety-three children with congenital heart disease (age M=5.34 years, 
SD=1.27) were randomized to CHIP-Family (N=49) or care as usual (no psychosocial 
care; N=44). CHIP-Family consisted of a one-day group workshop for parents, 
children, and siblings and an individual follow-up session for parents. CHIP-Family 
was delivered by psychologists, pediatric cardiologists, and physiotherapists. At 
baseline and 6-month follow-up, mothers, fathers, teachers, and the child itself 
completed questionnaires to assess psychosocial problems, school functioning, and 
sports enjoyment. Moreover, at 6-month follow-up, parents completed program 
satisfaction assessments.
Results. Although small improvements in child outcomes were observed in the 
CHIP-Family group, no statistically significant differences were found between 
outcomes of the CHIP-Family and care as usual group. Mean parent satisfaction 
ratings ranged from 7.4 to 8.1 (range 0–10).
Conclusions. CHIP-Family yielded high program acceptability ratings. However, 
compared to care as usual, CHIP-Family did not find the same extent of statistically 
significant outcomes as CHIP-School. Replication of promising psychological 
interventions, and examination of when different outcomes are found, is 
recommended for refining interventions in the future.
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Children with congenital heart disease (CHD) are at increased risk of a range of 
psychosocial problems. Therefore, the aim of the current study was to determine 
the effectiveness of an innovative psychosocial intervention, the Congenital Heart 
Disease Intervention Program (CHIP) – Family, in improving the psychosocial 
well-being of children with CHD and their families. The arguments for reducing 
psychosocial problems in these families are discussed below.
In children with CHD, emotional and behavioral problems may already emerge 
in infancy [1, 2]. Compared with healthy children, preschool and school-aged 
children with CHD have increased levels of internalizing and externalizing problems 
[3-8] and reduced levels of school performance [5, 7, 9]. Moreover, compared 
with healthy children, children with CHD more often require remedial teaching 
or special education [10-14] and face increased rates of grade repetition [4, 12, 
15]. Impaired social functioning and social cognition have also been reported [5, 
9, 16]. Children with CHD participate in fewer social activities [14] and are more 
often perceived to be withdrawn, not accepted by peers, and too dependent on 
others [9]. In adolescence and adulthood, CHD patients remain at increased risk 
of psychosocial difficulties [17-22].
As to physical activity levels of children with CHD, conflicting results have been 
reported. Several studies, including two systematic reviews, have reported reduced 
levels of physical activity in children with severe CHD [23-26]. However, others 
have found that physical activity levels of children with different CHD diagnoses 
do not differ from those of children from the general population [27].
It is increasingly recognized that parental mental well-being mediates psychosocial 
outcomes in children with CHD [4, 9] and that family factors are more important 
predictors of psychosocial outcomes of children with CHD compared to medical 
factors [28, 29]. Unfortunately, parents of children with CHD themselves are at 
increased risk of mental health problems, such as posttraumatic stress disorder, 
depression, and anxiety [30-32].
To prevent and decrease these difficulties in children with CHD and their families, a 
multidisciplinary, psychosocial intervention is needed. Research has demonstrated 
that families of children with CHD express a need for psychosocial care themselves 
[33, 34]. Until now, the only evidence-based psychosocial intervention in this field 
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was the CHIP-School program [35, 36]. CHIP-School consisted of a multidisciplinary 
1-day group workshop and individual follow-up session for parents of children 
with CHD who were entering school. The theoretical rationale of CHIP-School 
was derived from Thompson’s transactional stress and coping model [37]. This 
model states that the effect of an illness on a child’s well-being is mediated by 
familial coping and appraisal. The developers aimed to strengthen parental mental 
health and parenting skills, thereby indirectly increasing emotional resilience of 
children with CHD. CHIP-School yielded positive results with regard to maternal 
mental health, perceived strain on the family, and school absence of the child. With 
regard to child emotional and behavioral problems, no significant improvements 
were found. However, CHIP-School did not contain a specific child module. We 
reasoned that directly targeting both parents and children would improve the 
results previously obtained through CHIP-School.
Therefore, we have modified CHIP-School and added a specific child module 
specifically focused on improving emotional well-being, sports enjoyment, 
and school functioning. As mothers, fathers, and siblings are also part of this 
innovated and extended intervention, the intervention is titled “CHIP-Family”. We 
hypothesized that participating in the CHIP-Family intervention would improve the 
psychosocial well-being of children with CHD and their parents, family functioning, 
and parents’ disease-specific knowledge.
METHODS
This single-blinded parallel randomized controlled trial was approved by the 
Medical Ethics Committee of the Erasmus Medical Center and adhered to the 
ethical guidelines of the Declaration of Helsinki. Before participation, written 
informed consent was obtained from all patients’ parents or legal guardians. A 
detailed description of the study protocol has been published previously [38].
Participants
Children and their families were recruited during a one-year inclusion period (30 
September 2016 to 12 September 2017) via the Erasmus Medical Center – Sophia 
Children’s Hospital, a tertiary referral center for pediatric cardiology and cardiac 
surgery in the Netherlands, and nationally via the Dutch Patient Association for 
Congenital Heart Disease. Families of children who (1) underwent at least one 
invasive medical procedure for CHD (i.e., cardiac catheterization and/or open heart 
surgery) and (2) were attending kindergarten or first or second year of primary 
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with known intellectual impairment (intelligence quotient ≤ 70) were excluded, as 
a sufficient level of intelligence was required to participate in the child intervention 
program. Moreover, prematurely born children (i.e., gestational age at birth < 37 
weeks) with no other CHD than a patent ductus arteriosus were excluded, as 
families of prematurely born children experience different psychosocial problems 
[39]. Lastly, sufficient mastery of the Dutch language was required.
Procedure
As to patients of the Erasmus Medical Center, eligibility was assessed by screening 
patient records of 2- to 8-year-old children who had undergone an invasive cardiac 
procedure or who had received cardiac follow-up. Subsequently, parents of 
children who seemed to be eligible received an information letter explaining the 
purpose and content of the study. As to members of the Dutch Patient Association 
for Congenital Heart Disease, for privacy reasons, no medical information was 
available. Therefore, information letters explaining the purpose and content of the 
study were sent to parents of all 2- to 8-year-old children.
If parents indicated to be interested in participation or did not respond within 
2 weeks, eligibility was verified via a phone call. Before giving written informed 
consent, all families received a verbal explanation of the study and were invited 
to ask questions. Consequently, an independent researcher randomly assigned 
participants to the CHIP-Family intervention or care as usual control group, which 
only received medical care (allocation ratio 1:1). The researcher who collected all 
assessments and performed all analyses was blinded for randomization outcome. 
Randomization was stratified by school year (kindergarten versus primary school) 
and CHD severity. CHD severity was divided into limited to no residual heart 
defects versus mild to severe residual heart defects after cardiac intervention 
(see Table 1). This classification was made based on treatment-related aspects and 
intensity of cardiac follow-up [40]. Randomization block size was fixed at four per 
stratification category. Due to logistical reasons in the starting phase of the project, 
the first four families who consented to participate were allocated to the CHIP-
Family group without randomization. We limited the period between baseline 
assessment and the intervention to 2 weeks. Moreover, parents had to be notified 
earlier that they had to make practical arrangements to be able to participate in the 
CHIP-Family workshop for an entire day. For these two important logistic reasons, 
parents of patients were informed of randomization outcome prior to the baseline 
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assessment. The follow-up assessment took place 6 months after baseline. The 
participation flow-chart is shown in Figure 1.
Table 1 Stratification factor “CHD severity”.
Residual heart defects after cardiac intervention
Limited to none Mild to severe
Atrial Septal Defect (ASD)
Patent Ductus Arteriosus
Pulmonary valve stenosis
Total Anomalous Pulmonary Venous 
Connection
Ventricular Septal Defect (VSD)
Anomalous Left Coronary Artery from the 
Pulmonary Artery (ALCAPA)
Atrioventricular Septal Defect (AVSD)
Coarctation of the Aorta
Complex Biventricular (e.g. Truncus 
Arteriosus, aortic arch defects with VSD)
Univentricular heart defects – Fontan 
circulation
Ebstein’s Anomaly
(Sub)valvular Aortic Stenosis
Tetralogy of Fallot (TOF); including with 
Main Aorta to Pulmonary Connecting Artery 
(MAPCA)
Transposition of the Great Arteries
Intervention
The CHIP-Family intervention is an adaptation and extension of the CHIP-
School intervention [36]. CHIP-Family consisted of a 6-hour group workshop 
(three to five families per workshop) for parents and children and an individual 
1-hour follow-up session per parent couple. The developers of the original CHIP-
protocol conducted a 1-day training for four senior licensed clinical and health 
psychologists and five junior psychologists to deliver the parent module of the 
CHIP-Family intervention. A senior psychologist trained the junior psychologists 
to provide the child module. During the parent workshops and child workshops, 
protocol adherence was assessed through a standardized form by psychology 
master’s students (one student per workshop). For privacy reasons and due to 
the group format of the CHIP-Family workshops, it was not possible to videotape 
or audiotape the workshops. With the consent of parents, protocol adherence of 
the individual follow-up sessions was assessed through audiotapes by psychology 
master’s students.
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* 89 children and their families were randomly allocated to either the intervention group or 
care as usual control group. The first 4 children and their families were directly allocated to 
the CHIP-Family intervention group.
The 1-day parent workshop consisted of problem prevention therapy, 
psychoeducation, general parenting skills, skills specific to parenting a child with 
CHD (provided by two senior clinical psychologists for 4 hours), and medical issues 
(provided by a pediatric cardiologist supported by a senior clinical psychologist 
for 1 hour). The 1-hour lunch break gave families more opportunity to share their 
experiences.
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As background information, parents received all slides that were presented in the 
workshop, the CHIP manual [41] containing all topics covered during the workshop, 
several information leaflets, and a home assignment on problem prevention 
therapy. Approximately 4 weeks after the workshop, each parent couple received 
an individual follow-up session provided by a senior psychologist who was present 
at the parent workshop and a psychologist who was present at the child workshop. 
The follow-up session focused on questions or worries of individual families, future 
coping strategies, and the problem prevention home assignment.
Whereas the CHIP-School intervention consisted of a parent module, the CHIP-
Family module also comprised a specific child module. The child module consisted 
of a workshop that was held concurrently with the parent workshop. The child 
workshop consisted of cognitive behavioral exercises based on the evidence-
based Fun FRIENDS protocol [42, 43] and focused on strengthening self-esteem, 
regulating emotions, relaxation, problem solving skills, and positive thinking 
(provided by two junior psychologists who were supervised by two senior clinical 
psychologists for 4 hours). The children also did sport exercises based on a 
standardized exercise program [44] specifically developed for children with CHD 
and their siblings (provided by a physiotherapist and assistant for 1 hour). Each child 
was allowed to bring a 4- to 10-year-old sibling or friend, to normalize participation 
and to stimulate practice at home.
Thus, though predicated on a similar conceptual model, CHIP-Family differed from 
CHIP-School by having parallel modules/workshops for the whole family (children, 
siblings, and parents). In addition, CHIP-School included a bicycle exercise stress 
test. This was essentially a behavioral experiment to highlight to parents (in vivo 
and in the presence of a cardiologist) that vigorous exercise was safe with non-
concerning electrocardiogram rhythms evident throughout. Unfortunately, it was 
not possible to include this in the current CHIP-Family intervention for logistic 
reasons.
Instruments
All questionnaires were completed by both parents at baseline and 6-month 
follow-up, unless otherwise specified. Teachers completed only the 6-month 
follow-up questionnaires, because some teachers did not know the child 
sufficiently at baseline to fill out the questionnaires. If a child had multiple teachers, 
questionnaires were completed by the teacher who knew the child the best or spent 
the most time with the child. Children completed two sports-related questions 
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well-known questionnaires with adequate psychometric properties were used. 
All questionnaires were completed through a secure online system. Demographic 
variables were assessed through the Rotterdam Quality of Life interview [45].
Child outcomes
Child emotional and behavioral problems were the primary child outcome and were 
assessed through the Child Behavior Checklist (CBCL) [46] 1,½-5 (100 items; for 
4- and 5-year-olds) or CBCL/6-18 (120 items; for 6- to 8-year-olds).
Problem behavior at school was assessed through the Teacher’s Report Form (C-TRF 
[47]) 1½-5 (100 items; for 4- and 5-year-olds) or the TRF/6-18 [47] (120 items; for 
6- to 8-year-olds) which was completed by teachers.
Executive functioning was assessed through the Behavior Rating Inventory of 
Executive Functioning (BRIEF [48]; 63 items; for 6- to 8-year-olds) or BRIEF-
Preschool version (BRIEF-P [49]; 63 items; for 4- and 5-year-olds) which was 
completed by parents and teachers.
Children’s health related quality of life was assessed through the Child Health 
Questionnaire – Parent Form-50 (CHQ-PF50 [50]; 50 items).
School absence was assessed through the Rotterdam Quality of Life interview [45].
Children’s enjoyment of physical activity was assessed through an adjusted version 
of the Groningen Enjoyment Questionnaire (GEQ [51, 52]; 10 items) which was 
completed by parents and teachers. The sentencing of the GEQ items was adjusted 
to enable parents and teachers to fill out the questionnaire (e.g., “This child likes 
being physically active” instead of “I like being physically active”). In addition to the 
GEQ, children themselves were asked to answer two questions indicating their 
enjoyment of physical activity and how often per week they engage in physical 
activity.
Parental and family outcomes
Parental mental health was the primary parental outcome and was assessed through 
the Symptom Checklist-90-Revised (SCL-90-R [53]; 90 items), which measures 
symptom severity of mental health problems.
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Excessiveness and uncontrollability of parental worry were assessed through the Penn 
State Worry Questionnaire (PSWQ [54, 55]; 16 items).
Parenting stress was assessed through the short version of the Nijmeegse Ouderlijke 
Stress Index (NOSIK [56]; 25 items) and the Distress Thermometer (DT-P [57]; 42 
items).
Parents’ health related quality of life was assessed through the Short-form (36) Health 
Survey (SF-36 [58]; 36 items).
Family functioning was assessed through the general functioning subscale of the 
Family Assessment Device (FAD [59]; 12 items).
Parents’ knowledge about CHD (10 items) was assessed through the Rotterdam 
Knowledge Questionnaire for Congenital Heart Disease [52, 60].
Program satisfaction was assessed through a social validity questionnaire which 
parents completed 2 weeks after CHIP-Family and at 6-month follow-up.
Statistical analyses
Differences in baseline participant characteristics between the CHIP-Family and 
the care as usual groups were examined using t-tests, chi-square tests, and Fisher’s 
exact tests, where appropriate.
To determine the effectiveness of the CHIP-Family intervention, we compared 
the differences in change in parent- and child-reported outcomes over time 
between the CHIP-Family and care as usual group using generalized estimating 
equations (GEE) [61]. A GEE analysis accounts for the dependency between 
repeated observations and accommodates missing values [62]. The analyses were 
performed on an intention-to-treat basis. Patients were included in an analysis if 
an outcome was available at one or both assessment moments. For each outcome, 
we conducted separate GEE analyses. The interaction between time and group 
(i.e., CHIP-Family versus care as usual) was examined as the test of effectiveness of 
CHIP-family. We selected a normal distribution and an identity link function for the 
majority of outcomes. The SCL-90-R total score, DT-P total score, SF-36 physical 
component score, pleasure in sports reported by children, and sports participation 
per week were not normally distributed. Therefore, for these outcomes a gamma 
distribution with log link function was used.
80
Chapter 4
4Teacher-reported outcomes were only assessed at follow-up. We used t-tests to 
compare the difference in teacher-reported continuous outcomes between the 
CHIP-Family and care as usual group. Because the majority of children had not 
been absent from school the past month, school absence was dichotomized into 
0 days absent and ≥ 1 day absent and presented as percentage. To compare the 
difference in school absence between the CHIP-Family and care as usual group, 
chi-square tests were applied.
For the primary outcome variables (CBCL and SCL-90-R), the significance level was 
set at α = .05. To adjust for multiple testing within the secondary outcome variables 
of the child domain and the parental and family domain, we used a Bonferroni 
correction. In both domains, 17 tests were conducted. Therefore, results with 
p < .003 were considered statistically significant. All statistical analyses were 
performed using SPSS version 24 [63]. Sample size calculations can be found in a 
previous publication of the study design [38].
RESULTS
Participant characteristics
In total, 93 children were randomized into either the CHIP-Family (n = 49) or the 
care as usual group (n = 44). Non-participants’ cardiac diagnosis and gender were 
only available for patients of the Erasmus MC – Sophia Children’s Hospital (86.6% 
of eligible patients) and not for patients contacted via the Dutch Patient Association 
for Congenital Heart Disease (13.4% of eligible patients). Participants and non-
participants from the Erasmus MC – Sophia Children’s Hospital did not differ as 
to CHD severity (p = .06) and gender (p = .12). Other demographic data were not 
available.
Parents of three children did not complete any questionnaires after randomization. 
Therefore, the final sample consisted of 90 children (n = 47 CHIP-Family, n = 43 care 
as usual). The CHIP-Family and care as usual group did not differ from each other in 
terms of age, gender, CHD type, school year, recruitment center, comorbid physical 
illness, family composition, or social economic status (see Table 2), which indicates 
that randomization was successful. Four children were referred for further 
psychological care after participating in the CHIP-Family intervention (n = 44) and 
received this care after completion of the follow-up assessment. Problems such 
as anxiety and emotion regulation issues were noted in these children during the 
group workshop and/or individual follow-up session.
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Table 2 Baseline participant characteristics.
Characteristic
Intervention group
(N = 47)
Control group
(N = 43)
p-value
Child age, N 47 43 .426a
Mean years at baseline ± SD 5.43 ± 1.30 5.21 ± 1.26
Child gender, N 47 43 .527b
Male, N (%) 25 (53.2%) 20 (46.5%)
Residual heart defects after cardiac 
intervention, N
47 43 .844b
Limited to noned, N (%) 14 (29.8%) 12 (27.9%)
Mild to severed, N (%) 33 (70.2%) 31 (72.1%)
Parent-reported comorbid physical 
illness, N
42 38 .867b
Any, N (%) 14 (29.8%) 12 (31.6%)
School year at baseline, N 47 43 .791c
1 (kindergarten), N (%) 19 (40.4%) 20 (46.5%)
2 (kindergarten), N (%) 10 (21.3%) 8 (18.6%)
3 (primary school), N (%) 12 (25.5%) 12 (27.9%)
4 (primary school), N (%) 6 (12.8%) 3 (7.0%)
Child ethnicity, N 42 38 .728c
Dutch, N (%) 41 (97.6%) 37 (97.4%)
Other, N (%) 1 (2.4%) 1 (2.6%)
Family composition, N 42 38 .606c
Single parent, N (%) 2 (4.8%) 2 (5.3%)
Both biological parents at home, N (%) 37 (88.1%) 36 (94.7%)
Biological parent and partner, N (%) 3 (7.1%) 0 (0%)
Mothers’ highest completed education 
levele, N
42 36 .394c
Low, N (%) 0 (0%) 2 (5.6%)
Intermediate, N (%) 17 (40.5%) 15 (41.7%)
High, N (%) 25 (59.5%) 19 (52.8%)
Fathers’ highest completed education 
levele, N
36 29 .120c
Low, N (%) 1 (2.8%) 1 (3.4%)
Intermediate, N (%) 12 (33.3%) 16 (55.2%)
High, N (%) 23 (63.9%) 12 (41.4%)
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4Table 2 Continued
Characteristic
Intervention group
(N = 47)
Control group
(N = 43)
p-value
Recruitment center, N 47 43 .484b
Academic children’s hospital 33 (70.2%) 33 (76.7%)
Patient association 14 (29.8%) 10 (23.3%)
a T-test.
b Chi-square test.
c Fisher’s exact test.
d Limited to none: Atrial Septal Defect (ASD), Patent Ductus Arteriosus, Pulmonary valve 
stenosis, Total Anomalous Pulmonary Venous Connection, Ventricular Septal Defect (VSD). 
Mild, moderate, severe: Anomalous Left Coronary Artery from the Pulmonary Artery 
(ALCAPA), Atrioventricular Septal Defect (AVSD), Coarctation of the Aorta, Complex 
Biventricular (e.g. Truncus Arteriosus, aortic arch defects with VSD), Univentricular heart 
defects – Fontan circulation, Ebstein’s Anomaly, (Sub)valvular Aortic Stenosis, Tetralogy 
of Fallot (TOF); including with Main Aorta to Pulmonary Connecting Artery (MAPCA), 
Transposition of the Great Arteries.
e Low: primary education, lower vocational education, lower or middle general secondary 
education; Intermediate: middle vocational education, higher secondary education, pre-
university education; High: higher vocational education, university.
Protocol adherence
Workshops. Five families randomized into the CHIP-Family group did not participate 
in the CHIP-Family intervention. Of these five families, one family declined to 
participate in CHIP-Family and four families were unable to attend the intervention 
due to practical reasons. In total, 44 families participated in the CHIP-Family 
workshops. One family discontinued the intervention after approximately 1 hour, 
because the child was upset.
Of 34 (77.3%) families, both parents participated in the workshop. Of the remaining 
10 (22.7%) families, only the mother participated in the workshop. Twenty-eight 
(63.7%) children participated in the workshop with a sibling, 6 (13.6%) children 
participated with a friend, and 10 (22.7%) children participated without a sibling 
or friend. In nine parent workshops and seven child workshops, all the protocol 
topics were discussed. In the remaining two parent workshops and four child 
workshops, 96% of the protocol topics was discussed. This indicates excellent 
protocol adherence.
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Follow-up sessions. Of all families, at least one parent attended the follow-up 
session. Four psychology master’s students rated protocol adherence of a randomly 
selected 50% of the follow-up sessions. On average, 87% of the protocol topics was 
discussed in the randomly selected follow-up sessions.
Outcomes
Child, parental, and family outcomes are summarized in Tables 3 and 4. No 
statistically significant differences between the CHIP-Family and care as usual 
group were found in both the child outcomes (reported by children, mothers, 
fathers, and teachers) and the parental and family outcomes (reported by mothers 
and fathers).
Despite successful randomization, the baseline difference in CBCL total scores 
reported by mothers was statistically significant (p = .001), such that mothers in 
the CHIP-Family group reported more child emotional and behavioral problems 
at baseline than mothers in the care as usual group. No other baseline differences 
in outcomes were found. For both the CHIP-Family and the care as usual group, 
CBCL total scores reported by both mothers and fathers significantly decreased 
from baseline to follow-up (p = .001 and p < .001).
Program acceptability
Thirty-one (70.5%) mothers and 26 (76.5%) fathers who participated in CHIP-
Family rated program acceptability at 6-month follow-up. On a scale of 0-10, mean 
overall usefulness rating was 7.5 (SD = 1.6) and 7.8 (SD = 1.5), respectively, for 
the parent and child workshop. Mean satisfaction rating was 7.7 (SD = 1.2) and 
8.1 (SD = 1.3) for the parent and child workshop, respectively. Mean rating of the 
usefulness of the individual follow-up session was 7.4 (SD = 1.5). Mean rating of the 
likeliness that parents would recommend CHIP-Family to other families of children 
with CHD was 7.7 (SD = 1.5). Parents were asked to rate which components of 
CHIP-Family they found most useful (see Figure 2). Most parents perceived 
the psychosocial and medical explanation of the pediatric cardiologist (72.7%), 
meeting other families of children with CHD (61.8%), the child workshop (50.9%), 
and receiving skills tailored to parenting children with CHD (43.6%) as most useful 
elements of the intervention. At follow-up, a substantial percentage of parents 
(47.7%) reported using the techniques learnt in CHIP-Family sometimes (monthly).
Parents of children with less severe CHD (i.e., limited to no residual heart defects 
after cardiac intervention; see Table 1) rated usefulness of the child workshop more 
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4favorably (M = 8.4, SD = 1.6) compared to parents of children with more severe 
CHD (i.e., mild to severe residual heart defects after cardiac intervention; see Table 
1; M = 7.4, SD = 1.4), t(53) = 2.23, p = .03. Parents of children with less severe CHD 
also rated satisfaction with the child workshop more favorably (M = 8.6, SD = 1.3) 
compared to parents of children with more severe CHD (M  =  7.8, SD  =  1.2), 
t(53) = 2.47, p = .02.
DISCUSSION
The aim of the current randomized controlled trial was to examine the effect of 
the multidisciplinary, psychosocial CHIP-Family intervention on psychosocial well-
being of young children with CHD and their families. Parents evaluated usefulness 
of and satisfaction with CHIP-Family positively. Moreover, through CHIP-Family, 
the involved mental health care professionals were able to identify four children 
who had psychosocial issues which required additional psychological care. These 
psychosocial issues might otherwise have remained unnoticed and untreated. 
However, our findings indicate that, compared with care as usual, participation in 
CHIP-Family did not significantly improve the psychosocial well-being of children 
with CHD and their families at 6-month follow-up. This is in contrast with the 
results of the previously examined CHIP-School intervention, which yielded more 
positive results at 10-month follow-up [36].
The culture of replicability research in psychological interventions in general is 
poor and publication bias often amplifies the problem [64]. However, replication 
studies not only are important to confirm or question the impact of an intervention, 
but rather to yield important information to further refine interventions and 
evaluation protocols. Thus, Stehl and colleagues [65] found that a similar family 
focused intervention for parents of children with cancer, whilst successful later 
in the illness trajectory, yielded less impressive outcomes when delivered earlier 
in the illness cycle – despite the promising theoretical reasons why it might be 
even more effective. Law and colleagues’ [66] meta-analysis highlighted generally 
small to moderate effect sizes, and mostly on parental functioning in family-
focused interventions ultimately aimed at improving outcomes for the child. Again, 
important lessons in intervention focus and measurements used were discussed.
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Figure 2 Parents’ ratings of most useful components of the CHIP-Family intervention (mul-
tiple answers possible).
Following the results of the present study, we were interested in considering 
differences between CHIP-Family and the previous CHIP-School on which it was 
based, and what these might tell us about future interventions and evaluations. 
Two classes of differences may be important:
· The intervention – Some key differences may have been important. Firstly, 
as noted above, CHIP-School comprised a behavioral experiment – the bicycle 
exercise test – to directly challenge assumptions about fragility and poor exercise 
capacity. For logistical reasons, ours did not. CHIP-School authors noted that 
parents had rated this component as the most helpful (personal communication). 
Secondly, we incorporated parallel workshops for children and siblings. Whilst 
theoretically we expected this to enhance impact, having their children attend 
the same day may in fact have diluted the importance of, and engagement with, 
the primacy of the parent focus of the intervention. It should be noted, however, 
that parents did rate the child workshop positively. Finally, we had smaller groups 
of parents (three to five) compared to CHIP-School. Again, we expected this to 
enhance impact, but such may also have moderated the social facilitation and 
support impact of the groups.
· The sample – In CHIP-Family we had lower rates of uptake (24%) compared to 
CHIP-School (60%). Although our responders seemed similar to non-responders 
(see above) on CHD severity measures, our samples may have differed on other 
important psychosocial ways which our studies are not able to compare but which 
relate to the issue of targeting such interventions. It is difficult to draw clear 
conclusions here, but this merits consideration in future research. CHIP-School 
targeted families just before the child made the transition to school, whereas 
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[67] makes the case for timing of early interventions at the cusp of developmental 
transitions and this may be important.
As CHIP-Family was designed as a preventive intervention, patients and their 
families were not selected for participation in the RCT based on their level of 
psychosocial difficulties. Considering the baseline scores, participants seemed to 
be functioning relatively well. That is, compared with the general population, all 
mean scores fell within the normal range. One might expect that baseline scores 
would have been higher if we would have only included children with severe or 
complex CHD. However, a meta-analysis [8] has shown that disease severity 
in children with CHD is not related to internalizing, externalizing, and overall 
emotional and behavioral problems. Also, the majority of parents were highly 
educated. Significant improvements might have been found if we provided CHIP-
Family specifically to patients and families who suffered from clinically significant 
psychosocial difficulties.
Moreover, besides issues related to early childhood, several topics were discussed 
in the CHIP-Family intervention concerning future issues related to adolescence 
and young adulthood, such as alcohol use, smoking, sexuality, insurances, and 
career possibilities. This was done to provide parents an overall future perspective 
and also to encourage parents to ask for advice or help from the medical staff. 
Furthermore, these were topics often addressed by parents during the intervention. 
Whether this kind of psychoeducation has positive effects when these children 
reach adolescence could not be assessed within the shorter 6-month follow-up 
period.
Remarkably, although no differences in participant characteristics were found 
between the CHIP-Family and the care as usual group, a baseline difference was 
found in child emotional and behavioral problems reported by mothers. Mothers 
in the CHIP-Family group reported more child emotional and behavioral problems 
than mothers in the care as usual group. This might be explained by the fact that 
participants were aware of randomization outcome prior to baseline assessment. 
Due to logistical reasons, this could not be arranged otherwise. Parents might 
have psychologically prepared for the CHIP-Family intervention by reflecting on 
questions they wanted to discuss, which may have increased their awareness of 
problems and, consequently, increased their problem reports.
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Moreover, we found that both mother-reports and father-reports of the CBCL 
questionnaire in the CAU and CHIP-Family group improved similarly over time. 
This might be explained by the “question-behavior effect”. That is, behavior of 
participants can be affected by merely filling out questionnaires [68], which 
was done by parents of children in both the CAU and the CHIP-Family group. 
Furthermore, the information letters sent to potential participants contained 
information on common psychosocial issues in young children with CHD. Reading 
this information may have had a normalizing effect. Also, perhaps the feeling of 
receiving more attention from the hospital staff by participating in the study may 
have contributed to positive outcomes for both groups
Interestingly, we found that parents of children with less severe CHD rated 
usefulness of and satisfaction with the child workshop more favorably than parents 
of children with more severe CHD. This could be attributed to the fact that children 
with less severe CHD have less outpatient clinic visits compared to children with 
more severe CHD. Parents of children who make less clinic visits might appreciate 
the attention of health care professionals more compared to parents of children 
who are accustomed to more frequent visits to clinic. Alternatively, parents of 
children with more severe CHD might prefer a different child intervention program 
than parents of children with less severe CHD.
Strengths and limitations
This study has several strengths. Worldwide, CHIP-Family is the first psychosocial 
intervention for children with CHD that is comprised of both a specific child 
and parent module. Protocol adherence was strong. Moreover, fathers are 
underrepresented in pediatric research and, when fathers are included, mothers’ 
and fathers’ reports often are not analyzed separately [69, 70]. Both mothers and 
fathers participated in CHIP-Family and their outcome reports were analyzed 
separately.
A number of limitations should also be considered. Firstly, as mentioned above, 
informing participants of randomization outcome prior to the baseline assessment 
may have influenced the results. Secondly, due to the nature of the intervention, 
it was not possible to blind participants for group status. Thirdly, the differences 
in outcome scores in favor of the CHIP-Family group might have been statistically 
significant if the sample size would have been larger. Finally, perhaps we would have 
found larger effects if we had used more disease-specific questionnaires related to 
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not available in Dutch.
Conclusion
In summary, CHIP-Family was evaluated positively by participants and seems to 
meet parents’ and patients’ needs. However, the intervention did not significantly 
improve the psychosocial well-being of young children with CHD and their families 
at 6-month follow-up. As CHIP-Family did not meet its expectations, future research 
should focus on which patients and families will benefit most from a psychosocial 
intervention. Future research should also examine whether intervention programs 
should be adjusted according to CHD severity. Moreover, alternative formats in 
which psychosocial interventions may be provided could be considered, such 
as easily accessible online psychoeducation or group videoconferences. Also, 
psychosocial topics could be integrated into shared medical appointments [71], 
which show promising results.
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ABSTRACT
Background. Dilated cardiomyopathy (DCM) in children is an important cause of 
severe heart failure and carries a poor prognosis. Adults with heart failure are 
at increased risk of anxiety and depression and such symptoms predict adverse 
clinical outcomes such as mortality. In children with DCM, studies examining these 
associations are scarce.
Aims. We studied whether in children with DCM: (1) the level of emotional and 
behavioral problems was increased as compared to normative data, and (2) 
depressive and anxiety problems were associated with the combined risk of death 
or cardiac transplantation.
Methods. To assess emotional and behavioral problems in children with DCM, 
parents of 68 children, aged 1.5-18 years (6.9±5.7 years) completed the Child 
Behavior Checklist.
Results. Compared to normative data, more young children (1.5-5 years) with DCM 
had somatic complaints (24.3% vs. 8.0%; p < .001), but fewer had externalizing 
problems (5.4% vs. 17.0%; p = .049). Overall internalizing problems did not reach 
significance. Compared to normative data, more older children (6-18 years) showed 
internalizing problems (38.7% vs. 17.0%; p = .001), including depressive (29.0% 
vs. 8.0%; p < .001) and anxiety problems (19.4% vs. 8.0%; p = .023), and somatic 
complaints (29.0% vs. 8.0%; p < .001). Anxiety and depressive problems, corrected 
for heart failure severity, did not predict the risk of death or cardiac transplantation.
Conclusion. Children of 6 years and older showed more depressive and anxiety 
problems than the normative population. Moreover, in both age groups, somatic 
problems were common. No association with outcome could be demonstrated.
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5INTRODUCTION
Cardiomyopathies are disorders characterized by structural and functional 
abnormalities of the heart. The most common subtype in children is dilated 
cardiomyopathy (DCM), accounting for approximately 60% of pediatric 
cardiomyopathies [1, 2]. DCM, which is characterized by impaired systolic 
function and dilation of the left ventricle [3], is estimated to affect 0.57 per 
100,000 children annually [4]. Though disease presentation can vary greatly, 80% 
of patients show symptoms related to heart failure, such as fatigue, orthopnea, 
edema, and excessive sweating. Symptoms can also include circulatory collapse, 
arrhythmias, thromboembolic events, and sudden death [5]. Although some 
children recover [6], the prognosis of DCM generally is poor: within 2 years after 
diagnosis, approximately 40% of children die or undergo cardiac transplantation 
[4, 6-8], making DCM the leading indication for cardiac transplantation worldwide 
[9-11]. Considering the symptoms and prognosis of DCM, substantial effects on 
psychosocial wellbeing can be expected [12].
Compelling evidence from two meta-analyses shows that adults with heart 
failure are at increased risk of anxiety and depression [13, 14]. Few studies have 
examined the psychosocial wellbeing of children with DCM, but, indeed, it has been 
found that children with DCM have a lower health-related quality of life (HRQoL) 
than healthy children [12, 15-18]. However, studies examining emotional and 
behavioral problems in children with DCM are scarce. Moreover, the currently 
available studies have small sample sizes (n ≤ 15) and show contradictory results. 
In a cross-sectional study, half (n = 6 out of 12) of children with cardiomyopathy 
listed for cardiac transplantation showed clinically significant overall emotional and 
behavioral problems [19]. In contrast, a study examining depressive symptoms in 
children with DCM (n = 15) did not find higher rates of symptoms compared with 
healthy children [20]. However, it should be noted that these studies used different 
questionnaires.
Regarding the impact of impaired HRQoL on cardiac outcomes, two studies have 
shown that children’s physical HRQoL (reported by parents) predicts mortality and 
cardiac transplantation, independent from heart failure severity [15, 17]. Also, a 
meta-analysis [13] and reviews [21, 22] have consistently found that depressive and 
anxiety symptoms in adults with heart failure predict mortality and other adverse 
clinical outcomes, such as hospitalization and arrhythmias. However, to the best 
of our knowledge, the predictive value of depressive and anxiety symptoms in 
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children with DCM has not been previously studied. Information on the predictive 
value of depressive and anxiety symptoms may be valuable for clinical management 
strategies. Depressive and anxiety problems may lead to poorer self-care and, in 
turn, to disease progression [22].
The aim of the present study was twofold: firstly, we evaluated the level of parent-
reported emotional and behavioral problems in children with DCM compared with 
the general population. Secondly, we exploratively examined whether the level of 
parent-reported anxiety and depressive problems predicted the combined risk of 
death and cardiac transplantation whilst controlling for heart failure severity. Based 
on the aforementioned adult studies, we hypothesized that children with DCM 
would show more anxiety and depressive problems than children in the general 
population. Moreover, we hypothesized that anxiety and depressive problems 
would predict mortality in children with DCM independent from heart failure 
severity.
METHODS
All data used in this observational, cross-sectional study were derived from a 
larger multicenter longitudinal study in children with heart failure secondary to 
cardiomyopathy [15]. The study protocol was approved by the Medical Ethics 
Committee of the Erasmus Medical Center (protocol number NL45663.078) and 
by the institutional review boards of all participating centers. The study performed 
conformed to the ethical guidelines of the Declaration of Helsinki [23] and reported 
following the STROBE statement. Before participation, written informed consent 
was obtained from all patients’ parents or legal guardians and from all patients 
aged 12 years or above.
Participants
Participants were recruited from 1 October 2010 to 1 November 2015 through 
seven tertiary centers for pediatric cardiology in the Netherlands. The database 
was closed on 1 July 2017. Children were eligible to participate if they had heart 
failure secondary to DCM. DCM was defined as fractional shortening ≤25% and left 
ventricular end-diastolic dimension z-score >2 for body surface area. DCM could 
be idiopathic or secondary to other causes. Exclusion criteria were known mental 
retardation, congenital heart disease, neuromuscular disease, and insufficient 
mastery of the Dutch language by parents. In the current study, we only included 
1.5-18-year-old children due to age restrictions of the used questionnaire. Since 
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available, we did not recruit a healthy control group [24].
Procedure
Children were either included at DCM diagnosis or were included at an outpatient 
appointment for a previously diagnosed DCM in one of the participating tertiary 
pediatric cardiology centers. Demographic variables were obtained at inclusion. 
Socioeconomic status was based on the highest of both parents’ occupations and 
categorized into low, low to middle, middle, or high according to the international 
classification system [25]. Parents were asked to complete a questionnaire assessing 
their child’s emotional and behavioral problems during an outpatient clinic visit. 
During the same visit, a pediatric cardiologist completed the New York University 
Pediatric Heart Failure Index (NYU PHFI) [26]. This validated index assesses heart 
failure severity based on symptoms and medication use. Scores range from 0 to 30. 
A higher score indicates more severe heart failure.
Emotional and behavioral problems
One of each participant’s parents completed the problem section of the Child 
Behavior Checklist (CBCL) [27]. Depending on the child’s age, the CBCL 1½-5 
(100 items; children aged 1.5-5 years) or the CBCL/6-18 (120 items; children aged 
6-18 years) was completed. For both versions, response categories range from 
0 (not true) to 2 (very true or often true). The CBCL assesses overall emotional 
and behavioral problems and specific aspects of mental health and problem 
behavior. In addition to an overall total problem score, broadband scale scores 
can be calculated for Externalizing Problems (i.e., externally directed problems 
affecting the environment, such as aggression and delinquency) and Internalizing 
Problems (i.e., internally directed problems such as depression, anxiety, and somatic 
complaints). Furthermore, the CBCL 1½-5 consists of five scales based on the 
fifth edition of the Diagnostic and Statistical Manual Of Mental Disorders (DSM-
5; i.e., Depressive Problems, Anxiety Problems, Attention Deficit/Hyperactivity 
Problems, Oppositional Defiant Problems, and Autism Spectrum Problems). In 
addition, seven empirical scales can be calculated (i.e., Anxious/Depressed, Somatic 
Complaints, Attention Problems, Aggressive Behavior, Emotionally Reactive, 
Withdrawn, and Sleep Problems). The CBCL/6-18 consists of six DSM-5 based 
scales (i.e., Depressive Symptoms, Anxiety Problems, Somatic Problems, Attention 
Deficit/Hyperactivity Problems, Oppositional Defiant Problems, and Conduct 
Problems) and 8 empirical scales (i.e., Anxious/Depressed, Withdrawn/Depressed, 
Somatic Complaints, Social Problems, Thought Problems, Attention Problems, 
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Rule-Breaking Behavior, and Aggressive Behavior). On all scales, higher scores 
indicate more problems. For each scale, scores can be interpreted as falling in the 
normal, borderline, or clinical range by comparing scale scores with norm data. 
Scores in the borderline or clinical range indicate psychopathological problems 
with a need for clinical follow-up and/or intervention. The CBCL has adequate 
psychometric properties and normative data from the Dutch general population 
are available [24].
Endpoint
We used a combined endpoint of death and cardiac transplantation. Information on 
mortality and cardiac transplantation was retrieved from patient records. Follow-
up was censored at July 1, 2017.
Statistical analyses
Firstly, we examined whether the proportion of children scoring in the borderline 
or clinical range of emotional and behavioral problems was larger in our DCM study 
population than in the general population. All raw scale scores were converted to 
percentiles using the Achenbach System of Empirically Based Assessment Standard 
norm data, which is based on data of Dutch children from the general population 
and accounts for age and gender [27]. Conforming with the CBCL manual [27], for 
the Total Problems scale, Internalizing Problems scale, and Externalizing Problems 
scale, percentile scores of 83 or lower were defined as non-clinical and percentile 
scores of 84 or higher were defined as borderline/clinical. For the DSM scales and 
empirical scales, percentile scores of 92 or lower were defined as non-clinical and 
percentile scores of 93 or higher were defined as borderline/clinical. One sample 
binomial tests were conducted for each scale of the CBCL 1½-5 and the CBCL/6-
18 to test whether the proportion of children with DCM scoring in the borderline/
clinical range was higher than the proportion in the norm group.
Secondly, we conducted a Cox regression analysis to examine whether anxiety 
and depressive problems predicted the combined endpoint of death and cardiac 
transplantation whilst controlling for heart failure severity. The covariates entered 
into the model were the CBCL scale scores for Anxiety Problems and Depressive 
Problems and the NYU PHFI. We used t-scores to account for differences between 
the two versions of the CBCL (i.e., CBCL/1½-5 and CBCL/6-18) Anxiety Problems 
and Depressive Problems scale scores. The NYU PHFI was added to the model 
because heart failure severity is a known predictor of mortality [15]. All analyses 
were performed using SPSS Statistics version 24.0 [28].
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5RESULTS
In total, 144 children with DCM participated in the larger multicenter longitudinal 
study in children with heart failure secondary to cardiomyopathy from which data 
for the current study was derived. Of this group, 52 children were excluded from 
participation in the current study (N = 26 had a too short follow-up period to fill out 
the CBCL, N = 14 were younger than 1.5 years, N = 7 had a neuromuscular disease, 
N = 5 did not master the Dutch language sufficiently). Therefore, 92 children met 
the eligibility criteria for the current study, 68 of whom consented to participate 
in the current study (see Figure 1). Participant characteristics are presented in 
Table 1.
Figure 1 Participation flowchart.
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5Emotional and behavioral problems compared with the general population
1.5- to 5-year-old children (CBCL 1½-5)
The proportion of parent-reported emotional and behavioral problems in 1.5- to 
5-year-old children with DCM and children in the norm group is shown in Table 2. 
The CBCL 1½-5 was completed for 37 participants (by N = 9 fathers, N = 25 mothers, 
N = 3 parents together) at a median time of 19.0 months after DCM diagnosis (range 
10.0-65.0 months; see Table 1). Compared with the normative data of same-aged 
children (8.0% borderline or clinical score), a significantly larger proportion of 
children with DCM (24.0% borderline or clinical score) showed somatic complaints 
in the borderline or clinical range, p < .001. In contrast, the proportion of children 
showing a borderline or clinical level of externalizing problems was significantly 
smaller in the DCM study group (5.4% clinical or borderline score) than in the 
general population (17.0% borderline or clinical score), p = .049.
For the other scales, the proportions of borderline and clinical problems in 
children with DCM and children from the general population did not significantly 
differ. However, trends towards significance were found for more emotionally 
reactive (p = .062) and depressive problems (p = .062), and less attention deficit/
hyperactivity problems (p = .068).
Six- to 18-year-old children (CBCL/6-18)
The distribution of parent-reported emotional and behavioral problems in 6- to 
18-year-old children with DCM and children from the general population is shown 
in Table 3. The CBCL/6-18 was completed for 31 children (by n = 5 fathers, n = 23 
mothers, n  =  3 parents together) at a median time of 39.0 months after DCM 
diagnosis (range 12.0-177.0 months; see Table 1). Compared with normative data 
of same-aged peers, significantly larger proportions of children with DCM showed 
problems in the borderline or clinical range on the following scales: Internalizing 
Problems (p = .001; 17.0% vs. 38.7%), anxious/depressed problems (p = .023; 8.0% 
vs. 19.4%), somatic complaints (p < .001; 8.0% vs. 29.0%), depressive problems (p 
< .001; 8.0% vs. 29.0%), anxiety problems (p = .023; 8.0% vs. 19.4%), and somatic 
problems (p < .001; 8.0% vs. 25.8%). For the other scales, the proportion of 
borderline and clinical problems did not significantly differ between children with 
DCM and children from the general population.
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Predictive value of anxiety and depressive problems on endpoint
We examined whether anxiety and depressive symptoms predicted the combined 
risk of death or cardiac transplantation whilst controlling for NYU PHFI. The 
proportional hazard assumptions were not violated. Before July 1, 2017, 11 
participants (16.2%) had reached an endpoint. One had died and 10 had undergone 
cardiac transplantation. The results of the Cox regression analysis are presented 
in Table 4. Anxiety problems and depressive problems did not significantly predict 
death or cardiac transplantation. However, the NYU PHFI did significantly predict 
the risk of death or cardiac transplantation, p < .001. A one unit increase in the NYU 
PHFI resulted in a 42% higher risk of death or cardiac transplantation (hazard ratio 
1.42, 95% confidence interval 1.19-1.69).
Table 4 Results of Cox regression analysis.
95% CI*
Variable HR† Lower Upper p-value
Anxiety Problems (t-score) 0.98 0.89 1.09 .72
Depressive Problems (t-score) 0.98 0.88 1.08 .64
NYU PHFI‡ (per unit) 1.42 1.19 1.69 < .001
*CI = confidence interval 
† HR = hazard ratio 
‡ NYU PHFI = New York University Pediatric Heart Failure Index
DISCUSSION
The current study is the first to investigate emotional and behavioral problems 
in a substantial cohort of children with DCM. Some results are in line with our 
expectations. Importantly, we found that, compared with normative data of same-
aged peers, larger percentages of older children (6-18 years old) with DCM showed 
overall internalizing problems, anxiety problems, and depressive problems. Also, 
we found trends towards significance suggesting that, compared with normative 
data of same-aged peers, larger percentages of younger children (1.5-5 years old) 
with DCM showed emotionally reactive problems and depressive problems. These 
results are in line with meta-analyses in adult heart failure populations, which 
demonstrate an increased risk of anxiety and depression [13, 14].
Until now, only two studies have examined emotional and behavioral problems in 
children with DCM. The first study was conducted by Wray and Radley-Smith [19] 
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5who found that 50% of the children with cardiomyopathy in their study (n=19, age 
3½-17 years) showed a clinical level of overall emotional and behavioral problems 
on the CBCL questionnaire. In our study, this percentage was markedly lower (i.e., 
10.8% in younger children and 16.1% in older children). This difference may be due 
to the fact that all children with cardiomyopathy in Wray and Radley-Smith’s study 
were listed for cardiac transplantation, whereas in our study this was not the case.
In the second study, Menteer and colleagues [20] compared the level of depressive 
symptoms in children (aged 7-21 years) with DCM (n  =  15), children who had 
successfully undergone cardiac transplantation for heart failure (n = 23), and healthy 
children (n = 24). In contrast to our results, they found similar levels of depressive 
symptoms in all groups. That is, the level of depressive symptoms in children with 
DCM did not significantly differ from the level of depressive symptoms in healthy 
children and children who had undergone cardiac transplantation. However, 
it should be noted that Menteer and colleagues used small sample sizes, which 
limits the statistical power to detect differences between groups. Moreover, this 
discordance in results may be explained by the fact that we assessed depressive 
problems through the CBCL questionnaire whereas Menteer and colleagues used 
the Children’s Depression Inventory (CDI)[29]. Although both instruments assess 
depressive symptoms, previously, moderate correlations between CDI total scores 
and CBCL depressive problems scores have been found [30].
Depressive and anxiety problems in children with DCM may be caused by factors 
directly or indirectly related to the illness. For example, in other chronic illnesses, 
it has been shown that the symptoms of the illness itself [31, 32] and side effects 
of medical treatments [33] can provoke anxiety and depressive symptoms. More 
indirectly, illness uncertainty (i.e., uncertainty regarding prognosis, disease course, 
and treatment) can increase symptoms of depression and anxiety [31, 34]. This can 
be explained by the cognitive coping theory [35], which states that children interpret 
situations based on previous knowledge and experiences. When such information 
is lacking, a situation may be interpreted as a threat, which consequently increases 
symptoms of depression and anxiety [31, 36-39]. Similarly, medical treatments 
such as injections may be experienced as distressing and threatening, thereby 
increasing children’s anxiety levels [31]. Furthermore, it is known that parental 
overprotectiveness can promote anxiety and depressive symptoms in children 
with a chronic illness [31, 34, 40]. Depressive and anxiety problems may also have 
a biological cause. In adult [41, 42] and pediatric [43] heart failure populations, 
reduced brain tissue volumes have been found in brain areas which regulate mood. 
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Future research is needed to draw definite conclusions as to biological causes of 
mood problems in DCM.
Besides increased anxiety and depressive problems, we demonstrated that, 
compared with normative data, a larger percentage of young and older children 
with DCM showed a borderline or clinical level of somatic problems. This is not 
surprising considering all children had heart failure problems secondary to DCM. 
Furthermore, previous studies have reported reduced levels of physical health 
related quality of life in this population [15].
Other results of the current study were unexpected or contrary to our hypotheses. 
Firstly, we found that, compared with normative data, a smaller percentage of 
young children with DCM showed a borderline or clinical level of externalizing 
problems. In line with this result, we found a trend towards significance suggesting 
that, compared with normative data, a smaller percentage of young children with 
DCM showed attention deficit/hyperactivity problems. This might be explained by 
increased levels of fatigue reported in DCM [5], which may contribute to children 
showing less hyperactive behavior.
Secondly, contrary to our hypothesis, we found that anxiety and depressive 
problems in children with DCM did not predict the risk of death and cardiac 
transplantation whilst controlling for heart failure severity. However, in line with 
the results of a previous DCM study, heart failure severity (NYU PHFI) did predict 
the risk of death and cardiac transplantation [15]. In contrast with our findings, in 
adult heart failure populations, a multitude of studies have shown that depressive 
problems predict mortality and other adverse clinical outcomes [e.g., 13, 21, 44, 
45-48]. Furthermore, increasing evidence shows that anxiety problems predict 
mortality in adult heart failure [22]. An explanation for our different findings is 
that, in adults, depressive and anxiety problems can lead to poorer self-care [49]. 
In children, however, parents may compensate for children’s poorer self-care 
behaviors which subsequently diminishes the impact of depressive and anxiety 
problems on their physical health. Also, it should be noted that statistical power 
to detect associations was limited.
This study has several strengths. Studies exclusively examining pediatric 
cardiomyopathy patients are scarce [12]. As stated, the current study is the first to 
examine emotional and behavioral problems in a relatively large cohort of children 
with DCM. We recruited children with DCM through seven tertiary centers for 
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5pediatric cardiology. Also, we investigated problems in a broad age range (1.5 to 
18 years), using an internationally well-validated questionnaire (CBCL) to assess 
a wide range of emotional and behavioral problems. The multicenter recruitment 
and the inclusion of a broad age range improve the generalizability of our results 
in the pediatric DCM population. Moreover, we examined the predictive value 
of depressive and anxiety problems on mortality and cardiac transplantation 
whilst controlling for heart failure severity, which is a known predictor of adverse 
outcomes. Furthermore, results from our study population were compared to 
representative normative data matched on age and gender.
The results of this study must also be interpreted in light of a few limitations. Firstly, 
although the study sample is relatively large considering the prevalence of DCM, 
the number of events in the study was 11, which limits the statistical power of the 
prediction analyses. Secondly, we only used proxy-reports completed by parents 
because most participating children were too young to complete the self-report 
version of the CBCL [50]. Of the children who were old enough to complete the 
self-report version of the CBCL an insufficient number to analyze completed the 
questionnaire. The use of proxy-reports has been frequently debated. Studies have 
found that parent proxy-reports of quality of life in pediatric cardiac populations 
may differ from child self-reports [51, 52]. In another pediatric cardiac population, 
Patel and colleagues [53] found that parent-child agreement was stronger for 
more readily observable variables such as physical functioning and externalizing 
behavior and lower for variables which tend to be less visible, such as anxiety, 
emotional functioning, and internalizing behavior. In contrast, in a pediatric cardiac 
population, Marino and colleagues [54] found that parent-proxy reports and child 
self-reports on quality of life did not differ. Moreover, Wilmot and colleagues 
[16] reported moderate parent-child agreement on quality of life of children with 
cardiomyopathy. Considering the scarcity of research into emotional and behavioral 
problems in children with DCM, further research is needed using well-attuned 
self-reports as well. Thirdly, we combined both father and mother reports in our 
analyses. Although this may induce bias [55], it should be noted that the majority 
of questionnaires were completed by mothers and previous research has found 
moderately high inter-parent agreement on the CBCL [56]. Fourthly, considering 
the relatively long period of time between DCM diagnosis and participation in the 
current study (see Table 1), it should be noted that the current cohort represents 
children with chronic heart failure. Children who reached an endpoint or recovered 
shortly after diagnosis are likely underrepresented.
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In conclusion, this first study specifically examining emotional and behavioral 
problems of children with DCM showed, compared with normative data, 
significantly more borderline or clinical levels of anxiety, depressive problems, 
and somatic problems in 6-18-year-olds and significantly more borderline or 
clinical somatic problems and less externalizing problems in 1.5-5-year-olds. 
These findings demonstrate the importance of including routine screening for 
internalizing problems to the clinical management of children with DCM [10] 
and of providing psychosocial support attuned to the needs of these children. 
Considering the previously mentioned influence of parental behavior on anxiety 
and depressive symptoms in pediatric chronic illness, such psychosocial support 
should not only focus on the children themselves but also include their parents. 
Future research should focus on evidence-based psychosocial programs to treat 
and prevent internalizing problems in pediatric cardiomyopathy. As the available 
literature on emotional and behavioral wellbeing in pediatric cardiomyopathy is 
limited, many aspects remain to be studied. Considering previous adult studies and 
our findings, future research should focus on anxiety and depression in pediatric 
DCM. Moreover, as the results of our study show that emotional and behavioral 
problems in DCM seem to differ per age group, it would be useful to examine this in 
more age groups. Furthermore, a previous study [15], found that HRQoL in children 
with DCM was more impaired at diagnosis than more than 1 year after diagnosis. 
Whether this is also the case for emotional and behavioral problems remains to 
be studied. Also, since little is known about the psychosocial wellbeing of children 
with cardiomyopathy, future qualitative studies would be valuable.
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CHAPTER 6
EMDR for children with medically related 
subthreshold PTSD: short-term effects 
on PTSD, blood-injection-injury phobia, 
depression and sleep
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del Canho, Ramón J. L. Lindauer, Manon H.J. Hillegers, Henriette A. Moll, 
Wim A. Helbing, Elisabeth M. W. J. Utens
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ABSTRACT
Background. Pediatric illness, injury and medical procedures are potentially 
traumatic experiences with a range of possible negative psychosocial consequences. 
To prevent psychosocial impairment and improve medical adherence, evidence-
based psychotherapy should be offered if indicated. Eye movement desensitization 
and reprocessing (EMDR) has been found to reduce symptoms of posttraumatic 
stress disorder (PTSD) in adults. The evidence for the use with children is promising. 
Furthermore, recent studies indicate its effectiveness for the treatment of 
other psychological symptomatology. However, the effectiveness of EMDR in 
children with subthreshold PTSD after medically related trauma has not yet been 
investigated.
Objective. Investigating the short-term effectiveness of EMDR on posttraumatic 
stress, anxiety, depression and sleep problems in children with subthreshold PTSD 
after hospitalization through a randomized controlled trial (RCT).
Method. Following baseline screening of 399 children from various Dutch hospitals, 
74 children (4-15 years old) with medically related subthreshold PTSD were 
randomized to EMDR (n=37) or care-as-usual (CAU; n=37). Follow-up assessment 
took place after M=9.7 weeks. Generalized Estimating Equation (GEE) analyses 
were performed to examine the effectiveness of EMDR compared to CAU.
Results. Children in both groups improved significantly over time on all outcomes. 
However, the EMDR group improved significantly more as to child-reported 
symptoms of blood-injection-injury (BII) phobia and depression, and child-, and 
parent-reported sleep problems of the child. There was no superior effect of EMDR 
compared to CAU on subthreshold PTSD symptom reduction.
Conclusions. EMDR did not perform better than CAU in reducing PTSD symptoms 
in a pediatric sample of children with subthreshold PTSD after hospitalization. 
However, the study results indicate that EMDR might be superior in reducing 
symptoms of blood-injection-injury phobia, depression and sleep problems.
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A growing number of studies have confirmed posttraumatic stress reactions 
and other psychopathological symptoms in children and adolescents after 
hospitalization and medical procedures [1, 2]. Although many children are resilient 
and show a reduction in symptoms in the weeks after the medical event, some 
experience long-term impairing symptomatology or even develop a mental 
disorder. Common symptoms after medical events are posttraumatic stress, 
anxiety (especially blood-injection-injury phobia), mood and sleep problems [2-5]. 
Prevalence rates of posttraumatic stress disorder (PTSD) in children after chronic 
illness (e.g., heart disease) or acute injury (e.g., after traffic accidents) vary from 12 
to 31% [6, 7]. PTSD is a serious mental disorder which is associated with substantial 
impairment in cognitive, academic, social and emotional functioning [8-11]. Similar 
impairment is seen in children with subthreshold PTSD (i.e. not meeting all criteria 
for a full diagnostic PTSD), which is even more common than full diagnostic PTSD, 
namely 25-38% [1, 2, 12, 13]. These findings underscore the clinical significance 
of subthreshold PTSD and suggest a need for appropriate treatment options. 
However, subthreshold PTSD is often overlooked and stays untreated which can 
lead to worsening of the symptoms and full diagnostic PTSD [14]. While treatment 
possibilities for full diagnostic PTSD are widely studied, evaluations of treatment 
options for subthreshold PTSD are very scarce [15, 16].
Eye movement desensitization and reprocessing (EMDR) is one of the most 
studied evidence-based psychotherapies for PTSD treatment in adults [17-19]. Like 
many psychotherapies, EMDR was developed for adults and was later adapted 
for children. Consequently, scientific studies into the effectiveness of EMDR 
for children are underrepresented [20, 21]. Two meta-analyses and one review 
including only a few studies show promising results regarding EMDR for children 
[22-24]. Interestingly, a recent meta-analysis comparing the effectiveness of EMDR 
and cognitive behavioral therapy (CBT) showed that children with subthreshold 
PTSD exhibited significantly greater reductions in PTSD symptoms following 
treatment than those who were reported to have full diagnostic PTSD [25]. 
However, the effectiveness of EMDR for children has not yet been investigated 
focusing solely on children with subthreshold PTSD.
EMDR has originally been developed as PTSD treatment, but it has also been shown 
to be useful for the treatment of other mental health issues [26]. Evidence suggests 
that EMDR reduces symptoms of anxiety and depression in children [24, 27-29] and 
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sleep problems in adults [30]. However, these EMDR treatment outcomes have not 
yet been studied in pediatric medical settings.
The use of EMDR in medical settings was recently recommended by the developer 
of EMDR herself [31]. However, studies into the effectiveness of EMDR in a 
pediatric medical setting are scarce. Kemp and colleagues [32] found significant 
PTSD symptom reduction after four EMDR sessions in children (6-12 years) 
who were injured in motor vehicle accidents and initially met two or more PTSD 
criteria. However, this study had a very small sample size (controls n=14, EMDR 
n=13). Another small study with children who experienced a road traffic accident 
(n=11) found significant reductions of PTSD, general anxiety, and depression after 
an average of 2.4 EMDR sessions [33]. However, this study did not use a control 
group. A very small quasi-experimental study in Iranian children who survived 
serious traffic accidents also claims to show positive results of EMDR, but no firm 
conclusions can be drawn from the article due to methodological reasons [34]. 
Furthermore, a study in children who had experienced different kinds of traumas, 
including a small subsample of children with medically related trauma (23% 
accidents, 7% serious illness), also found promising results for EMDR in reducing 
PTSD symptoms [35]. Again, the sample size was small (CBT n=23, EMDR n=25).
Overviewing this rather unexplored field, systematic research in larger samples 
remains urgently needed. Our study represents the first randomized controlled 
trial that specifically aims to investigate the effectiveness of EMDR in reducing 
medically related subthreshold PTSD after hospitalization for pediatric illness 
or injury. Secondary aims were to test the effectiveness of EMDR in reducing 
children’s anxiety (especially blood-injection-injury phobia), depression and sleep 
problems.
METHODS
Design
This randomized controlled trial (RCT) represents a single-center study. All therapy 
sessions took place in the Erasmus MC - Sophia children’s hospital in Rotterdam, 
the Netherlands. Participants were recruited via the Sophia children’s hospital 
(divisions of pediatrics and pediatric cardiology), the pediatrics division of the 
Maasstad hospital in Rotterdam, the pediatric cardiology division of the Radboud 
UMC Nijmegen, and nationally through the Dutch Association for patients with 
a congenital heart defect, and the Dutch non-profit organization Heartchild 
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been published previously [36]. The study was approved by the Medical Ethics 
Committee of the Erasmus Medical Center in the Netherlands, registered in 
the Dutch Trial Register (NTR5801), and performed conform the Declaration of 
Helsinki [37].
Participants
The target group was 4-15-year-old children with medically related subthreshold 
PTSD after >1 hospitalization(s) of at least one night. The presence of subthreshold 
PTSD was first investigated with the Children’s Responses to Trauma Inventory 
(CRTI) [38]. Subthreshold PTSD was defined as either (1) fulfilling at least two of the 
three DSM-IV PTSD symptom criteria (re-experience, avoidance or hyperarousal) 
and/or (2) having an above average score (>60th percentile) on the CRTI; without 
a full diagnostic PTSD score on a semi-structured interview afterwards. The last 
hospitalization or additional medical procedure(s) should have occurred at least 
4 weeks and at most 5 years ago. The inclusion period was from July 2016 until 
May 2018.
The screening for subthreshold PTSD took place during a baseline assessment 
(T1). For this assessment, we included children who had been hospitalized 1) after 
consultation at an emergency department due to acute injury or illness, or 2) at a 
pediatric cardiology department due to a congenital or acquired heart defect. Both 
groups encompassed children who experienced single (type I trauma) or multiple 
(type II trauma) medical events. In this study, we defined type I trauma as a first 
hospitalization of previously healthy children. Type II trauma was defined as >2 
hospitalizations or an additional medical procedure (e.g. surgery) next to an one-
time hospitalization.
Exclusion criteria were: (1) intellectual disability (IQ<70); (2) parental inability to 
read or write Dutch; (3) diagnosis of a chronic illness for the emergency department 
subgroup; (4) previous successful treatment for medically related PTSD; and (5) 
current psychological treatment.
Procedure
After informed consent was obtained, 420 participants were asked to fill out 
questionnaires to screen for PTSD symptoms (primary outcome) and other related 
psychosocial symptoms (secondary outcomes) during a baseline assessment 
[39]. Subsequently, children (aged 8-15 years) with baseline scores indicating at 
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least subthreshold levels of PTSD were invited for a semi-structured interview 
(Clinician-Administered PTSD Scale for Children and Adolescents, CAPS-CA) [40]. 
For children aged 4-7 years with at least subthreshold levels of PTSD, one parent 
was interviewed using the PTSD module of the Diagnostic Infant and Preschool 
Assessment (DIPA) [41]. Since our study focused on children with subthreshold 
PTSD, children with a full diagnostic PTSD score on the interview were excluded 
and referred for treatment. Seventy-four children with subthreshold PTSD were 
randomized on a 1:1 ratio into the EMDR (n=37) or care-as-usual group (CAU; n=37). 
Randomization was stratified by trauma type (i.e. type I vs. type II trauma) and age 
(i.e. 4-11 vs. 12-15) using blocks, and performed by an independent researcher 
using opaque envelopes. Questionnaires were filled out at baseline (T1) and during 
a follow-up assessment M= 9.7 (SD=2.5) weeks after the first EMDR session (T2). 
Of the 74 randomized children, three (EMDR n=2; CAU n=1) were erroneously 
randomized due to misinterpretation of their score (two children scored only one 
point below the cut-off). Within the EMDR group, four children did not start with 
EMDR at all after randomization. See figure 1 for an overview.
Measures
Children >6 years of age were asked to fill out questionnaires. Parent-report 
was asked for children of all included ages. Participants were asked to fill out the 
questionnaires with regard to a medical event. All questionnaires have adequate 
psychometric properties.
Primary outcome
PTSD symptoms were measured using the Dutch version of the CRTI [38]. The CRTI 
contains 24 PTSD items which can be divided into three subscales related to the 
DSM-IV-TR symptom clusters of PTSD (intrusion, avoidance, and hyperarousal). 
The total PTSD score can range from 17 to 85, with a higher score indicating more 
problems. The scores on the subscales intrusion and hyperarousal can range from 
5-25 and on avoidance from 7-35.
Secondary outcomes
Symptoms of depression were measured through the total score of the Dutch 
Children’s Depression Inventory 2 (CDI-2) [42]. The parent version contains 17 
items with a 4-point Likert scale and the child version contains 28 items with a 
3-point Likert scale. Scores can range from 0 to 51 (parent-version) or 56 (child-
version). A higher score indicates more problems.
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measured through the BII subscale (7 items) and the total score (69 items) of the 
Dutch Screen for Child Anxiety Related Emotional Disorders (SCARED-NL) [43]. 
Responses are scored on a 3-point Likert scale (0-2) with a maximum score of 14 
(BII subscale) and 138 (total score). A higher score indicates more problems.
Sleep problems were measured using the total score of the Dutch Sleep Self Report 
(SSR, 23 items) [44] and the Dutch parallel parent version called Child Sleep Habits 
Questionnaire (CSHQ, 35 items) [45]. Responses are rated on a 3-point Likert scale 
(1-3) with maximum total scores of 69 (SSR) and 99 (CSHQ). Again, a higher score 
indicates more sleep problems.
Figure 1 Participation flow chart.
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Social validity questions were added to investigate parents’ and children’s 
subjective evaluation of the EMDR treatment. Three aspects of social validity 
(satisfaction with EMDR, usefulness of EMDR and recommendation of EMDR) were 
assessed in the EMDR group at T2. A 10-point Likert scale (0-10) was used with a 
higher score indicating more satisfaction, perceived usefulness and willingness to 
recommend EMDR.
Intervention
EMDR is based on the assumption that traumatic memories are stored inadequately. 
During therapy, the child is asked to think about a currently disturbing memory 
while simultaneously focusing on a bilateral stimulation (i.e. eye movements). 
This initiates processing of the memory. The working mechanism of EMDR is still 
unclear. The hypothesis with most support is that engaging in two simultaneous 
tasks (i.e. eye movements and thinking about a disturbing memory) draws on the 
limited capacity of the working memory and therefore decreases the vividness of 
the image [46].
Children in the EMDR group received M=3.5 (SD=1.9) EMDR sessions (intake 
included) of approximately 50 minutes. Parents were allowed to be present during 
the sessions when the child agreed on this with the therapist. EMDR therapy was 
provided by five licensed and experienced clinical psychologists following the 
standard Dutch EMDR protocol for children and adolescents [47] or the adapted 
version for young children [48, 49]. EMDR treatment was completed when (1) 
Subjective Units of Distress (SUDs) of all selected memories regarding the medical 
trauma were zero and/or (2) positive cognitions were established (rated by the 
child) and/or (3) child, parents and therapist agreed that PTSD symptoms had 
sufficiently decreased. Children in the CAU group only received standard medical 
care.
Treatment integrity
All five EMDR-therapists participated in regular supervision sessions provided by 
a EMDR Europe consultant (licensed supervisor). All EMDR sessions were video-
taped. If no consent for videotaping was obtained, the therapists provided detailed 
written records. All sessions of 10 randomly chosen children (27%) were rated on 
protocol adherence by a trained research psychologist and two trained Master 
students in psychology, supervised by the aforementioned research psychologist. 
Rating was done with an EMDR-specific treatment integrity checklist with a total 
score ranging from 0-16. There was good agreement between all three independent 
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with 95%.
Statistical analyses
We conducted t-tests and χ2-tests to test differences between the EMDR and 
CAU group baseline characteristics. Correlations between child and parent report 
were analyzed using Pearson’s r and differences were tested using paired sample 
t-test. To test for differences in outcome scores between both groups in the total 
sample, Generalized Estimating Equations (GEE) with an unstructured correlation 
matrix were performed following the intention-to-treat principle. We conducted 
a GEE analysis for each outcome separately. In each analysis, we first added time 
(T1 vs. T2) and group (EMDR vs. CAU) as factors. Interactions between time and 
group were tested for significance with Wald χ2 tests. Second, if the interaction was 
significant, we ran the GEE analyses again adding age, gender and whether the child 
had experienced >1 other non-medical stressful life events as covariates. Third, 
for all significant interactions, we also added trauma type, hospital department, 
and time since last medical event as covariates and, for explorative analyses, their 
interaction with time and group.
In addition, we ran the analyses of the first step again 1) following the per-protocol 
principle and 2) without the three erroneously randomized children. Effect sizes 
were measured with Cohen’s d by dividing the difference between the estimated 
means of both groups at T2 by the pooled standard deviation at T1 [50]. SPSS 
version 24.0 was used for all statistical analyses.
RESULTS
Baseline characteristics
At baseline, no differences were found between the EMDR and CAU group with 
regard to baseline demographics. See Table 1 for more information. However, the 
EMDR group had a significantly higher mean score at baseline on the child-reported 
total sleep problem score than the CAU group [t(65) = -2.3, p<.05].
Parent-child agreement
PTSD symptoms. The correlation between child and parent report on the primary 
outcome (CRTI) was moderate (r=.31) at T1 and high (r=.56) at T2. Differences 
between child and parent report at the two time points were not significant.
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Symptoms of depression. The correlation between parent and child report on 
depression was high at T1 (r=.58) and T2 (r=.76). Differences between child and 
parent report could not be tested due to incomparable questionnaires.
Symptoms of BII phobia and anxiety in general. Parent and child report for BII 
phobia was high at T1 (r=.71) and T2 (r=.75). There were significant differences 
in the T1 scores for parent report (M=5.06, SD=3.16) and child report (M=5.76, 
SD=3.21); t(66)=-2.35, p=.02. The correlation between parent and child report on 
the SCARED-NL total score was also high at T1 (r=.53) and T2 (r=.75). There were 
no significant differences between child and parent report.
Sleep problems. The correlation between child and parent report on sleep 
problems were high at T1 (r=.53) and T2 (r=.79). To test for differences between 
child and parent reported sleep problems, CSHQ total scores were divided by 
35 (number of CSHQ items) and then multiplied by 23 (number of SSR items). At 
both assessment points, children (M
T1
= 37.09, SD
T1
=5.97; M
T2
=34.18, SD
T2
=6.36) 
reported significantly more sleep problems than parents (M
T1
= 32.70, SD
T1
=5.47; 
M
T2
=30.23, SD
T2
=5.50); t
T1
(66)=-6.47, p=.00 and t
T2
(56)=-7.56, p=.00.
Primary outcome
Outcomes of the EMDR and CAU group are shown in Table 2. Children in both 
groups showed a similar reduction in PTSD symptoms from baseline to follow-up. 
EMDR was not significantly superior compared to CAU in reducing child-reported 
(b=-0.5, p=.853) and parent-reported (b=-3.5, p=.275) PTSD symptoms of the child. 
The same was true for all three PTSD subscales.
Secondary outcomes
From baseline to follow-up, child-reported symptoms of blood-injection-injury 
phobia decreased significantly more in the EMDR group than in the CAU group 
(b=-1.5, p=.034). This effect remained significant in a secondary GEE analysis 
controlling for age, gender and other stressful life events (b=-1.5, p=.034, Cohen’s 
d=-.46). In contrast, parent-reported BII phobia symptom reduction in the child 
did not differ significantly between the EMDR group and the CAU group (b=-0.5, 
p=.364).
As to child-reported anxiety symptoms, EMDR was not superior in reducing child-
reported total anxiety symptoms compared to CAU (b=-6.8, p=.101). The same was 
true for parent-reported total child anxiety symptoms (b=-3.8, p=.288).
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group than in the CAU group (b=-2.5, p=.037). This effect remained significant after 
controlling for age, gender and other stressful life events (b=-2.5, p=.037, Cohen’s 
d=-.40). As to parent-reported symptoms of depression of the child, a trend towards 
significance in favor of the EMDR group was found (b=-2.6, p=.05).
With regard to child-reported sleep problems we found a significant larger 
reduction from baseline to follow-up for the EMDR group compared with the CAU 
group (b=-3.6, p=.003). This effect remained significant after controlling for age, 
gender and other stressful life events (b=-3.6, p=.003, Cohen’s d=-.63). Children’s 
sleep problems reported by the parents also reduced significantly more in the 
EMDR group than the CAU group (b=-2.8, p=.032). However, this effect was not 
significant anymore after controlling for age, gender and other stressful life events 
(b=-2.6, p=.059, Cohen’s d=-.31).
Explorative analyses
No significant differences in treatment effect were found for trauma type and 
hospital department. However, the effect of EMDR in reducing child-reported 
symptoms of depression and sleep problems were larger the longer ago the last 
medical event happened.
Additional analyses
Per-protocol analyses revealed some minor deviations regarding the secondary 
outcomes compared to intention-to-treat analyses. In addition to the findings that 
EMDR was superior to CAU in treating BII phobia (child-report), depression (child-
report) and sleep problems (child-report and parent-report), per-protocol analyses 
showed that EMDR was also superior in treating parent-reported symptoms of 
depression of the child and child-reported total anxiety score.
Furthermore, we did another analysis without the children who were erroneously 
randomized. In contrast to the previous analyses, improvements between baseline 
and follow-up regarding child-reported depressive symptoms and parent-reported 
sleep problems of the child were not significantly larger for the EMDR group 
anymore. However, the superior effects of EMDR on child-reported BII phobia 
symptoms and child-reported sleep problems remained significant.
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Social validity
On a scale of 1 to 10, mean child (n=29) and parent (n=31) ratings of satisfaction 
with EMDR treatment were 8.2 (SD=1.6) and 8.0 (SD=1.1), respectively. The mean 
level of perceived usefulness of EMDR rated by children was 7.8 (SD=1.9) and by 
parents 6.8 (SD=2.3). On average, the willingness to recommend EMDR to others 
was rated with a 7.9 (SD=2.3) by children and with a 7.7 (SD=1.7) by parents.
DISCUSSION
This study presents outcomes of the first randomized controlled trial investigating 
the effectiveness of EMDR compared with CAU for children with medically related 
subthreshold PTSD after hospitalization for illness or injury. Children of both 
groups improved over time, but EMDR was superior in reducing symptoms of 
depression and BII phobia, and sleep problems.
We found significant improvements for both the EMDR and the CAU group 
over time on all outcomes. This could be due to the fact that children in the CAU 
group participated in a baseline psychological screening and an interview with 
a psychologist and, thereby, received additional attention from a professional. 
Participating in a structured assessment and hearing that PTSD symptoms 
were of subthreshold nature might be therapeutic in itself by acknowledging 
and normalizing the child’s symptoms. Furthermore, research suggests that 
participating in a psychological study can decrease psychosocial symptomatology 
[51, 52].
With regard to PTSD symptom reduction, EMDR was as effective as CAU. 
This is in contrast to two meta analyses reporting on smaller studies [22, 24]. 
However, these studies did not specifically focus on medically related trauma and 
subthreshold PTSD. It is possible that with medically related subthreshold levels 
of PTSD, receiving attention from a mental health professional is enough to reduce 
symptoms and that EMDR, therefore, had no superior effect compared to CAU in 
our sample. Bearing in mind the limited resources of psychotherapists, a stepped-
care model might be most efficient and cost-effective for monitoring and treating 
symptoms. This model proposes that mental health care is provided in steps and 
based on the needs of the child, with only those with persistent severe symptoms 
progressing to psychotherapy [53]. Additionally, natural remission from PTSD 
symptoms can also occur [14, 54]. Exact remission rates, however, of children with 
medically related subthreshold PTSD are unknown. Future research should provide 
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that we did not find any harmful effect of EMDR and that parents and children 
evaluated EMDR as very satisfactory.
Sleep problems are part of the DSM-V criteria for PTSD. However, sleep problems 
are rarely investigated as treatment outcome of EMDR. The present study 
presents support for the use of EMDR to reduce sleep problems in children after 
hospitalization. This is in line with Raboni et al. [30], who showed that EMDR 
treatment of PTSD improved sleep quality in adults.
Furthermore, PTSD tends to be closely related to specific phobias as these often 
have a traumatic origin too [55]. Interestingly, we found a superior effect of EMDR 
in reducing child-reported symptoms of blood-injection-injury phobia. This is in 
line with previous research indicating a positive effect of EMDR on dental phobia 
[56, 57]. Our finding that EMDR can reduce BII is clinically very relevant: it may 
be beneficial for future medical adherence as phobic patients tend to avoid the 
source of their fear.
Level of medical adherence has also been found to be smaller in patients who suffer 
from depression [58]. In line with previous findings, our results indicate that child-
reported symptoms of depression decreased significantly more in the EMDR group 
than in the CAU group [28, 59] and, thereby, possibly improved medical adherence.
As to our multi-informant approach, correlations between child and parent report 
were moderate to high. Still, children reported significantly higher mean scores on 
BII phobia at T1 and sleep problems at T1 and T2 compared to parent-report. Earlier 
research has also found that child report tends to be higher than parent report 
on both outcomes [60, 61]. It has been argued that some aspects of internalizing 
problems and sleep may manifest beyond parent’s awareness and therefore child-
report might be more reliable [62, 63]. However this might not be true for young 
children. The additional analyses revealed that per-protocol analyses showed 
additional superior effects of EMDR on reducing child-reported anxiety and parent-
reported symptoms of depression of the child. However, per-protocol analyses 
represents the best-case scenario and may therefore show an exaggerated effect 
[64]. Furthermore, we also tested whether the benefits of EMDR remained when 
the three erroneously randomized children were eliminated from the statistical 
analyses. The superior effects of EMDR on child-reported BII phobia and sleep 
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problems remained significant. Since results were changing during the additional 
analyses, results of this study should be interpreted with caution.
Finally, we also explored whether trauma type (I vs. II), type of department 
(emergency vs. cardiology) or time since last medical event (0-5 years) influence the 
found treatment effects. In accordance to Diehle et al. [35], treatment effect was 
not related to trauma type. The same was true for hospital department. However, 
the time elapsed since the last medical event did influence the treatment effect. 
The longer ago the last medical event happened, the more effective was EMDR in 
reducing child-reported symptoms of depression and sleep problems. This finding 
is explorative and should be tested in future studies.
Strengths and limitations
This study presents several strengths. First, our sample size was relatively large 
compared to earlier research into the effectiveness of EMDR in children. Second, 
we used parent and child report for all outcomes and included a broad age range. 
Third, we recruited participants throughout the Netherlands which increases 
generalizability. Fourth, all therapists received regular supervision and treatment 
integrity was assessed by multiple independent raters. Fifth, randomization was 
stratified and done by an independent researcher. Sixth, the researcher who was 
responsible for all assessments was blinded for randomization outcome. Finally, we 
specified the trauma type that children in our sample had experienced and explored 
the effects of trauma type during analyses.
Some limitations should also be noted. First, it should be noted that the CAU 
group did not represent real care-as-usual as this group received a psychological 
screening and interview in addition to regular medical care. No similar attention 
placebo control group was provided. Second, follow-up questionnaires were sent 
to participants 8 weeks after the first EMDR session regardless of whether EMDR 
was completed or not for methodological reasons. Therefore, the time between 
completion of EMDR and follow-up was different for every participant and six 
participants had not completed therapy when filling out the follow-up assessment. 
Third, EMDR might be more effective in children with more severe PTSD symptoms. 
However, it would have been unethical to randomize children with full diagnostic 
PTSD into a CAU group when other treatment options for PTSD are available. 
Fourth, due to the nature of EMDR it was not possible to blind participants to 
their group allocation. Finally, we did not assess parental mental health which is 
associated with parent report of the child’s emotional wellbeing [65] and we did 
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when an active parental treatment component would be added [27, 66].
Despite the mentioned possible limitations, this study represents the largest RCT 
up-to-date investigating the effectiveness of EMDR in children with medically 
related subthreshold PTSD after hospitalization.
Conclusion
In children with medically related subthreshold PTSD, EMDR and CAU performed 
similarly well at reducing PTSD symptoms. However, the present study provides 
some indication for the effectiveness of EMDR in reducing BII phobia, depression 
and sleep problems. No firm conclusions can be drawn from these findings since 
results changed during additional analyses. Comparable studies should be done to 
support the implementation of EMDR as an evidence-based therapy for BII phobia, 
depression and sleep problems after pediatric hospitalization.
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CHAPTER 7
General discussion
GENERAL DISCUSSION
The overall focus of the current thesis was to examine and improve the psychosocial 
well-being of children with congenital or acquired heart defects. The main aims 
were to study:
(1) whether anxiety problems in young children with anxiety disorders decreased 
after participating in the Fun FRIENDS program;
(2) the effectiveness of the CHIP-Family intervention on the psychosocial well-
being of young children with congenital heart defects (CHDs) and their families;
(3) the level of emotional and behavioral problems in children with dilated 
cardiomyopathy (DCM);
(4) the effectiveness of eye movement desensitization and reprocessing (EMDR) in 
children with medically-related subthreshold posttraumatic stress disorder 
(PTSD).
 
The main aims, methods, and findings are summarized in Table 1. In the following 
section, our findings are summarized and placed in a broader perspective. We 
will also discuss the implications of our findings for the development of future 
psychosocial interventions in this population, suggest directions for future 
research, and discuss clinical implications.
FUN FRIENDS PROGRAM FOR YOUNG CHILDREN WITH ANXIETY 
DISORDERS
In chapter 2, we described our explorative pilot study examining whether anxiety 
symptoms in 28 children with anxiety disorders decreased after participating in 
the Dutch version of the cognitive behavioral (CBT) Fun FRIENDS program. From 
pre-intervention to direct post-intervention, we found a significant decrease in 
anxiety problems, the mean number of anxiety disorders, symptom interference, 
and overall emotional and behavioral problems. These results are in line with 
previous findings of Fun FRIENDS trials in clinical settings [1-3].
We also examined whether gender, age, and level of pre-intervention anxiety 
problems predicted treatment progress. We found that a higher level of pre-
intervention anxiety problems predicted more treatment progress, but gender 
and age did not appear to be significant predictors. Though the results of previous 
studies are inconsistent, a systematic review has shown that most studies have 
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and outcome in children with anxiety disorders [4].
We did not find significant decreases as to externalizing problems. As the main aim 
of the Fun FRIENDS program is to decrease and/or prevent internalizing problems 
such as anxiety and depression [5], it is not surprising that externalizing problems 
did not significantly decrease from pre-intervention to post-intervention. Moreover, 
the participating children were primarily referred for treatment because of anxiety 
problems and had pre-intervention levels of externalizing problems comparable 
to normative data, which makes significant improvements in this domain neither 
likely nor necessary.
Research into anxiety problems in preschoolers has only emerged in the past 
decade. At the start of this project, the Fun FRIENDS program was the only 
available standardized intervention for young children with anxiety disorders in 
the Netherlands. Our study and previous studies examining Fun FRIENDS yielded 
promising results as to treatment progress of children with anxiety problems. 
Because children with a CHD are especially at increased risk of internalizing 
problems [6], we reasoned that a psychosocial intervention for this population 
should include exercises aimed at decreasing anxiety. Therefore, we incorporated 
exercises of the Fun FRIENDS program into the child module of the CHIP-Family 
program.
CHIP-FAMILY INTERVENTION FOR YOUNG CHILDREN WITH 
CHDS AND THEIR FAMILIES
Chapter 3 presents the trial design of our study into the effectiveness of the 
CHIP-Family intervention. The previously developed and investigated CHIP-
School program aimed to indirectly improve the psychosocial well-being of young 
children with CHD by providing a psychosocial intervention for their parents [7]. 
Though CHIP-School showed promising results, we aimed to improve the effects 
of the intervention by innovating the program and by adding a specific child 
module for children with CHD and a sibling or friend. We expected that targeting 
the child directly and including family members would optimize the effects of the 
intervention.
151
General discussion
Ta
b
le
 1
 S
um
m
ar
y 
of
 m
ai
n 
ai
m
s 
an
d 
m
ai
n 
fin
di
ng
s 
of
 th
is
 th
es
is
.
C
h
ap
te
r
Sh
o
rt
 t
it
le
A
im
Sa
m
p
le
M
et
h
o
d
s
M
ai
n 
fin
di
ng
s
2
C
B
T
 fo
r 
an
xi
et
y 
d
is
o
rd
er
s 
in
 
yo
u
n
g 
ch
ild
re
n
: 
th
e 
F
u
n
 F
R
IE
N
D
S 
p
ro
gr
am
To
 e
xa
m
in
e 
w
h
et
h
er
 
yo
u
n
g 
ch
ild
re
n
 w
it
h
 
an
xi
et
y 
d
is
o
rd
er
s 
sh
o
w
ed
 le
ss
 a
n
xi
et
y 
af
te
r 
p
ar
ti
ci
p
at
in
g 
in
 F
u
n
 
F
R
IE
N
D
S
.
n=
28
 c
hi
ld
re
n 
w
it
h 
an
xi
et
y 
d
is
o
rd
er
s
(4
-8
 y
ea
rs
 o
ld
, M
=6
.6
, 
SD
=1
.1
)
D
es
ig
n
:
R
et
ro
sp
ec
ti
ve
 o
p
en
 t
ri
al
.
T
1
: p
re
-i
n
te
rv
en
ti
o
n
T
2
: d
ir
ec
t 
p
o
st
-i
n
te
rv
en
ti
o
n
P
ar
en
t-
re
p
o
rt
 m
ea
su
re
s:
· A
D
IS
-C
: n
u
m
b
er
 o
f a
n
xi
et
y 
d
is
o
rd
er
 d
ia
gn
o
se
s,
 s
ym
p
to
m
 
in
te
rf
er
en
ce
· C
B
C
L:
 e
m
o
ti
o
n
al
 a
n
d
 
b
eh
av
io
ra
l p
ro
b
le
m
s
St
at
is
ti
ca
lly
 s
ig
ni
fic
an
t d
ec
re
as
es
 fr
om
 p
re
-
in
te
rv
en
ti
o
n
 t
o
 p
o
st
-i
n
te
rv
en
ti
o
n
 in
:
· n
u
m
b
er
 o
f a
n
xi
et
y 
d
is
o
rd
er
s;
· s
ym
p
to
m
 in
te
rf
er
en
ce
;
· o
ve
ra
ll 
em
o
ti
o
n
al
 a
n
d
 b
eh
av
io
ra
l p
ro
b
le
m
s;
· i
n
te
rn
al
iz
in
g 
p
ro
b
le
m
s;
· a
n
d
 a
n
xi
et
y 
p
ro
b
le
m
s.
N
on
-s
ig
ni
fic
an
t d
ec
re
as
es
 in
:
· a
n
xi
o
u
s/
d
ep
re
ss
ed
 p
ro
b
le
m
s;
· a
n
d
 e
xt
er
n
al
iz
in
g 
p
ro
b
le
m
s.
H
ig
h
er
 p
re
-i
n
te
rv
en
ti
o
n
 a
n
xi
et
y 
le
ve
ls
 
p
re
d
ic
te
d
 m
o
re
 t
re
at
m
en
t 
p
ro
gr
es
s.
 G
en
d
er
 
an
d
 a
ge
 d
id
 n
o
t.
3
C
H
IP
-F
am
ily
 fo
r 
yo
u
n
g 
ch
ild
re
n
 
w
it
h
 C
H
D
 a
n
d
 
th
ei
r 
fa
m
ili
es
: t
ri
al
 
d
es
ig
n
To
 d
es
cr
ib
e 
th
e 
ra
ti
o
n
al
e 
an
d
 c
o
n
te
n
t 
o
f t
h
e 
C
H
IP
-
Fa
m
ily
 in
te
rv
en
ti
o
n
 a
n
d
 
th
e 
d
es
ig
n
 o
f t
h
e 
R
C
T
 in
to
 
th
e 
ef
fe
ct
iv
en
es
s 
C
H
IP
-
Fa
m
ily
; a
 m
u
lt
id
is
ci
p
lin
ar
y 
p
sy
ch
o
so
ci
al
 in
te
rv
en
ti
o
n
 
fo
r 
yo
u
n
g 
ch
ild
re
n
 w
it
h
 
C
H
D
 a
n
d
 t
h
ei
r 
fa
m
ili
es
.
C
h
ild
re
n
 e
lig
ib
le
 fo
r 
p
ar
ti
ci
p
at
io
n
 in
 t
h
e 
R
C
T
 a
re
 d
es
cr
ib
ed
 in
 
th
is
 c
h
ap
te
r.
T
h
e 
d
es
ig
n
 a
n
d
 m
ea
su
re
s 
o
f 
th
e 
R
C
T
 a
re
 d
es
cr
ib
ed
 in
 t
h
is
 
ch
ap
te
r.
N
o
t 
ap
p
lic
ab
le
.
152
Chapter 7
7Ta
b
le
 1
 C
o
n
ti
n
u
ed
C
h
ap
te
r
Sh
o
rt
 t
it
le
A
im
Sa
m
p
le
M
et
h
o
d
s
M
ai
n 
fin
di
ng
s
4
C
H
IP
-F
am
ily
 fo
r 
yo
u
n
g 
ch
ild
re
n
 
w
it
h
 C
H
D
 a
n
d
 
th
ei
r 
fa
m
ili
es
: 
re
su
lt
s
To
 e
xa
m
in
e 
th
e 
ef
fe
ct
iv
en
es
s 
o
f t
h
e 
C
H
IP
-F
am
ily
 in
te
rv
en
ti
o
n
 
in
 im
p
ro
vi
n
g 
p
sy
ch
o
so
ci
al
 
w
el
l-
b
ei
n
g 
o
f y
o
u
n
g 
ch
ild
re
n
 w
it
h
 C
H
D
 a
n
d
 
th
ei
r 
fa
m
ili
es
.
n=
9
3
 c
h
ild
re
n
 w
it
h
 
C
H
D
(3
-8
 y
ea
rs
 o
ld
, 
M
=5
.3
4,
 S
D
=1
.2
7)
D
es
ig
n
:
Si
n
gl
e-
b
lin
d
ed
 r
an
d
o
m
iz
ed
 
tr
ia
l w
it
h
 C
A
U
 c
o
n
tr
o
l g
ro
u
p
.
T
1
: p
re
-i
n
te
rv
en
ti
o
n
T
2
: 6
-m
o
n
th
 fo
llo
w
-u
p
P
ri
m
ar
y 
p
ar
en
t-
re
p
o
rt
 
m
ea
su
re
s:
· C
B
C
L:
 e
m
o
ti
o
n
al
 a
n
d
 
b
eh
av
io
ra
l p
ro
b
le
m
s
· S
C
L-
9
0
-R
: p
ar
en
ta
l m
en
ta
l 
h
ea
lt
h
· A
t 
6
-m
o
n
th
 fo
llo
w
-u
p
, c
h
ild
 a
n
d
 p
ar
en
t 
o
u
tc
o
m
es
 o
f t
h
e 
C
H
IP
-F
am
ily
 a
n
d
 C
A
U
 
gr
ou
p 
di
d 
no
t s
ig
ni
fic
an
tl
y 
di
ff
er
.
· P
ar
en
ts
 r
at
ed
 t
h
e 
C
H
IP
-F
am
ily
 in
te
rv
en
ti
o
n
 
p
o
si
ti
ve
ly
.
5
E
m
o
ti
o
n
al
 a
n
d
 
b
eh
av
io
ra
l 
p
ro
b
le
m
s 
in
 
ch
ild
re
n
 w
it
h
 
D
C
M
To
 in
ve
st
ig
at
e 
in
 c
h
ild
re
n
 
w
it
h
 D
C
M
:
· t
h
e 
le
ve
l o
f e
m
o
ti
o
n
al
 
an
d
 b
eh
av
io
ra
l p
ro
b
le
m
s 
co
m
p
ar
ed
 t
o
 n
o
rm
at
iv
e 
d
at
a;
· a
n
xi
et
y 
an
d
 d
ep
re
ss
iv
e 
p
ro
b
le
m
s 
p
re
d
ic
t 
th
e 
co
m
b
in
ed
 r
is
k 
o
f d
ea
th
 o
r 
ca
rd
ia
c 
tr
an
sp
la
n
ta
ti
o
n
.
n=
6
8
 c
h
ild
re
n
 w
it
h
 
D
C
M
(1
.5
-1
8
 y
ea
rs
 o
ld
, 
M
=6
.8
7,
 S
D
=5
.7
2)
D
es
ig
n
:
O
b
se
rv
at
io
n
al
 c
ro
ss
-
se
ct
io
n
al
 s
tu
d
y
O
n
e 
as
se
ss
m
en
t
P
ar
en
t-
re
p
o
rt
 a
n
d
 m
ed
ic
al
 
m
ea
su
re
s:
· C
B
C
L:
 e
m
o
ti
o
n
al
 a
n
d
 
b
eh
av
io
ra
l p
ro
b
le
m
s
· N
Y
U
 P
H
F
I:
 h
ea
rt
 fa
ilu
re
 
se
ve
ri
ty
· E
n
d
p
o
in
t:
 m
o
rt
al
it
y 
an
d
 
ca
rd
ia
c 
tr
an
sp
la
n
ta
ti
o
n
C
o
m
p
ar
ed
 t
o
 n
o
rm
at
iv
e 
d
at
a:
· m
o
re
 y
o
u
n
g 
(1
.5
-5
 y
ea
rs
) c
h
ild
re
n
 w
it
h
 
D
C
M
 s
h
o
w
ed
 s
o
m
at
ic
 c
o
m
p
la
in
ts
;
· l
es
s 
yo
u
n
g 
ch
ild
re
n
 w
it
h
 D
C
M
 s
h
o
w
ed
 
ex
te
rn
al
iz
in
g 
p
ro
b
le
m
s.
C
o
m
p
ar
ed
 t
o
 n
o
rm
at
iv
e 
d
at
a,
 m
o
re
 o
ld
er
 
(6
-1
8
 y
ea
rs
) c
h
ild
re
n
 w
it
h
 D
C
M
 s
h
o
w
ed
:
· o
ve
ra
ll 
in
te
rn
al
iz
in
g 
p
ro
b
le
m
s;
· d
ep
re
ss
iv
e 
p
ro
b
le
m
s;
· a
n
xi
et
y 
p
ro
b
le
m
s;
· a
n
d
 s
o
m
at
ic
 c
o
m
p
la
in
ts
.
W
h
er
ea
s 
h
ea
rt
 fa
ilu
re
 s
ev
er
it
y 
p
re
d
ic
te
d
 
th
e 
co
m
b
in
ed
 r
is
k 
o
f d
ea
th
 o
r 
ca
rd
ia
c 
tr
an
sp
la
n
ta
ti
o
n
, a
n
xi
et
y 
an
d
 d
ep
re
ss
iv
e 
p
ro
b
le
m
s 
d
id
 n
o
t.
153
General discussion
Ta
b
le
 1
 C
o
n
ti
n
u
ed
C
h
ap
te
r
Sh
o
rt
 t
it
le
A
im
Sa
m
p
le
M
et
h
o
d
s
M
ai
n 
fin
di
ng
s
6
E
M
D
R
 fo
r 
ch
ild
re
n
 w
it
h
 
m
ed
ic
al
ly
-r
el
at
ed
 
su
b
th
re
sh
o
ld
 
P
T
S
D
: s
h
o
rt
-t
er
m
 
ef
fe
ct
s
To
 d
et
er
m
in
e 
th
e 
sh
o
rt
-
te
rm
 e
ff
ec
ti
ve
n
es
s 
o
f 
E
M
D
R
 in
 c
h
ild
re
n
 w
it
h
 
su
b
th
re
sh
o
ld
 P
T
S
D
 a
ft
er
 
h
o
sp
it
al
iz
at
io
n
.
n=
74
 c
hi
ld
re
n 
w
it
h 
m
ed
ic
al
ly
-r
el
at
ed
 
su
b
th
re
sh
o
ld
 P
T
S
D
(4
-1
5
 y
ea
rs
 o
ld
, 
M
=9
.6
, S
D
=2
.9
)
D
es
ig
n
:
Si
n
gl
e-
b
lin
d
ed
 r
an
d
o
m
iz
ed
 
tr
ia
l w
it
h
 C
A
U
 c
o
n
tr
o
l g
ro
u
p
.
T
1
: p
re
-i
n
te
rv
en
ti
o
n
T
2
: 2
 m
o
n
th
s 
af
te
r 
b
as
el
in
e
P
ar
en
t-
 a
n
d
 c
h
ild
-r
ep
o
rt
 
m
ea
su
re
s:
· C
R
T
I:
 P
T
S
D
 s
ym
p
to
m
s
· C
D
I-
2
: d
ep
re
ss
io
n
 
sy
m
p
to
m
s
· S
C
A
R
E
D
-N
L:
 b
lo
o
d
-
in
je
ct
io
n
-i
n
ju
ry
 p
h
o
b
ia
, 
an
xi
et
y
· S
SR
 &
 C
S
H
Q
: s
le
ep
 
p
ro
b
le
m
s
C
h
ild
re
n
 in
 t
h
e 
E
M
D
R
 a
n
d
 t
h
e 
C
A
U
 g
ro
u
p
 
im
pr
ov
ed
 s
ig
ni
fic
an
tl
y 
ov
er
 ti
m
e 
on
 a
ll 
o
u
tc
o
m
es
.
C
h
ild
re
n
 in
 t
h
e 
E
M
D
R
 g
ro
u
p
 im
p
ro
ve
d
 
si
gn
ifi
ca
nt
ly
 m
or
e 
th
an
 th
e 
C
A
U
 g
ro
up
 
re
ga
rd
in
g:
· c
h
ild
-r
ep
o
rt
ed
 s
ym
p
to
m
s 
o
f b
lo
o
d
-
in
je
ct
io
n
-i
n
ju
ry
 p
h
o
b
ia
;
· c
h
ild
-r
ep
o
rt
ed
 d
ep
re
ss
io
n
;
· c
h
ild
- a
n
d
 p
ar
en
t-
re
p
o
rt
ed
 s
le
ep
 p
ro
b
le
m
s 
o
f t
h
e 
ch
ild
.
A
b
b
re
vi
at
io
n
s:
 A
D
IS
-C
 =
 A
nx
ie
ty
 D
is
or
de
rs
 In
te
rv
ie
w
 S
ch
ed
ul
e 
fo
r D
SM
-I
V
 - 
C
hi
ld
 V
er
si
on
; C
A
U
 =
 c
ar
e 
as
 u
su
al
; C
B
C
L 
= 
C
hi
ld
 
B
eh
av
io
r C
he
ck
lis
t;
 C
B
T 
= 
co
gn
it
iv
e 
be
ha
vi
or
al
 th
er
ap
y;
 C
D
I-2
 =
 C
hi
ld
re
n’
s 
D
ep
re
ss
io
n 
In
ve
nt
or
y 
2;
 C
H
D
 =
 c
on
ge
ni
ta
l h
ea
rt
 d
ef
ec
ts
; 
C
H
IP
 =
 C
on
ge
ni
ta
l H
ea
rt
 D
is
ea
se
 In
te
rv
en
ti
on
 P
ro
gr
am
; C
R
TI
 =
 C
hi
ld
re
n’
s 
R
es
po
ns
es
 to
 T
ra
um
a 
In
ve
nt
or
y;
 C
SH
Q
 =
 C
hi
ld
re
n’
s 
Sl
ee
p 
H
ab
it
s 
Q
ue
st
io
nn
ai
re
; D
C
M
 =
 d
ila
te
d 
ca
rd
io
m
yo
pa
th
y;
 E
M
D
R
 =
 e
ye
-m
ov
em
en
t d
es
en
si
ti
za
ti
on
 a
nd
 re
pr
oc
es
si
ng
; N
Y
U
 P
H
FI
 =
 N
ew
 Y
or
k 
U
ni
ve
rs
it
y 
Pe
di
at
ri
c 
H
ea
rt
 F
ai
lu
re
 In
de
x;
 P
TS
D
 =
 P
os
tt
ra
um
at
ic
 S
tr
es
s 
D
is
or
de
r;
 R
C
T 
= 
ra
nd
om
iz
ed
 c
on
tr
ol
le
d 
tr
ia
l; 
SC
A
R
ED
-N
L 
= 
Sc
re
en
 fo
r C
hi
ld
 
A
nx
ie
ty
 R
el
at
ed
 D
is
or
de
rs
, D
ut
ch
 v
er
si
on
; S
C
L-
90
-R
 =
 S
ym
pt
om
 C
he
ck
lis
t-
90
-R
ev
is
ed
; S
SR
 =
 S
le
ep
 S
el
f-
R
ep
or
t;
 T
1 
= 
fir
st
 a
ss
es
sm
en
t 
m
om
en
t;
 T
2 
= 
se
co
nd
 a
ss
es
sm
en
t m
om
en
t.
154
Chapter 7
7To the best of our knowledge, CHIP-Family is the first standardized psychosocial 
intervention for young children with CHD which includes a specific child module. 
As mentioned above, the child module contained CBT exercises based on the Fun 
FRIENDS program. These CBT exercises were provided by two trained junior 
psychologists. The child module also contained sports exercises provided by a 
pediatric physiotherapist and a physiotherapy assistant. In the parent module, 
parents discussed and practiced problem prevention therapy, general parenting 
skills, parenting skills specific to children with CHD, and related medical issues. The 
parent module was provided by two senior clinical psychologists with expertise in 
CHD and a pediatric cardiologist. All parent couples received a follow-up session 
with a psychologist who was present at the child workshop and a psychologist 
who was present at the parent workshop. In the follow-up session, parent couples 
discussed any remaining questions or worries, the most helpful components of the 
program, future coping strategies, and the problem prevention home assignment.
Chapter 4 presents the results of our randomized controlled trial (RCT) into the 
effectiveness of CHIP-Family on parental mental health, children’s emotional and 
behavioral problems, and family functioning. We compared CHIP-Family to care 
as usual (CAU; regular medical care only). In total, we provided 11 workshops and 
corresponding individual follow-up sessions. We found that, compared with CAU, 
participation in the CHIP-Family program did not result in significant improvements 
at 6-month follow-up as to child and parental psychosocial well-being and family 
functioning. In addition, father-reports and mother-reports of children’s emotional 
and behavioral problems did significantly improve in both the CAU and the CHIP-
Family group.
These improvements in emotional and behavioral problems in both groups may 
have been caused by merely participating in the study. That is, it can be debated 
whether participants in the CAU condition actually received CAU, because all 
participants received information and additional attention (explained below) from 
professionals which is generally not part of standard practice. Usually, children 
with CHD are only referred for mental health care if psychosocial problems are 
noticed by their pediatric cardiologist or if parents themselves explicitly indicate 
a need for care. However, prior to participation in the CHIP-Family RCT, eligible 
families received an information letter explaining the rationale of the study, which 
can be considered as encompassing psychoeducation. All families also received 
at least one phone call from the researchers and, prior to participation, some 
parents discussed the study with their child’s pediatric cardiologist. Furthermore, 
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parents in both the CAU and the CHIP-Family group completed questionnaires at 
baseline and follow-up. Previous research has described that simply completing a 
questionnaire can influence subsequent behavior: a phenomenon described as the 
‘question-behavior effect’ [8]. The baseline assessment may have increased parents’ 
awareness of emotional and behavioral problems. Subsequently, they may have 
attempted to decrease these problems [9], which may have resulted in decreased 
scores at follow-up. Similar result patterns have been reported in previous RCTs 
in other pediatric chronic illnesses such as inflammatory bowel disease [10-12]. 
Relatedly, the results may have been influenced by the test-retest effect [9]. That 
is, from pre-test to post-test, mean scores of psychosocial problems often decrease, 
even without an intervention.
Despite randomization (stratified for age and CHD severity), we found that, at 
baseline, mothers from the CHIP-Family group reported more emotional and 
behavioral problems in their children than mothers from the CAU group. Since 
participants were randomly allocated to either group, this finding was unexpected. 
However, for methodological and practical reasons, parents were aware of 
randomization outcome prior to completing the baseline assessment, which may 
have influenced the results. That is, in order to limit the period between a family’s 
baseline assessment and participation in the CHIP-Family workshop to two weeks, 
we had to ask families whether they would be able to attend the program on a 
specific date. Parents also had to make practical arrangements at work (take a 
whole day off) and at their children’s school in advance. As a result of being aware 
of randomization outcome, mothers randomized into the CHIP-Family group may 
have prepared for the program by reflecting and focusing more on their children’s 
problems, which may have increased their reports of emotional and behavioral 
problems in their child.
Next to standardized outcome measures, we assessed parents’ satisfaction 
regarding CHIP-Family through a specific questionnaire developed to this 
end. Parents were highly satisfied with the program and scored its usefulness 
positively. They considered the psychosocial and medical explanation by a pediatric 
cardiologist, meeting other families, and the child workshop to be the most valuable 
components of the program. The majority of participating parents had a high 
educational level and most parents who participated in the CHIP-Family program 
mentioned that they had already searched for information on CHD and parenting 
skills. Nevertheless, parents were very satisfied with the program. On the other 
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7hand, highly motivated parents may tend to be more positive as to the program’s 
usefulness and satisfaction, which may have induced bias.
Importantly, in four children who participated in the CHIP-Family program, 
parents and the psychologists indicated a need for additional psychosocial care. 
Subsequently, our team referred these children for further psychological care. In 
contrast, we did not refer any children from the CAU group for further care. This 
indicates that CHIP-Family facilitated mental health care professionals and parents 
to detect psychosocial problems in children. Without CHIP-Family, these problems 
may have remained unnoticed. This is clinically relevant, because detecting and 
treating psychosocial problems at an early stage may prevent the development of 
chronic disorders and more severe problems [13-15]. An alternative explanation 
could be that children in the CHIP-Family group experienced more problems 
than children in the CAU group, which may also be reflected by the higher level 
of baseline emotional and behavioral problems reported by mothers in the CHIP-
Family group compared with the CAU group. Overall, the previously examined 
CHIP-School yielded more positive results than CHIP-Family [7]. Nevertheless, 
the results of the CHIP-Family RCT offer valuable information. Replicating 
studies is central to any science [16]. Unfortunately, studies examining the effect 
of psychological interventions in children with a CHD are very scarce, let alone 
replication studies [17]. This scarcity could be increased by publication bias: 
scientific journals tend to publish more studies reporting statistically significant 
results than studies reporting non-significant or opposite results [18, 19]. This is 
unfortunate, because replication studies provide information on which ingredients 
are valuable in improving interventions – also when results are not statistically 
significant.
Below, we discuss which ammunition the results of the CHIP-Family RCT provide 
to further refine psychosocial interventions for children with a CHD regarding the 
following questions:
• Target group: who should receive a psychosocial intervention?
• Content: what should the intervention entail?
• Mode of delivery: how should the intervention be provided?
• Timing: when should the intervention be provided?
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Target group
In pediatric chronic illness, it is well-established that parental mental health 
influences children’s psychosocial well-being [e.g., 20, 21-23]. Moreover, chronic 
illness such as CHD affects the whole family [24-28]. For these reasons, family-
centered psychosocial interventions are commonly recommended nowadays 
[29]. Though family-related topics were discussed, the previously examined CHIP-
School intervention only included a parent program [7]. By providing a psychosocial 
intervention for parents, the developers aimed to indirectly improve child 
outcomes [23]. As mentioned, in developing CHIP-Family, we hypothesized that 
adding a specific child module would further improve child outcomes. Interestingly, 
the results of our RCT examining the CHIP-Family program did not support this 
hypothesis. CHIP-School yielded more positive outcomes than CHIP-Family on 
parent, family, and child outcomes. An explanation for this might be that, in CHIP-
Family, parent workshops and child workshops were held simultaneously. Parents 
considered the child workshop to be one of the three most valuable components 
of CHIP-Family. However, involving children in the workshop may have reduced 
parents’ focus on and perceived importance of the parent module of CHIP-Family. 
This seems to indicate that including both parents and children in a psychosocial 
intervention does not necessarily improve outcomes. As demonstrated by a 
recent meta-analysis, it is currently unknown whether the effect of psychosocial 
interventions can be improved by including not only parents, but also the child 
itself [20].
Furthermore, one might expect that children with more severe CHDs require 
more psychosocial care. However, this does not appear to be the case. A meta-
analysis has shown that emotional and behavioral problems are not related to 
illness severity [6]. In the CHIP-Family workshops, parents of children with different 
types of CHD reported that they experienced similar difficulties, regardless of the 
severity of residual heart defects.
Content
In developing a psychosocial intervention for children with CHD, several treatment 
classes can be considered. The parent module of CHIP-Family and CHIP-School 
mainly consisted of problem prevention therapy (PPT) and CBT. Previous meta-
analyses examining psychosocial interventions targeting parents of chronically ill 
children have found beneficial results on parental outcomes of PPT and of CBT [20, 
30, 31]. The child module of CHIP-Family primarily consisted of CBT exercises from 
the Fun FRIENDS program. Parents who participated in CHIP-Family considered 
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cardiologist and discussing these topics with other families to be the most valuable 
components of the program. During the explanation of the pediatric cardiologist, 
questions and discussions were stimulated and coached by two senior clinical 
psychologists with expertise in the field. Two senior psychologists were present the 
whole day, which enabled them to gather parents’ questions throughout previous 
parts of the workshop program.
As to CHIP-School, however, parents considered the bicycle exercise stress test to 
be the most valuable component [personal communication with the developers of 
CHIP-School]. The bicycle exercise stress test was a behavioral experiment in which 
the child was encouraged to perform vigorous exercise whilst being monitored by 
a cardiologist. Parents were present and were assured by the cardiologist that the 
heart rhythms monitored through the electrocardiogram were non-concerning 
throughout the exercise. For logistical reasons, this component could not be 
implemented in the CHIP-Family program. As mentioned, however, CHIP-Family did 
include sports exercises developed and supervised by a pediatric physiotherapist. 
Though parents attended part of this sports program, this may not have had the 
same reassuring effect as the bicycle exercise stress test in the presence of a 
cardiologist. Clearly, parents appreciated the involvement of professionals from 
multiple disciplines in CHIP-Family and CHIP-School. This is valuable, as children 
with chronic illnesses such as CHD face a broad range of difficulties [29, 32].
The duration of the intervention may also affect outcomes. Both the CHIP-School 
and CHIP-Family program are relatively brief interventions. This can be considered 
a strength, as this minimizes the burden of treatment for participants and the time 
investment required of the involved professionals. However, to further improve 
outcomes, an intervention of a longer duration may be needed. As mentioned 
above, the Fun FRIENDS program showed promising results in a clinical setting. Fun 
FRIENDS consists of 12 weekly 1.5-hour sessions, whereas the CBT component 
of the CHIP-Family child program was merged into one 4 hour session. If CBT 
exercises are practiced repeatedly, it is more likely that lasting improvements will 
be obtained.
It should also be recalled that, in the CHIP-Family RCT, parents in both the CAU 
and the CHIP-Family group did report improvements from baseline to 6-month 
follow-up in children’s emotional and behavioral problems. This suggests that 
merely receiving psychoeducation may be sufficient in improving outcomes.
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Mode of delivery
The CHIP-Family intervention was provided face-to-face. The workshops were 
provided in a group format. As previously noted, parents rated meeting other 
families of children with a CHD as one of the most valuable aspects of the CHIP-
Family program. Parents appreciated the opportunity to discuss issues with 
parents who had gone through similar experiences. Formulated by some as an 
“eye-opener”, sharing similar experienced may have a normalizing effect. In CHIP-
Family, workshop group sizes were smaller (3 to 5 families, 4 to 10 parents) than in 
CHIP-school (9 to 12 parents). We expected that smaller group sizes would enable 
more personal attention and, therefore, enhance impact. However, on the other 
hand, larger group sizes may also increase the support impact of the group format.
Though the group format of CHIP-Family was highly appreciated, alternative modes 
of intervention delivery could also be considered. As stated in the previous section, 
receiving psychoeducation seems to improve children’s outcomes. Within this 
framework, an online evidence-based patient information portal may be of value. 
A previous pilot study has shown that patients with CHD appreciate and apply 
such an information portal [33]. A multicenter stepped-wedge trial examining the 
effects of this information portal for cardiac patients is currently being conducted 
at the Erasmus MC.
Timing
Intervening at a young age has several advantages. Problem behaviors and thoughts 
may be easier to modify, as problems may be less ingrained and neuroplasticity of 
young children is higher [34]. Moreover, if left untreated, psychosocial problems 
may become chronic and persist into adolescence and adulthood [35, 36]. Providing 
an effective early intervention can minimize the impact of psychosocial problems 
on the development and future life of a child [34, 37-39]. Indeed, previous studies 
[1-3] and our results regarding the Fun FRIENDS program suggest that early 
intervention can be effective.
According to Drotar [40], psychosocial interventions should be provided at times 
of developmental transitions. For this reason, CHIP-School targeted families of 
children who were entering school. CHIP-Family included families of children 
who were starting preschool or kindergarten. Some participating children had 
already entered preschool or kindergarten. Perhaps CHIP-Family would have 
obtained more favorable results if all participating children were at the start of 
the developmental transition of entering school. Participating parents did confirm 
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Furthermore, parents often mentioned that they would have appreciated an 
intervention such as CHIP-Family earlier in the illness trajectory. According to 
parents, they had already dealt with the most severe difficulties. However, evidence 
also indicates that a psychosocial intervention should not be provided too early: a 
psychosocial intervention for parents of children with cancer was effective when 
delivered later in the illness trajectory, but did not prove to be as successful earlier 
in the illness trajectory [41].
EMOTIONAL AND BEHAVIORAL FUNCTIONING IN PEDIATRIC 
DCM
In chapter 5, we examined the proportion of borderline and clinical emotional and 
behavioral problems in a cohort of children with DCM compared to the general 
population. Though multiple cross-sectional and cohort studies have examined 
emotional and behavioral functioning in pediatric CHD, such studies in pediatric 
DCM are scarce. In our study, we found that, compared to normative data [42], a 
significantly smaller proportion of young children (i.e., 1.5- to 5-year-olds) with 
DCM showed externalizing problems (5.4% versus 17.0%) and a significantly larger 
proportion of young children showed somatic complaints (24.3% versus 8.0%). 
Moreover, compared to normative data [42], a significantly larger proportion of 
older children (i.e., 6- to 18-year-olds) with DCM showed internalizing problems 
(38.7% versus 17.0%), including depressive, anxiety, and somatic problems.
Only two small previous studies have examined emotional and behavioral problems 
in pediatric cardiomyopathy. The first study [43] (n=19) included 3.7- to 14.2-year-
old children with cardiomyopathy who were listed for cardiac transplantation. 
Half of all participants showed a clinical level of overall emotional and behavioral 
problems as reported by parents on the CBCL. In our study, this proportion was 
much smaller for both 1.5- to 5-year-olds (10.8%) and 6- to 18-year-olds (16.1%). 
Presumably, being listed for cardiac transplantation increased the level of 
emotional and behavioral problems in the previous study. This increase could be 
due to elevated uncertainty as to prognosis and treatment [44, 45]. Also, anxiety 
and depressive symptoms in children listed for cardiac transplantation may be 
increased because they experience more physical symptoms of their illness [44, 
46] and may have to undergo more frequent and more intensive medical treatments 
[47]. Furthermore, it is well-known that parental mental health influences the 
psychosocial well-being of the affected child [20-23, 48]. We hypothesize that 
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parents of children listed for cardiac transplantation experience increased levels 
of anxiety which subsequently can increase the child’s level of emotional and 
behavioral problems. In interpreting the results of this study, the small sample size 
should be taken into account.
The second previously published study [49] (n=15) included 7- to 21-year-old 
children and adolescents with DCM. Contrary to our results, this study found 
that the level of depressive problems did not differ between children with DCM, 
healthy children (n=24), and children who had successfully undergone cardiac 
transplantation for heart failure (n=23). Again, in interpreting these results, the 
small sample size should be taken into account. In addition to a different age range, 
this study used the CDI to assess depressive problems, whereas we used the CBCL. 
Importantly, the CDI was completed by the participating children themselves, 
whereas the CBCL is a caregiver-report questionnaire.
Besides examining the level of emotional and behavioral problems in DCM, 
we investigated whether depressive and anxiety problems predicted cardiac 
transplantation and mortality, independent from heart failure severity. Whereas 
heart failure severity did appear to predict cardiac transplantation and mortality, 
depressive and anxiety problems did not. This result was unexpected, because 
in adult heart failure populations, multiple studies have shown that depressive 
and anxiety problems predict adverse clinical outcomes and mortality [50, 51]. 
Depressive and anxiety problems in adults can diminish self-care and health 
behaviors, subsequently placing adults with heart failure at risk for adverse 
outcomes [52]. Regarding pediatric DCM, parents may put efforts in reducing 
depressive and anxiety problems and may compensate for children’s diminished 
self-care, subsequently reducing the risk for adverse outcomes in these children.
Our findings indicate that a psychosocial intervention may be needed for children 
with DCM. However, considering the scarcity of studies examining the psychosocial 
well-being of these children, more research is needed before firm conclusions can 
be drawn. Future research should examine the level of psychosocial problems in 
children with DCM and determine the content of a psychosocial intervention. Since 
children with DCM seem to suffer from internalizing problems (i.e., anxiety and 
depression), we recommend to investigate the effectiveness of CBT interventions, 
as CBT is the treatment of first choice for children with internalizing problems [53, 
54].
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In chapter 6, we conducted an RCT to investigate the effectiveness of EMDR in 
children with medically-related subthreshold PTSD compared to CAU (regular 
medical care only). We included children with CHD, children with acquired heart 
defects, and children who had been admitted to an emergency department. All 
participating children were required to have been admitted to a hospital for at 
least one night. This is the first study examining the effect of EMDR in children 
with CHD. Approximately 2 months after the start of EMDR or CAU, we found that 
children in both the CAU and the EMDR intervention group significantly improved 
on posttraumatic stress symptoms, general anxiety, blood-injection-injury phobia, 
depression, and sleep problems. The finding that both groups improved over 
time may be attributed to the phenomenon that merely participating in a study 
may result in better psychosocial outcomes (as described above in the section 
discussing the CHIP-Family study). All eligible patients received an information 
letter explaining the content of the study. This information letter also contained 
psychoeducational information on consequences of a hospital admission and 
traumatic events. Furthermore, before inclusion in the EMDR RCT, potential 
participants were screened for PTSD symptoms and completed a semi-structured 
interview with a psychologist. Participants were screened because only children 
with subthreshold PTSD were included in the RCT. Psychoeducation or attention 
from a psychologist might be sufficient to decrease problems in children with 
subthreshold PTSD. That is, following a potentially traumatic medical event, it may 
be sufficient for a number of children to receive an information letter and a phone 
call from a mental health care professional providing psychoeducation. Within this 
framework, the previously mentioned online evidence-based patient information 
portal may provide a valuable format [33].
Compared to the CAU group, children in the EMDR group did significantly improve 
on self-reported symptoms of blood-injection-injury phobia and depression, and 
on parent-reported and child-reported sleep problems of the child. EMDR did not 
result in more favorable outcomes as to PTSD symptom reduction. Most of our 
results are in line with previous research [55-59]. In contrast to earlier studies, 
EMDR did not prove superior in reducing PTSD symptoms. Two meta-analyses 
reporting on small RCTs did find a superior effect of EMDR on PTSD symptoms 
compared with CAU, a waitlist, or a non-established trauma treatment [60, 61], 
whereas we did not. A possible explanation for this discrepancy is that the studies 
included in the meta-analyses also targeted children and adolescents with clinically 
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diagnosed PTSD who likely experienced higher levels of symptom severity than the 
children included in our RCT.
In an exploratory analysis, we found that outcomes as to child-reported symptoms 
of depression and sleep problems in the EMDR group were more favorable if more 
time had elapsed since the last medical event. Nevertheless, some adult studies 
advocate early EMDR intervention after trauma [62]. The best time to provide 
EMDR to children with medically-related trauma remains to be investigated.
Again, next to standardized outcome measures, we assessed children’s and 
parents’ satisfaction with the EMDR treatment. Overall, treatment satisfaction 
and usefulness were evaluated positively. In the CHIP-Family workshop groups, 
multiple parents reported that they had successfully received EMDR themselves 
for their own posttraumatic stress symptoms (PTSS) or PTSD due to medical events 
of their child [26].
STRENGTHS AND LIMITATIONS
The strengths and limitations of the studies described in this thesis have been 
discussed extensively in the previous chapters. In short, the single-blind RCTs 
described in this thesis add to the limited evidence-based knowledge body 
concerning psychosocial interventions for children with heart defects. Treatment 
integrity was high, as were parents’ satisfaction ratings. Worldwide, our RCT into 
CHIP-Family was the first to examine a psychosocial intervention for CHD including 
a specific child module. Also, fathers were actively involved in the intervention and 
completed assessments, which is rare in pediatric research [20, 63, 64]. The EMDR 
study was the first study to examine the effectiveness of EMDR in children with 
CHD-related and other medically-related subthreshold PTSD. Moreover, this study 
included reports from multiple informants and had a relatively large sample size 
considering previous studies into EMDR for children. Participants for the EMDR 
and CHIP-Family study were recruited in multiple centers across the Netherlands, 
which increases the generalizability of the results. Furthermore, our study on the 
Fun FRIENDS program was the first study examining this program in a European 
sample of young children with anxiety disorders. We also examined emotional 
and behavioral problems in a substantial cohort of children with DCM; a largely 
unexplored field. Children of all ages were recruited in seven hospitals across the 
Netherlands, again increasing the generalizability of our results.
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FRIENDS, CHIP-Family, and emotional and behavioral problems in children with 
DCM, we primarily used parent-proxy reports. Though the use of parent-proxy 
reports is common within the field of pediatric psychology, this can be considered 
a methodological limitation as agreement among different informants generally 
is found to be moderate [65-69]. Furthermore, though the sample sizes of our 
studies were relatively large considering previous studies and prevalence rates, the 
sample sizes may have compromised statistical power and subsequently increased 
the chance of type II errors (i.e., false negatives). Moreover, as discussed above, 
parents in the CHIP-Family trial were aware of randomization outcome prior to 
the baseline assessment, which may have influenced the results. Besides, we may 
have found more favorable outcomes if we had included children with more severe 
psychosocial problems in the CHIP-Family and EMDR studies. However, it would 
have been unethical to randomize children with a clinical level of problems into a 
CAU group.
DIRECTIONS FOR FUTURE RESEARCH
Future research should be conducted on the Fun FRIENDS program, psychosocial 
interventions for children with heart defects, and the psychosocial functioning 
of children with DCM. We incorporated elements of the Fun FRIENDS program 
into the CHIP-Family program to decrease internalizing problems in children with 
CHD. However, regarding Fun FRIENDS as a treatment program for young children 
with anxiety disorders, randomized controlled trials with adequate sample sizes 
are needed to draw definite conclusions on its effectiveness. This is important, as 
early intervention can prevent the development of more severe, chronic problems 
[34-39] and our and previous Fun FRIENDS trials show promising results [1-3].
Regarding psychosocial interventions for children with heart defects and their 
families, four recommendations for future research can be postulated. Firstly, 
most studies on psychosocial problems in pediatric heart defects are cross-
sectional studies. Despite the fact that international guidelines have advocated 
that psychosocial care should be incorporated in standard clinical practice for CHD 
[70], studies aimed at developing and testing the effectiveness of interventions 
are still lacking and should be initiated and executed. Secondly, the added value of 
including a child module in a psychosocial intervention for pediatric heart disease 
should be further examined [20]. Thirdly, research should identify which children 
and families could benefit sufficiently from psychoeducation alone and which 
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children and families require additional psychosocial care. Fourthly, the timing of 
providing EMDR therapy should be investigated in children with medically-related 
(subthreshold) PTSD. Our results showed some indications that time elapsed since 
the event was positively related with outcomes.
As current psychosocial research in children with DCM is limited to health-related 
quality of life, many questions remain to be answered. Firstly, we examined 
parent-reports of emotional and behavioral functioning of children with DCM. 
It would be valuable to examine children’s own experiences as well. Secondly, 
studies should investigate whether disease severity in pediatric DCM is related 
to the level of emotional and behavioral problems. This information would help 
to identify which children are in need of a psychosocial intervention. Thirdly, we 
examined the difference in emotional and behavioral problems in younger (i.e., 
1.5 to 5-year-olds) and older (i.e., 6 to 18-year-olds) children with DCM. Again, 
to identify children at risk for psychosocial problems, it would be valuable to 
examine age differences in more detail. Fourthly, though our study comprised a 
substantial sample size considering the prevalence of pediatric DCM, studies with 
larger sample sizes are required to increase statistical power and generalizability of 
results. Fifthly, researchers may consider conducting a qualitative study to examine 
the psychosocial well-being of children with DCM and potential difficulties they 
experience.
As to pediatric psychology in general, researchers should aim to establish consensus 
on which illness-specific and general measurement instruments should be used. 
The heterogeneity of used measurement instruments complicates the comparison 
of results. Often, it is unclear whether differences in outcomes reflect actual 
differences or differences in specificity or sensitivity of assessment instruments.
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• Early intervention by means of the Fun FRIENDS program for young 
children with anxiety disorders can be beneficial. Its effectiveness in 
clinical settings remains to be further established through an RCT.
• We recommend structural screening through questionnaires for children 
with a CHD on psychosocial problems and symptoms of posttraumatic 
stress [70].
• We recommend structural screening through questionnaires for children 
with DCM on psychosocial problems; mainly on symptoms of anxiety and 
depression.
• Effective psychosocial interventions for families of children with a CHD 
need to be developed and should be incorporated in standard clinical 
practice. Psychoeducational portals offer a promising option but should 
be further examined.
• Psychoeducation can be sufficient in decreasing symptoms of 
posttraumatic stress in children and adolescents with subthreshold PTSD 
after medical trauma.
• EMDR can be beneficial for children with increased symptoms of blood-
injection-injury phobia, depression, and sleep problems after a medical 
trauma.
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SUMMARY
The main aim of this thesis was to examine and improve the psychosocial well-being 
of children with congenital or acquired heart disease. The general introduction 
in chapter 1 describes the background and main aims of the studies included 
in this thesis. The umbrella term ‘congenital heart defects’ (CHDs) describes 
multiple structural abnormalities of the heart and/or intrathoracic great vessels 
which emerge before birth. CHDs are the most common birth defect, estimated 
to affect 8 out of 1,000 live births. Children with a CHD are at elevated risk 
of emotional and behavioral problems (especially internalizing problems), 
posttraumatic stress symptoms, social problems, school problems, low exercise 
levels, and neuropsychological deficits. Moreover, developmental milestones such 
as starting school are more challenging for children with a CHD and their families 
than for healthy peers and their families. It is well-known that parental mental 
health influences children’s well-being. Unfortunately, parents of children with a 
CHD are also more likely to experience mental health problems. Previously, to 
improve the psychosocial well-being of children with a CHD and their families, 
the multidisciplinary Congenital Heart Disease Intervention Program (CHIP) - 
School was developed by Dr. McCusker and colleagues from the Royal Belfast 
Hospital for Sick Children. CHIP-School targeted to improve the psychosocial 
well-being of parents of children with a CHD who were entering school, aiming 
to indirectly improve children’s outcomes. Though CHIP-School obtained positive 
results regarding maternal mental health, perceived strain on the family, and 
school absence, children’s psychosocial well-being did not significantly increase. 
To improve these results, we extended and innovated the CHIP-School program by 
also including exercises for young children with CHDs and siblings in the program, 
thereby creating the CHIP-Family intervention. In this thesis, we investigated 
whether CHIP-Family improved the psychosocial well-being of young children (4-7 
years old) with a CHD and their families.
Furthermore, high levels of posttraumatic stress symptoms and posttraumatic 
stress disorder (PTSD) have been described in children who were hospitalized or 
underwent painful medical procedures. In adults, eye movement desensitization 
and reprocessing (EMDR) has been established as an effective treatment for 
posttraumatic stress symptoms and PTSD. In children, however, relatively few 
studies have been conducted into EMDR, but available studies show promising 
results. However, the trauma types studied were not focused specifically on 
medically-related trauma, but mainly concerned abuse, violence, or natural 
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8disasters. Therefore, in this thesis we aimed to examine the effectiveness of 
EMDR in children with a subthreshold PTSD after a medically-related event, 
including children with a CHD. The focus was on subthreshold PTSD as this is often 
underestimated, but may result in similar impairments as a clinical diagnosis of 
PTSD.
Another aim of this thesis was to study emotional and behavioral problems 
of children with dilated cardiomyopathy (DCM), an acquired heart disease. 
Cardiomyopathies are disorders of the heart muscle. DCM is the most common 
type in children, affecting approximately 0.57 to 0.73 per 100,000 children per 
year. DCM has a poor prognosis and is the leading cause of cardiac transplantation. 
Research has already shown that children with DCM have lower health-related 
quality of life (HRQoL) than their healthy peers and that physical HRQoL predicts 
mortality and cardiac transplantation. However, since little was known about 
emotional and behavioral problems in pediatric DCM, we performed a study into 
these problems.
Chapter 2 describes the results of our clinical open trial of the previously developed 
cognitive behavioral (CBT) Fun FRIENDS program for 4-8-year-old children with an 
anxiety disorder. We aimed to investigate outcomes of the Fun FRIENDS program 
for clinically anxious children, but also aimed to investigate its outcomes since 
several exercises of the Fun FRIENDS program were implemented in the CHIP-
Family intervention for young children with CHDs and their siblings. In our open 
trial, we investigated whether emotional and behavioral problems of 28 young 
children (4-8 years old) with anxiety disorders decreased after completing the CBT 
Fun FRIENDS program. Fun FRIENDS comprises 12 weekly group sessions (1.5 
hour each) which were provided to groups of 3 to 5 children. From pre-intervention 
to direct post-intervention, parents’ reports on the Child Behavior Checklist 
(CBCL) significantly decreased as to overall emotional and behavioral problems, 
internalizing problems, and on the DSM-scale anxiety problems, whereas scores 
on the empirical anxious/depressed problems scale and externalizing problems did 
not decrease. Assessments using the Anxiety Disorders Interview Schedule for 
Children (ADIS-C) showed that the mean number of anxiety disorders and level of 
symptom interference significantly decreased. Our results are largely in line with 
previous positive findings regarding the Fun FRIENDS program. However, in 8 to 
12-year-old children, previous trials have found that the FRIENDS for Life program, 
on which Fun FRIENDS was based, also elicited positive results as to depressive 
problems. Presumably, depressive and externalizing problems did not significantly 
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decrease in children in our trial, because these children did not have high levels of 
depressive or externalizing problems at baseline.
Chapter 3 describes the study protocol of a randomized controlled trial (RCT) to 
test the effectiveness of the multidisciplinary psychosocial CHIP-Family program 
for young children with a CHD and their families. Ninety-three families were 
randomized into care as usual (CAU; medical care “only”) or CAU plus CHIP-
Family. CHIP-Family consisted of a parent module and a child module. The parent 
module consisted of a 6-hour group workshop and an individual 4-week follow-up 
session. In the group workshop, two psychologists provided psychoeducation and 
discussed and practiced problem prevention techniques and parenting skills. A 
pediatric cardiologist addressed medical and psychosocial issues in the presence 
of a psychologist. In the follow-up session, individual parent couples discussed 
the problem prevention home exercise, remaining questions, and future coping 
strategies with two psychologists. The child module consisted of a 6-hour group 
workshop in which children with a CHD participated with a sibling or friend. Two 
psychologists taught the children CBT techniques through exercises from the 
Fun FRIENDS protocol (e.g., helpful thoughts, relaxation techniques, coping with 
emotions). Also, the children did sports exercises with a pediatric physiotherapist 
in the presence of their parents. Outcomes were completed at baseline and 
6-month follow-up by parents, teachers, and the child itself. Primary outcomes
were children’s emotional and behavioral problems and parental mental health.
Secondary outcomes concerned family functioning, children’s school functioning, 
sports enjoyment, and quality of life, and parents’ worry, disease-specific
knowledge, quality of life, and program satisfaction.
In chapter 4, we presented the results of our RCT into the effectiveness of CHIP-
Family (CHIP-Family group: N=49 vs. CAU group: N=44). Though parents evaluated 
CHIP-Family positively (mean ratings 7.4-8.1 on a 10-point scale), compared to 
CAU, the CHIP-Family program did not elicit significant improvements on the 
aforementioned outcomes. However, in both the CAU and the CHIP-Family group, 
fathers and mothers reported significant decreases as to children’s emotional and 
behavioral problems. These decreases may be explained by parents’ heightened 
awareness of emotional and behavioral problems induced by merely participating 
in the study. Overall, CHIP-Family generated less favorable results than the 
previously developed CHIP-School. This may be due to differences in the protocols 
and timing of the interventions. CHIP-School included a bicycle exercise stress 
test to challenge parents’ assumptions regarding their child’s fragility, whereas, for 
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8logistical reasons, in our CHIP-Family study it was not possible to include a bicycle 
exercise stress test. Furthermore, including the child module may have diminished 
the importance as perceived by parents of the CHIP-Family parent program. Finally, 
in CHIP-Family, some children were already attending school, whereas in CHIP-
School children were all in the developmental transition of starting school.
In chapter 5, we described the results of our study into the level of emotional 
and behavioral problems in children with DCM (N=68, 1.5-18 years old). We also 
examined whether depressive and anxiety symptoms corrected for heart failure 
severity predicted death or cardiac transplantation. Compared to normative data, 
a significantly larger proportion of young children (i.e., 1.5-5-year-olds) with DCM 
experienced a clinical or borderline level of somatic complaints (24.3% vs. 8.0%), 
whereas a significantly smaller proportion showed externalizing problems (5.4% vs. 
17.0%). As to older children with DCM (i.e., 6-18-year-olds), compared to normative 
data, a larger proportion showed internalizing problems (38.7% vs. 17.0%), including 
somatic, depressive, and anxiety problems. The two previous small studies showed 
inconsistent results. The first study found that 50% (N=6 out of 12) of children 
with cardiomyopathy who were listed for cardiac transplantation experienced 
clinical levels of emotional and behavioral problems. The second study, however, 
specifically examined depressive problems in pediatric DCM (N=15) and did not 
find an elevated level of symptoms. Furthermore, our results showed that the risk 
of death or cardiac transplantation was not predicted by anxiety or depressive 
problems, but was positively associated with heart failure severity. In adult heart 
failure populations, the association between anxiety and depressive problems and 
adverse clinical outcomes is well-established. An explanation for the discrepancy 
with our findings concerning the predictive value of anxiety/depressive problems 
may be that, in children, parents may function as a buffer by compensating for 
anxious/depressed children’s diminished self-care.
Chapter 6 presents the short-term results of our RCT examining the effectiveness 
of EMDR in children with medically-related subthreshold PTSD. After screening 
399 children, we randomized 74 children (4-15 years old) who had subthreshold 
PTSD following at least one hospitalization into CAU (N=37; medical care “only”) or 
EMDR treatment (N=37). To measure symptoms of posttraumatic stress, anxiety, 
depression, and sleep problems, parents and children completed questionnaires 
at baseline and approximately 10 weeks after the start of EMDR or CAU. Children 
in both the CAU and the EMDR group improved significantly on all outcomes. 
Remarkably, EMDR was not superior in improving posttraumatic stress symptoms. 
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However, children in the EMDR group did show significantly larger improvements 
regarding blood-injection-injury phobia and depression (child-report), and 
children’s sleep problems (parent-report and child-report). Our results suggest that 
receiving psychoeducation from a mental health care professional and screening 
for psychological problems may be sufficient to decrease PTSD symptoms in 
children with subthreshold PTSD.
Finally, in chapter 7 we provide a general discussion in which we summarized 
and discussed the main findings of this manuscript (see above) and provided 
recommendations for future research and clinical practice. To improve psychosocial 
interventions for children with heart defects, the target group, content, mode of 
delivery, and timing should be considered. Regarding the target group, it is widely 
established that such an intervention should be family-focused. However, our 
results indicate that directly including young children in an intervention may 
not necessarily improve the effectiveness of an intervention. Regarding the 
content of the intervention, CBT and problem prevention therapy have shown 
most beneficial results. As the difficulties experienced by children with a CHD 
encompass a broad medical and psychosocial range, involving professionals from 
multiple disciplines is valuable. In our CHIP-Family study, the psychosocial and 
medical topics discussed by a pediatric cardiologist and discussing such topics 
with other families were considered most useful. However, in the CHIP-School 
study, the bicycle exercise stress test was rated as the most helpful component. 
Moreover, to further improve children’s outcomes, an intervention with multiple 
sessions may be needed. Now, the CBT exercises were combined into one 4-hour 
session. Regarding the mode of delivery, as mentioned, the group format was highly 
appreciated by parents. Perhaps a larger group format as used in CHIP-School 
optimizes the support impact, whereas it may decrease levels of personal attention. 
An online evidence-based patient information portal might offer sufficient support 
for children with subclinical psychological symptoms. Regarding the timing of a 
psychosocial intervention, early intervention in children has a number of benefits. 
Early intervention may prevent disorders from becoming chronic and through 
early intervention effects may be optimized as problems are less engrained and 
neuroplasticity is higher. However, CHIP-School may have obtained more positive 
results than CHIP-Family because the intervention was timed more specifically at 
a developmental transition. As to EMDR, our results suggested that decreases in 
depressive and sleep problems were larger if more time had elapsed since the last 
medical event.
180
Chapter 8
8The studies described in this thesis add to the limited body of knowledge as to 
psychosocial interventions for children with heart defects. For both the CHIP-
Family and EMDR intervention, treatment integrity and parents’ satisfaction 
ratings were high. Furthermore, our study examining the effectiveness of CHIP-
Family was the first to examine a psychosocial intervention with a specific module 
for children with a CHD. The EMDR study was the first study that investigated 
EMDR in children with medically-related subthreshold PTSD. Moreover, in the 
CHIP-Family, EMDR, and the DCM studies, we recruited participants from multiple 
centers across the Netherlands, which improves generalizability of our findings. 
Another strength is that, considering prevalence rates and previous research, our 
studies into EMDR and DCM used substantial sample sizes.
A future RCT is needed to determine the effectiveness of Fun FRIENDS in treating 
anxiety disorders. As to children with heart defects, future research should invest 
in developing and testing effective psychosocial interventions. The added value 
of a specific child module also remains to be examined. Furthermore, it would 
be valuable to investigate which children and families benefit sufficiently from 
psychoeducation alone. Regarding EMDR, the best timing to provide treatment 
for children should be studied. As to pediatric DCM, many psychosocial aspects 
remain to be examined. Future research should investigate children’s self-reports of 
emotional and behavioral problems, the association between disease severity and 
the level of emotional and behavioral problems, examine age differences in more 
detail, and perform qualitative analyses. At the end of chapter 7, a description of 
implications and recommendations for clinical practice is provided.
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SAMENVATTING
Het doel van dit proefschrift was om het psychosociale welzijn van kinderen met 
een aangeboren of verworven hartziekte te onderzoeken en te verbeteren. De 
algemene inleiding in hoofdstuk 1 beschrijft de achtergrond en hoofddoelen van de 
studies die opgenomen zijn in dit proefschrift. ‘Aangeboren hartafwijking’ (AHA) is 
een overkoepelende term die verschillende afwijkingen beschrijft in de bouw van 
het hart en/of de grote intrathoracale bloedvaten. AHA’s ontstaan per definitie 
voor de geboorte. AHA’s zijn de meest voorkomende aangeboren afwijking: 
naar schatting 8 van de 1.000 levendgeborenen hebben een AHA. Kinderen 
met een AHA hebben een verhoogd risico op emotionele en gedragsproblemen 
(met name internaliserende problemen), posttraumatische stresssymptomen, 
sociale problemen, schoolproblemen, verminderde fysieke activiteit en 
neuropsychologische problemen. Bovendien bieden mijlpalen zoals het starten 
van school grotere uitdagingen voor kinderen met een AHA en hun gezin dan 
voor gezonde leeftijdsgenoten en hun gezin. We weten hiernaast dat de mentale 
gezondheid van ouders invloed heeft op het welzijn van hun kinderen. Ouders 
van kinderen met een AHA hebben zelf ook meer kans op psychische problemen. 
Voorheen is, om het psychosociale welzijn van kinderen met een AHA en hun gezin 
te verbeteren, het multidisciplinaire Congenital Heart Disease Intervention Program 
(CHIP) - School ontwikkeld door prof. dr. McCusker en zijn collega’s van het Royal 
Belfast Hospital of Sick Children in Ierland. De CHIP-School interventie had als 
doel het psychosociale welzijn te verbeteren van ouders van kinderen met een 
AHA die voor het eerst naar school gingen, en beoogde indirect het welzijn van 
de kinderen te verbeteren. Hoewel CHIP-School positieve resultaten behaalde 
met betrekking tot de mentale gezondheid van moeders, belasting van het gezin 
en schoolabsentie, nam het psychosociale welzijn van de kinderen niet significant 
toe. Om deze resultaten te verbeteren, hebben we het CHIP-School programma 
uitgebreid door een module met oefeningen voor jonge kinderen met een AHA en 
hun broers en zussen in het programma op te nemen. Deze vernieuwde interventie 
heet “CHIP-Familie”. Vervolgens hebben we, zoals beschreven in dit proefschrift, 
onderzocht of deelname aan CHIP-Familie het psychosociale welzijn van jonge 
kinderen (4-7 jaar oud) met een AHA en hun families verbeterde.
Daarnaast zijn verhoogde niveaus van posttraumatische stresssymptomen 
en posttraumatische stressstoornis (PTSS) beschreven bij kinderen die een 
ziekenhuisopname of medische procedures hebben ondergaan. Bij volwassenen 
is de effectiviteit van eye movement desensitization and reprocessing (EMDR) in 
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8het behandelen van posttraumatische stresssymptomen en PTSS al aangetoond. 
Bij kinderen zijn er nog relatief weinig studies gedaan naar EMDR, maar de 
resultaten van de beschikbare studies zijn veelbelovend. De in eerdere studies 
onderzochte trauma’s waren echter anders van aard (met name geweld, misbruik, 
of natuurrampen) en niet medisch gerelateerd. Daarom was een doel van dit 
proefschrift om de effectiviteit van EMDR bij kinderen met subklinische PTSS na 
een medisch gerelateerd trauma te onderzoeken. Een deel van de deelnemers aan 
dit onderzoek betrof kinderen met een AHA. De nadruk lag op subklinische PTSS, 
omdat subklinische PTSS vaak wordt onderschat, maar kan leiden tot vergelijkbare 
beperkingen als een klinische PTSS.
Een ander doel van dit proefschrift was het bestuderen van emotionele en 
gedragsproblemen van kinderen met gedilateerde cardiomyopathie (DCM). 
Cardiomyopathie is een aandoening van de hartspier. DCM is het meest 
voorkomende type bij kinderen en treft ongeveer 0,57 tot 0,73 per 100.000 
kinderen per jaar. DCM heeft over het algemeen een slechte prognose en is de 
meest voorkomende reden voor een harttransplantatie. Eerder onderzoek heeft al 
aangetoond dat kinderen met DCM een lagere gezondheidsgerelateerde kwaliteit 
van leven (GKvL) hebben dan hun gezonde leeftijdsgenoten en dat fysieke GKvL 
mortaliteit en harttransplantatie voorspelt. Omdat er echter weinig onderzoek 
gedaan is naar emotionele en gedragsproblemen bij kinderen met DCM, hebben 
wij onderzoek gedaan naar deze problemen en de resultaten in dit proefschrift 
beschreven.
Hoofdstuk 2 beschrijft de resultaten van onze klinische open trial van het 
eerder ontwikkelde cognitief gedragstherapeutische (CGT) Fijn VRIENDEN-
programma voor kinderen van 4-8 jaar met een angststoornis. We wilden de 
resultaten na het volgen van het Fijn VRIENDEN-programma onderzoeken bij 
kinderen met een angststoornis. Daarnaast waren wij in de resultaten van het 
Fijn VRIENDEN-programma geïnteresseerd, omdat verschillende oefeningen 
van het Fijn VRIENDEN-programma werden opgenomen in de CHIP-Familie 
interventie voor jonge kinderen met een AHA en hun broertjes en zusjes. In onze 
open trial onderzochten we of emotionele en gedragsproblemen van 28 jonge 
kinderen (4-8 jaar oud) met angststoornissen afnamen na het voltooien van het 
CGT Fijn VRIENDEN-programma. Dit programma bestaat uit 12 wekelijkse 1,5 
uur durende groepssessies die gegeven werden aan groepen van 3 tot 5 kinderen. 
Van pre-interventie tot directe post-interventie lieten ouderrapportages op de 
Child Behavior Checklist (CBCL) significante verminderingen zien met betrekking 
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tot algehele emotionele en gedragsproblemen, internaliserende problemen en de 
score op de DSM-schaal angstproblemen, terwijl de scores op de empirische schaal 
angstig/depressieve problemen en externaliserende problemen niet significant 
verminderden. Bovendien nam het gemiddelde aantal angststoornissen en de 
symptoominterferentie aanzienlijk af, zoals bepaald met het Anxiety Disorders 
Interview Schedule for Children (ADIS-C). Onze resultaten zijn grotendeels in lijn 
met eerdere bevindingen betreffende het Fijn VRIENDEN programma. Uit eerdere 
onderzoeken met kinderen van 8-12 jaar is echter gebleken dat het VRIENDEN 
voor het Leven-programma, waarop Fijn VRIENDEN is gebaseerd, positieve 
resultaten behaalde met betrekking tot depressieve problemen. Vermoedelijk 
namen depressieve en externaliserende problemen niet significant af in onze studie 
omdat onze deelnemers geen hoge niveaus van depressieve of externaliserende 
problemen hadden voorafgaand aan de interventie.
Hoofdstuk 3 beschrijft het studieprotocol van ons gerandomiseerd gecontroleerd 
onderzoek (RCT) naar de effectiviteit van het multidisciplinaire psychosociale CHIP-
Familie programma voor jonge kinderen met een AHA en hun gezin. Drieënnegentig 
gezinnen werden gerandomiseerd in de controlegroep (“alleen” medische zorg) 
of in de CHIP-Familie groep. CHIP-Familie bestond uit een oudermodule en een 
kindermodule. De oudermodule bestond uit een groepsworkshop van 6 uur en 
een individuele vervolgsessie één maand na de workshop. In de groepsworkshop 
gaven twee psychologen voor psycho-educatie en bespraken en oefenden ze 
probleempreventietechnieken en opvoedvaardigheden. Een kindercardioloog 
besprak in bijzijn van een psycholoog medische en psychosociale kwesties. In 
de vervolgsessie bespraken ouderparen de probleempreventie thuisopdracht, 
resterende vragen en toekomstige copingstrategieën met twee psychologen. De 
kindermodule bestond uit een 6 uur durende groepsworkshop waaraan kinderen 
met een AHA deelnamen met een broer of zus of vriend(in). Twee psychologen 
leerden de kinderen CGT-technieken aan door middel van oefeningen uit het Fijn 
VRIENDEN protocol (bijvoorbeeld helpende gedachten, ontspanning, omgaan 
met emoties). Ook deden de kinderen in de aanwezigheid van hun ouders 
sportoefeningen met een kinderfysiotherapeut. Bij baseline en na 6 maanden 
werden vragenlijsten ingevuld door ouders, leerkrachten en de kinderen zelf. 
Primaire uitkomstmaten waren de emotionele en gedragsproblemen van kinderen 
en de mentale gezondheid van de ouders. Secundaire uitkomstmaten hadden 
betrekking op het functioneren van het gezin, functioneren op school, plezier 
in sport en kwaliteit van leven van het kind, ouderlijke zorgen, ziekte specifieke 
kennis, kwaliteit van leven van het ouders en tevredenheid over het programma.
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effectiviteit van CHIP-Familie (CHIP-Familie groep: N=49 versus controlegroep: 
N=44). Hoewel deelnemende ouders CHIP-Familie positief beoordeelden 
(gemiddelde beoordelingen 7,4 tot 8,1 op een 10-puntsschaal), leverde het 
programma vergeleken met de gebruikelijke zorg geen significante verbeteringen 
op bovengenoemde uitkomstmaten. Echter, in zowel de controle- als de CHIP-
Familie groep rapporteerden vaders en moeders een significante vermindering 
in emotionele en gedragsproblemen van hun kinderen. Deze vermindering 
kan mogelijk worden verklaard vanuit ouders’ verhoogde bewustwording van 
emotionele en gedragsproblemen door deelname aan het onderzoek. Over het 
algemeen werden met CHIP-Familie minder positieve resultaten behaald dan met 
het eerder onderzochte CHIP-School programma. Dit kan verklaard worden vanuit 
verschillen in de protocollen en timing van de interventies. In CHIP-School was 
onder andere uit een fietstest voor kinderen opgenomen om overtuigingen van 
ouders met betrekking tot de kwetsbaarheid van hun kind op de proef te stellen. 
De fietsproef kon om logistieke redenen niet worden opgenomen in het protocol 
van CHIP-Familie. Ook kan het toevoegen van een specifieke kindermodule het 
belang dat ouders zagen ten aanzien van de oudermodule hebben overschaduwd. 
Ten slotte ging een aantal kinderen die meededen aan het CHIP-Familie onderzoek 
ten tijde van het aanbieden van de interventie al naar school, terwijl alle kinderen 
in eerdere CHIP-School programma nog met school moesten starten.
In hoofdstuk 5 beschrijven we de resultaten van ons onderzoek naar het niveau 
van emotionele en gedragsproblemen bij kinderen met DCM (N=68, 1,5-18 jaar 
oud). Ook onderzochten we of depressieve en angstsymptomen, gecorrigeerd 
voor ernst van hartfalen, overlijden of harttransplantatie voorspelden. Vergeleken 
met normatieve data ondervond een significant groter deel van de jonge kinderen 
met DCM (d.w.z. 1,5- tot en met 5-jarigen) een klinisch of borderline niveau aan 
somatische klachten (24,3% versus 8,0%), terwijl een aanzienlijk kleiner deel 
externaliserende problemen vertoonde (5,4% versus 17,0%). Vergeleken met 
normatieve data vertoonde een significant groter deel van de oudere kinderen met 
DCM (d.w.z. 6- tot en met 18-jarigen) internaliserende problemen (38,7% versus 
17,0%), waaronder somatische, depressieve en angstproblemen.
De twee kleine eerder gepubliceerde studies vonden tegenstrijdige resultaten. 
De eerste studie toonde aan dat 50% (N=6 van de 12) van de kinderen met 
cardiomyopathie die op de wachtlijst stonden voor een harttransplantatie een 
klinisch niveau van emotionele en gedragsproblemen vertoonde. De tweede 
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studie, daarentegen, onderzocht specifiek het niveau van depressieve problemen 
in kinderen met DCM (N=15) en vond geen verhoogde klachten. Hiernaast vonden 
we in onze studie dat het risico op mortaliteit en harttransplantatie niet voorspeld 
werd door angst of depressieve problemen, maar wel positief geassocieerd was 
met de ernst hartfalen. In populaties van volwassenen met hartfalen is het verband 
tussen angst- en depressieve problemen en ongunstige klinische resultaten goed 
vastgesteld. Een verklaring voor het verschil met onze resultaten wat betreft de 
voorspellende waarde van angst- en depressieve problemen kan zijn dat ouders 
bij kinderen kunnen fungeren als een buffer door te compenseren voor de 
verminderde zelfzorg van kinderen met angstige en depressieve klachten.
In hoofdstuk 6 werden de korte termijn resultaten besproken van onze RCT naar de 
effectiviteit van EMDR bij kinderen met medisch gerelateerde subklinische PTSS. 
Na het screenen van 399 kinderen randomiseerden we 74 kinderen (4-15 jaar oud) 
met subklinische PTSS na minimaal één ziekenhuisopname in een controlegroep 
(N=37; “alleen” medische zorg) of EMDR-behandeling (N=37). Om symptomen van 
posttraumatische stress, angst, depressie en slaapproblemen te meten, vulden 
ouders en kinderen vragenlijsten in bij baseline en ongeveer 10 weken na de start 
van de EMDR. Kinderen in zowel de controle- als de EMDR-groep gingen significant 
vooruit op alle uitkomstmaten. Kinderen in de EMDR-groep vertoonden echter 
significant grotere vooruitgang met betrekking tot bloed-injectie-letselfobie en 
depressie (gerapporteerd door kinderen) en met betrekking tot slaapproblemen 
(gerapporteerd door kinderen en ouders). Mogelijk kan psycho-educatie voldoende 
zijn om PTSS-symptomen te verminderen bij kinderen met subklinische PTSS.
In de algemene discussie in hoofdstuk 7 hebben we de belangrijkste bevindingen 
van dit proefschrift samengevat en besproken en hebben we aanbevelingen gedaan 
voor toekomstig onderzoek en de klinische praktijk. Om psychosociale interventies 
voor kinderen met hartafwijkingen te verbeteren, moet rekening worden gehouden 
met de doelgroep, inhoud, wijze van aanbieden en timing. Met betrekking tot de 
doelgroep is algemeen bekend dat een dergelijke interventie gezinsgericht moet 
zijn. Onze resultaten geven echter aan dat het rechtstreeks betrekken van jonge 
kinderen bij een interventie niet noodzakelijkerwijs de effectiviteit van een 
interventie verbetert. Wat betreft de inhoud van de interventie, hebben CGT en 
probleempreventietherapie de meest positieve resultaten laten zien. Omdat de 
problemen die kinderen met een AHA ondervinden een breed scala van medische 
en psychosociale kwesties omvatten, is het nuttig om professionals uit meerdere 
disciplines te betrekken. In onze CHIP-Familie studie werden de psychosociale en 
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8medische onderwerpen besproken door een kindercardioloog en het bespreken 
van dergelijke onderwerpen met andere families het nuttigst geacht. In het CHIP-
School-onderzoek werd de fietsstresstest echter als het nuttigste onderdeel 
beoordeeld. Bovendien kan een interventie met meerdere sessies nodig zijn om 
de resultaten van de kinderen verder te verbeteren. Nu waren de CGT oefeningen 
immers samengevoegd in één korte sessie (4 uur). Wat betreft het format waarin de 
interventie wordt aangeboden werd het groepsformat zeer op prijs gesteld door 
ouders. Mogelijk zorgt een grotere groep, zoals in CHIP-School gebruikt werd, 
voor meer ondersteunende impact, terwijl dit ook de persoonlijke aandacht kan 
verminderen. Een online evidence-based patiënteninformatieportaal biedt mogelijk 
voldoende ondersteuning voor kinderen en tieners met subklinische psychologische 
symptomen. Wat de timing van een psychosociale interventie betreft, heeft vroege 
interventie bij kinderen een aantal voordelen. Vroege interventie kan voorkomen 
dat aandoeningen chronisch worden en door vroege interventie kunnen de 
effecten worden geoptimaliseerd, omdat problemen minder diepgeworteld zijn 
en de neuroplasticiteit hoger is. CHIP-School heeft echter mogelijk meer positieve 
resultaten behaald dan CHIP-Family doordat de interventie meer specifiek was 
gepland voor een ontwikkelingstransitie. Wat EMDR betreft, suggereerden onze 
resultaten dat de afname van depressieve en slaapproblemen groter was als er 
meer tijd was verstreken sinds de laatste medische gebeurtenis.
De studies beschreven in dit proefschrift dragen bij aan de beperkte kennis die 
nu beschikbaar is wat betreft psychosociale interventies voor kinderen met 
hartafwijkingen. Van zowel de CHIP-Familie als de EMDR-interventie waren de 
behandelintegriteit en de tevredenheid van ouders hoog. Bovendien was ons 
onderzoek naar de effectiviteit van CHIP-Familie het eerste onderzoek dat een 
psychosociale interventie onderzocht met een specifieke module voor kinderen 
met een AHA. De EMDR-studie was de eerste studie die EMDR onderzocht bij 
kinderen met medisch gerelateerde subklinische PTSS. Bovendien hebben we 
in de CHIP-Familie, EMDR en de DCM-onderzoeken deelnemers uit meerdere 
centra vanuit heel Nederland geworven, wat de generaliseerbaarheid van onze 
bevindingen ten goede komt. Een ander sterk punt is dat, gezien de prevalentie 
van DCM en vergeleken met eerder onderzoek, onze onderzoeken naar EMDR en 
DCM substantiële steekproefgroottes gebruikten.
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In de toekomst is een RCT nodig om de effectiviteit van Fun FRIENDS te kunnen 
bepalen bij de behandeling van angststoornissen. Wat betreft kinderen met 
hartafwijkingen, zou toekomstig onderzoek moeten investeren in het ontwikkelen 
en testen van effectieve psychosociale interventies. De toegevoegde waarde van 
een specifieke kindermodule moet ook nog worden onderzocht. Verder zou het 
waardevol zijn om te onderzoeken welke kinderen en gezinnen voldoende baat 
hebben bij alleen psycho-educatie. Met betrekking tot EMDR moet de beste 
timing voor de behandeling van kinderen nader worden bestudeerd. Wat DCM 
bij kinderen betreft, moeten nog veel psychosociale aspecten worden onderzocht. 
Toekomstig onderzoek moet zelfrapportage van kinderen met betrekking tot 
emotionele en gedragsproblemen, het verband tussen de ernst van de ziekte en 
het niveau van emotionele en gedragsproblemen en leeftijdsverschillen in meer 
detail onderzoeken en kwalitatieve analyses uitvoeren. Aanbevelingen voor de 
klinische praktijk worden gegeven aan het einde van hoofdstuk 7.
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